Multifunctional mesoporous nanoparticles for catalysis, sensing and drug delivery applications by Niedermayer, Stefan
DISSERTATION ZUR ERLANGUNG DES DOKTORGRADES
DER FAKULTÄT FÜR CHEMIE UND PHARMAZIE
DER LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN
MULTIFUNCTIONAL MESOPOROUS
NANOPARTICLES FOR CATALYSIS,
SENSING AND DRUG DELIVERY
APPLICATIONS
STEFAN NIEDERMAYER
aus
Rain am Lech
2013

Erklärung
Diese Dissertation wurde im Sinne von § 7 der Promotionsordnung vom 28. Novem-
ber 2011 von Herrn Prof. Dr. Thomas Bein betreut.
Eidesstattliche Versicherung:
Diese Dissertation wurde eigenständig und ohne unerlaubte Hilfe erarbeitet.
Ort, Datum Unterschrift
Datum der Einreichung: 14.11.2013
1. Gutachter: Prof. Dr. Thomas Bein
2. Gutachter: Prof. Dr. Christoph Bräuchle
Tag der mündlichen Prüfung: 17.12.2013
ii
Danksagung
Diese Arbeit wäre nicht möglich gewesen ohne die Unterstützung von vielen Leuten,
welchen ich meine tiefste Dankbarkeit aussprechen möche.
Als Erstes möchte ich mich bei meinem Doktorvater Professor Thomas Bein für
die Aufnahme in seine Forschungsgruppe sehr herzlich bedanken. Die steten Diskus-
sionen über laufende Projekte und vor allem das Vertrauen in den Erfolg von selbst
erdachten Forschungsarbeiten haben mich sehr motiviert. Ausserdem bedanke ich
mich für die Unterstützung bei meinem Stipendienantrag, sowie für die unermüdliche
Hartnäckigkeit bei dem ”Kampf" mit der Personalabteilung um meine vertragliche
Einstufung. Auch für die Möglichkeit, meine Projekte auf zahlreichen Konferen-
zen präsentieren zu können, bin ich sehr dankbar. Highlights für mich waren hier
sicherlich die NanoHealth Konferenz in Seoul, sowie das MRS spring meeting in San
Francisco.
Professor Christoph Bräuchle möchte ich ebenfalls sehr herzlich für die exzellente
Zusammenarbeit danken. Durch die gemeinsame Kooperation und die stets sehr
interessanten Meetings konnte ich viel lernen. Zusätzlich bedanke ich mich sehr her-
zlich für die Erstellung des Zweitgutachtens.
Bei Professor Ernst Wagner möchte ich mich ebenfalls für die tolle Kooperation
und die Einführung in die Welt der Tierexperimente bedanken. Diese Experimente
haben uns grundlegende Einsichten über das Verhalten unserer Partikel in lebenden
Tieren gewährt.
Des Weiteren möchte ich Danke sagen bei Privatdozent Stefan Thalhammer für die
Kooperation im Dengue Fieber Projekt. Zusätzlich möchte ich mich noch für das
iii
Danksagung
Ausleihen der vier Taschenatlanten bedanken, welche es hoffentlich bei der Vertei-
digung zurück gibt.
Ein riesiges Dankeschön geht an Veronika Weiß für die unendlich vielen Zellbilder
meiner Partikel und der Bereitschaft immer wieder neue Experimente zu entwickeln
und durchzuführen. Ausserdem auch dafür Danke, dass Du mir nie böse gewesen
bist, wenn die Proben mehr Bakterien als Partikel enthalten haben.
In Verbindung mit diesem Projekt gilt mein Dank auch Annika Herrmann und Dr.
Daniel Edinger aus der Gruppe von Professor Ernst Wagner. Vielen Dank für die
viele Zeit (vor allem von Annika im Tierstall), die sofortige Bereitschaft an dem
Projekt zu arbeiten und natürlich mir immer wieder zu erklären welches Signal zu
welchem Organ in den Tieren gehört.
Aus der Gruppe von Stefan Thalhammer möchte ich mich ganz herzlich bei Elisan-
gela Linares für die tolle Kooperation und die Ausdauer, nach den anfangs nicht
gerade ermutigenden Ergebnissen, bedanken. Schön dass es sich am Ende gelohnt
hat immer wieder neue Dinge zu testen.
Aus der eigenen Gruppe möchte ich mich für die Kooperation mit Dr. Benjamin
Mandlmeier bedanken. Durch die Zusammenarbeit konnten wir nicht nur eine
Publikation schreiben, sondern ich konnte mich dadurch auch über der Türe in
dem Labor im zweiten Stock verewigen. Meinem langjährigen Bürokollegen Benni
gilt neben dem Dank für die exzellente wissenschaftliche Zusammenarbeit, auch
besonderer Dank für die tägliche Kooperation an der Kaffeemaschine und dem
Geschirrspüler. Herzlichen Dank auch an Stefan und Andi für die Bereitstellung
der MIL-Nanopartikel und die interessanten Diskussionen zu diesem Thema. Be-
danken möchte ich mich auch bei Christian, Basti und Alex für die vielen lustigen
Tage und Wochen auf Konferenzen in der ganzen Welt. In diesem Zusammenhang
möchte ich mich ganz herzlich bei den Mitgliedern der MesoBio Subgroup, Anderl,
Axel, Valentina, Basti, Alex, Christian, Cindy, Karin, Noggi, Martina und Stefan
für die sehr unterhaltsamen und konstruktiven Gespräche bedanken. Vielen Dank
natürlich auch an den Rest der Gruppe für die lustige Zeit und dafür dass ich als
“Externer” so super aufgenommen wurde. Ganz besonders möchte ich mich auch
iv
Danksagung
bei meinen Bürokollegen, Johann, Benni, Fabi, Hans, Norma, Flo, Ilina, Enrico und
Mona für die tolle Zeit und die gebotene Abwechslung zum harten Laboralltag be-
danken. In diesem Zusammenhang bedanke ich mich auch beim Hedgefonds-Team,
unnamed, Flo, Team Amerika und BrinkyBain für die unzähligen Schneebälle und
Wassermelonen.
Ein herzliches Dankeschön geht an Basti für die vielen PovRay Kunstwerke, welche
ganz entscheidend zur Illustrierung der einzelnen Projekte beigetragen haben. Vie-
len Dank für die unzähligen Stunden die du hierfür am PC verbracht hast. Ganz
besonderer Dank gilt Tina dafür, dass sie sich um einfach ALLES kümmert und
uns Doktoranden das Leben so einfach wie möglich macht. Ausserdem kann man
Tina zu jeder Zeit aufsuchen und sie findet immer ein offenes Ohr für die Sorgen und
Nöte, nicht nur im wissenschaftlichen Sinn. Ebenso möchte ich mich bei Regina
bedanken. Insbesondere dafür dass Regina mir als verwaltungstechnischem Anal-
phabeten immer wieder (und wenn es sein musste auch wiederholt) erklärt hat, wie
welches Formular auszufüllen ist und mir somit viel Zeit und Nerven erspart hat.
Dank gilt auch meiner Bachelorstudentin Tanja, sowie meinen Praktikanten Sarah,
Marina, Martina, Carina, Sarah, Arne, Evelyn und Wenyu. Bedanken möchte ich
mich auch bei Evelyn für ihr Vertrauen, nach ihrem Praktikum auch noch ihre Mas-
terarbeit von mir leiten zu lassen.
Besonderer Dank gilt gilt meinen Elten für die tatkräftige Unterstützung in all den
Jahren. Vor allem bin ich sehr dankbar dass sie mir ermöglichten ein Semester in
Bath und zwei Semester in Paris zu studieren. Ihre persönliche und finanzielle Un-
terstützung und die Tatsache dass sie sich für meine Arbeit interessierten (auch,
wenn es manchmal nicht so leicht zu erklären war, was ich hier so treibe) machten
diese Arbeit überhaupt erst möglich.
Ausserdem möchte ich mich bei meiner geliebten Sabine für ihre stete Unterstützung
bedanken. Dir, liebe Sabine, danke ich von ganzem Herzen dass du immer für mich
da bist und dein Leben mit mir teilst. Ich freue mich schon sehr auf unsere gemein-
same Zeit im schönen Rain. Danke.
v
Danksagung
vi
Abstract
Mesoporous materials have attracted increasing attention in the past decades. Based
on host-guest interactions, many different applications in the fields of catalysis, drug
delivery, separation of fine chemicals, adsorption of biomolecules, or more recently,
water-splitting, photovoltaic and energy storage have been demonstrated with this
class of materials. Infiltration of the mesoporous frameworks can lead to composites
with properties that differ from the individual bulk materials. Hence, knowledge
about the interactions of the guest species with the pore walls plays an important
role for the creation of new systems. The synthesis of mesoporous nanoparticles
offers the possibility to design concepts that can be used in targeted drug delivery
and biological sensing applications.
The present work is focused on the synthesis and modification of nanometer-sized,
mesoporous materials and their investigation for the use in biocatalysis, targeted
drug delivery and immunoassay applications.
Information on the pH inside the pores of mesoporous silica particles was gained by
infiltration with pH indicator molecules. With this approach, we could show that
the pH inside the pores of mesoporous silica immersed in buffer solutions may differ
significantly from the bulk pH, depending on the pore size of the material and the
ionic strength of the buffer solution. Covalent attachment of catalytic centers within
the mesopores allowed us to investigate the impact of pore wall functionalization on
the catalytic performance of the catalyst-silica composite material.
In a second project, a cap system for nanosized mesoporous carbon spheres was
developed. It was demonstrated that surface oxidation of carbon spheres synthe-
sized by an inverse opal templating technique results in stable colloidal suspensions
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of single particles that can be sealed with a supported lipid bilayer. For the first
time we were able to show successful capping and on demand release of guests from
mesoporous carbon materials.
pH-responsive release of different cargos and targeting of specific cells was inves-
tigated in a joint project between the groups of Prof. Bein, Prof. Bräuchle and
Prof. Wagner. We developed a modular toolbox based on a mesoporous silica core,
capped with a pH-responsive polymer. The use of bifunctional polymers allowed the
sequential attachment of different functionalities, depending on the final task of the
delivery vehicle. With this system, we were able to demonstrate successful delivery
of different cargos into living cells and targeting thereof. Animal experiments in
mouse models revealed an excellent biodistribution of the nanocarriers, as well as
succcesfull targeting of KB breast cancer in vivo.
This concept of pH-responsive capping of nanoparticles with polymers was trans-
ferred to a different class of material. We used crystalline metal-organic framework
nanoparticles, to create a drug delivery system based on this material. The particles
were functionalized with the same polymer-based cap system that was developed for
mesoporous silica. In this project, we could demonstrate on demand release of fluo-
rescent dyes as model drugs upon changing the pH of the media.
Finally, together with the group of PD Dr. Stefan Thalhammer we introduced a
completely new field of application for mesoporous silica nanoparticles. By incor-
poration of catalytic centers into the cores and attachment of recognition sites to
the outer surface, we were able to demonstrate the use of these multifunctional
nanoparticles in immunoassay applications. Compared with state of the art detec-
tion systems for NS1 antigens, we were able to show enhanced performance of our
system.
To summerize, three different topics were investigated in this thesis. In a first
project, we could gain insights into the behavior of catalytic centers within diffe-
rently functionalized mesoporous silica. In further projects, a variety of drug delivery
systems was introduced. Additionally, we introduced a completely new field of appli-
cation for mesoporous silica nanoparticles aimed at immunoassay based biosensing.
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Chapter 1
Introduction
1.1 The history of porous materials
Before 1992, two classes of materials were used extensively as heterogenous cata-
lysts, adsorption media and ion exchangers. These materials consisted of micro-
porous (pore diameters ≤ 20 Å) and mesoporous (∼ 20-500 Å) inorganic solids. [1,2]
In the last 20 years, advances in various fields such as hydrogen storage, [3–5] heat
storage, [6] photovoltaics, [7,8] chemical sensors, [9–11] nanodevices [12,13] and medical ap-
plications [14,15] require the development of ordered porous materials with controllable
size and pore morphology. [16] Zeolites, having pore diameters in the range of 0.5 to
1 nm, have pores which are too small for immobilization of enzymes, antibodies
or the controlled release of large molecules. Therefore mesoporous silica materi-
als with larger pore diameters had to be developed. In their well-known paper,
Kresge and co-workers from Mobil Oil company introduced a means of combining
sol-gel chemistry with liquid-crystalline templating to create a novel type of silica-
based molecular sieves named the M41S family including MCM-41 (MCM = Mobile
Composition of Matter), with 2D hexagonal pore arrangement, MCM-48 with a 3D
cubic pore system and MCM-50 with a 1D arrangement of layered sheets. [1,17] In
this type of material, the pores were templated by surfactants, whereas the walls
were build from amorphous silica. After removal of the surfactant, an open porous
structure with an internal surface area of around 1000 m2g−1 and pore diameters
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in the range of 3-5 nm were obtained. Subsequently different synthesis strategies
and numerous kinds of surfactants were developed. Today, it is possible to syn-
thesize materials with pore sizes in the range of 2-50 nm, and pore arrangements,
particle sizes and shapes [16] that are tailor-made for many applications of interest
like controlled release, [18] immobilized enzymes for catalysis, [19,20] or the growth of
nanowires within the confined space of cylindrical mesopores. [21–23]
In the late 1980’s, advances in the synthesis of zeolites drew academic attention to-
wards the synthesis of new classes of porous materials. [24–26] A very important class of
porous compounds was introduced in 1995 by Yaghi et al.. [27] The concept of ”metal
organic frameworks” (MOFs) is based on the formation of a three-dimensional hy-
brid framework consisting of inorganic metal ion centers and organic linkers. These
frameworks typically consist of di-, tri-, or tetravalent metal centers connected by
chelating organic linker molecules. As chelating groups carboxylates, phosphonates,
sulfonates and nitrogen derivatives have been reported. [25,28] Similar to the deve-
lopment of zeolites, the first published examples of MOFs showed microporosity. A
few years later, Ferey et al. reported the first mesoporous MOF with a pore size of
≥ 2 nm. [29] Moreover, this new ”MIL” (Materiaux de Institut of Lavoisier) was the
first crystalline mesoporous solid. [30] The MOF material with the largest pores so
far was reported by Deng et al. with an average pore size of 9.8 nm which is large
enough to incorporate proteins like GFP. [31] Related to the concept of metal organic
frameworks, Yaghi et al. developed porous materials with covalent bonds instead of
coordinative bonds. This material was named covalent organic frameworks (COFs)
and can be obtained by the reversible condensation reaction of organoboronic acids
with diol-moieties. [32] With this approach 1D porous networks can be synthesized.
Linear pores are formed via π − π interactions between the layers. Dogru et al.
showed the great potential of these materials as conducting and light absorbing
electrodes in photoelectronic devices. [33]
2
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1.2 The synthesis of mesoporous silica materials
Mesoporous silica materials are usually synthesized via a liquid-crystal templating
approach, in which alkoxysilanes condense around a template that determines the
final shape of the pores. As template materials, surfactants or combinations of
surfactants and small molecules are used. Cooperative self-assembly and ”true”
liquid-crystal templating processes are the two main pathways in the synthesis of
mesoporous structured materials, as shown in Figure 1.1. [16]
Figure 1.1: Two strategies for the synthesis of mesoporous materials: (A) cooperative self-assembly; (B) ”true”
liquid-crystal templating process. [16]
Condensation of the silica source can either be acid or base catalyzed, and water
or alcohols are usually used as solvents. Many different synthesis protocols have been
described, depending on the nature of surfactant and precursor molecules. [16,34,35] In
the case of cationic surfactants, strong ionic interactions between the positively
charged headgroup of the template (e. g. CTAC, CTAB) and the negatively charged
oligosilicates strongly influence the formation mechanism of mesoporous silica, and
no initial liquid crystalline phase is required. [36,37] Coulomb forces lead to an assem-
bly of positively charged headgroups of the template around negatively charged silica
oligomers. This balance in charge drastically reduces the template’s solubility within
the aqueous reaction mixture and leads, as a result of optimization of the interfacial
3
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energy, to the formation of micelles. The final mesostructure is formed by further
polymerization of the silicate species (Figure 1.1 A). [16] The second prominent path-
way discussed in the literature is called the ”true"’ liquid crystal templating pathway.
Here, true or semi-liquid-crystal mesophases are already present under the reaction
conditions, which often requires high concentrations of usually nonionic surfactants
(e. g. Pluronic P123, F127) as templates. [38] Condensation of inorganic precursors
around these liquid crystals leads to frameworks with amorphous pore walls (Figure
1.1 B). [16] The evaporation induced self assembly method (EISA), which is used in
the preparation of mesoporous silica films can also be assigned to this pathway. [39,40]
1.3 Mesoporous silica nanoparticles
In the early stage of mesoporous silica research, the main focus was based on the
development of materials with different pore sizes, morphologies and the formation
mechanisms thereof. The most famous families, MCM and SBA show particle di-
ameters in the micrometer range. Many applications such as drug delivery require
mesoporous nanoparticles with diameters in the range of 20-300 nm. With a care-
ful control of the self-assembly process and the silica condensation rate, not only
mesostructures and morphologies, but also the particle size can be tailored. [41] In
1999, Brinker and coworkers developed an aerosol-based procedure for the prepara-
tion of mesoporous silica nanospheres (MSNs) with different pore morphologies. [42]
This method relies on an EISA process taking place in the confined space of small
aerosol droplets (Figure 1.2).
Small droplets of a homogeneous water/ethanol solution containing silica pre-
cursors and surfactants in a concentration below the critical micelle concentration
are created by an atomizer and pass through a reaction chamber with different tem-
perature zones, followed by separation of the resulting particles. Using different
structure directing agents, lamellar, cubic or hexagonally ordered mesoporous silica
particles with a geometric size distribution of 2 were obtained. With this method,
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Figure 1.2: Left: Diagram of the aerosol reactor. Right: TEM micrographs of mesostructured nanoparticles
obtained with this method. [41,42]
particles with a size distribution around 120 nm and tunable pore sizes between 3
and 40 nm were synthesized.
Grun, [43] Cai, [44] Mann [45] and Ostafin [46] were the first who succeeded in the syn-
thesis of mesoporous silica nanoparticles from solution in a modified Stöber method.
Submicrometer sized MCM-41 spherical particles were prepared by Grün et al. in
a modified Stöber method simply by adding a cationic surfactant to the synthesis
mixture. [43] Uniform MSNs with different pore sizes and mesostructures were syn-
thesized from mixtures of alcohol, water, ammonia and different structure directing
agents. It was found that monodisperse MSNs are formed through aggregation of
small clusters during the initial stage of the synthesis. [47] By seperating the nuclei
formation from the particle growth, Mou et al. were also able to synthesize monodis-
perse MSNs. [48] The size of the MSNs could be modulated by the variation of the
pH in the reaction solution. [49] Lower pH values resulted in smaller particles due to
higher condensation rates and thus production of more nuclei.
Suzuki et al. synthesized MSNs with a dual surfactant system. In their approach a
cationic surfactant acting as structure directing agent and the non-ionic surfactant
Pluronic F127 serving as a steric stabilizer was used. Pluronic F127 formed a layer
around the surfactant-silicate hybrid material and suppressed grain growth, which
resulted in MSNs with a mean diameter of 50 nm in a concentrated solution. [50] Be-
sides non-ionic surfactants, other surface protecting agents like PEG, [51] L-lysine [52]
and triethanolamine (TEA) [53] were used to limit particle growth.
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1.4 Functionalization of mesoporous silica
For the incorporation of specific functionalities into mesoporous silica, reactive
groups bearing organic moieties have to be attached to the silica surface. Func-
tionality can be introduced via the modification of silanol groups present at the
surface. The groups show chemical reactivity and can be reacted with alkoxy- or
chlorosilane derivatives to introduce organic functionality via a condensation reac-
tion. Generally, two main approaches of modification exist: co-condensation and
postsynthethic grafting. [54]
Co-condensation. The co-condensation approach involves the condensation re-
action between tetraalkoxysilanes with organoalkoxysilanes (R’xSi(OR)4−x), which
results in a direct modification of the surface. [55] In a first step, the organosilanes
are hydrolyzed which changes their hydrophilic/hydrophobic balance. The resulting
hydroxysilanes serve as a cosurfactant that is incorporated via the organic residue
into the micelles. A major drawback of this method is the relatively low achievable
degree of functionalization as the incorporation into the micelles can lead to less or-
der of the mesoporous structure in the final material. On the other hand, sequential
co-condensation offers the possibility to synthesize mesoporous silica nanoparticles
with orthogonal functionalities in the pores and on the outer surface as shown in
figure 1.3. [56]
Figure 1.3: Co-condensation approach for the creation of core-shell-functionalized MSNs.
Postsynthetic grafting. In the postsynthetic grafting approach, mesoporous
materials are functionalized after synthesis. Hydroxyl groups present within the
mesopores and at the external surface are condensed with trifunctional organosi-
lanes R’Si(OR)3 in organic solvents. This method shows two major advantages
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compared to the co-condensation approach: First, maximal surface coverage can be
achieved without pertubation of the order of the mesoporous framework. Second,
further stabilization of the mesoporous framework by calcination can be conducted
prior to the functionalization. On the other hand, several drawbacks limit the use of
the postsynthetic grafting method compared to the co-condensation approach. Mul-
tilayer deposition of the organosilane can lead to a decrease in pore-size and to the
formation of bottle-necks at the entrance of the pores. As the whole surface of the
material is functionalized, the direct synthesis of core-shell-functionalized materials
is not possible.
More recently, alternative routes to achieve organic functionality on mesoporous ma-
terials have been reported. The direct formation of Si-C bonds with metalorganic
reagents like Grignard or organolithium compounds were introduced. [57,58] With this
method, multilayer deposition can be avoided, but the relatively harsh conditions
can lead to a partial degradation of the mesoporous material.
1.5 Targeted drug delivery with mesoporous silica
nanoparticles
In recent years, functional nanoparticles have attracted much attention in the fight
against various diseases including bone tissue engineering, [59] diabetes, [60,61] inflam-
mation [62] and cancer [63] which can be seen in the number of publications per year
(Figure 1.4). [64]
With the help of nanoparticles, drug molecules can be hidden inside the carrier
until the delivery vehicle has reached its target site. After arriving at the desired
tissue or single cells, the sealing of the nanoparticles needs to be opened either
independently or by an external trigger. Targeted drug delivery can offer several
advantages like reduced drug doses or minimized side effects. In this context, MSNs
contribute significantly to overcome several challenges due to their high internal sur-
face area and pore volume, tunable pore sizes, colloidal stability and the possibility
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Figure 1.4: Statistics of papers indexed in the ISI web of science by the topic of ”mesoporous silica" and ”drug
delivery". [64]
to attach different kinds of functionalities to a single particle. Since mesoporous
silica exhibits excellent biocompatibility, [65–67] it has been widely investigated as a
drug delivery platform in targeted drug delivery. [68–70] To be able to serve as a multi-
functional delivery tool, the final particle has to fulfill several requirements as shown
in figure 1.5. [71]
Figure 1.5: Cartoon of an ideal drug delivery vehicle based on MSN. [71]
In the cartoon, several different possible functionalizations are depicted. The ba-
sis of the system is built by a multifunctional mesoporous silica nanoparticle. Core-
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shell architecture with orthogonal functionalities offers the possibility to achieve
control over interactions of drug molecules with the pore walls whereas different
moieties can be selectively attached to the outer particle surface. To prevent prema-
ture release of the cargo (red) from the nanoparticles, gatekeeping molecules (blue)
need to be attached that enable opening and closing of the pores on demand. This
can be accomplished either by conformational changes of the gatekeeper itself or
by decomposition or changes in chemical properties of the linker molecule between
the MSN and the gatekeeper. Further attachment of fluorescent labels (yellow) al-
lows to track mechanisms of cellular uptake and quantification of MSNs within cells
with fluorescence spectroscopy. Targeting ligands (orange) enable attachment of
MSNs to specific receptors overexpressed on the desired cancer cell surface. Spacer
molecules (green) are essential to ensure good dispersability of the carrier system in
the body to avoid undesired agglomeration in healthy tissue. Optionally, if mem-
brane non-permeable molecules have to be delivered, a trigger for endosomal release
(purple) is required to release the cargo into the cytosol of the cancer cell. If it is
possible to implement all requirements mentioned above within a single particle, the
efficacy of state of the art therapy approaches can be significantly enhanced while
simultaneously reducing financial costs.
1.5.1 Stimuli-responsive gatekeeping systems
To achieve the final goal of targeted drug delivery, it is important to release the drug
only at the desired location under defined conditions. In the last 15 years many
different concepts of molecular capping systems were investigated, attracting re-
searchers from various scientific disciplines. So far, the most prominent release mech-
anisms include enzyme-responsive, redox-responsive, light-responsive, temperature-
responsive or pH-responsive systems of different kinds. Most gatekeeping systems
reported so far rely on the use of bulky object like proteins, cyclodextrins or in-
organic nanoparticles that block the pores after attachment to the external silica
surface. [72–75] Schlossbauer et al. reported on a delivery system based on the strong
interaction between biotin and avidin. [74,76] In a first publication, MSNs were reacted
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Figure 1.6: Concept of a programmable molecular valve system. The avidin caps are opened by melting the DNA
linkers at specifically chosen temperatures. [76]
on the outer particle surface with biotin. After loading of a fluorescent model drug,
avidin was added to seal the particles. Release experiments showed tight closure of
the system prior to the addition of the protease trypsin which led to degradation of
the protein cap. Based on these findings, a programmable temperature responsive
system was developed (Figure 1.6). In this approach, one strand of a double-stranded
DNA was attached to the outer surface of MSN. The second strand was functiona-
lized in a way that after hybridization of the DNA, biotin was located close to the
particle surface. In this system, the release depended on the melting temperature
of the DNA which depends on the length of the double-strands.
A redox-responsive release mechanism was studied by Lin et al.. CdS or iron
oxide nanoparticles were attached via a disulfide-bridge containing linker. They
were able to show a release of vancomycin and adenosine triphosphate upon addition
of reducing agents like mercaptoethanol or dithiothreitol that are able to reduce
disulfides to thiols. [72,77] Photoresponsive release of rhodamine B was introduced by
Zink et al. by using the fact that β-cyclodextrines (β-CD) show different affinity
towards azobenzenes in different conformational states. [78] The high affinity of β-CD
to trans azobenzenes was used to create a tight sealing around MSNs. Irradiation
of the sample led to a conformational change in the azobenzene unit resulting in
detachment of β-CD followed by the release of rhodamine B. Lin et al. showed
that gold nanoparticles attached via a photocleaveable linker to MSNs can act as a
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photoresponsive drug delivery vehicle (Figure 1.7). [79] By irradiation with UV-light,
the linker molecule is cleaved, resulting in a negatively charged part connected to
the gold nanoparticle that is repelled by the also negatively charged silica surface.
Figure 1.7: Cartoon of the construction and function of a photocleaveable delivery vehicle. [79]
In 2003, Tanaka and co-workers designed a photo-controlled reversible drug re-
lease system based on MCM-41 that does not rely on the concept of bulky stoppers
attached via cleaveable linker molecules to the particle surface. [80] They showed
that attachment of coumarin molecules to MCM-41 results in cyclobutane coumarin
dimers upon irradiation with UV-light (310 nm) followed by sealing of the pore
entrances of MCM-41. Reversible opening was achieved when the wavelength of
UV irradiation was changed to 250 nm. A similar approach without bulky gatekee-
pers was introduced by our group in which the pH-dependent release of ibuprofen
from MSNs was shown. [81] MSNs functionalized with aminopropyl-functionalities on
the outer surface were reacted with 4-sulfophenyl isothiocyanate. Closure was ob-
tained via the interaction of the sulfonic acid groups and the remaining protonated
aminogroups at the surface. The release of ibuprofen was triggered by an increase of
the pH in the solution leading to electrostatic repulsion of the sulfonic acid moiety
and the silica surface. A very sophisticated approach for sealing MSNs was reported
by Zink et al.. They designed a base-activated Curcurbit[6]uril (CB[6]) pseudoro-
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taxane cap-system attached to the silica surface via an azide-alkyne cycloaddition.
Upon deprotonation at pH 10, CB[6] detached from the surface resulting in a release
of the model drug (see Figure 1.8). [82] This concept was further developed into an
acid-activated cap system by the same group. [83] The organic chain was functiona-
lized in a way that it contains three ammonium moieties: two tetramethylene and
a terminal anilinium unit (see Figure 1.8). The function of the MSNs relies on the
difference in basicity of the anilinium nitrogen atom in comparison with the other
two tetramethylene nitrogen atoms. The anilinium nitrogen atom is approximately
106-fold less basic than the alkyl nitrogen, resulting in a deprotonation at neutral
pH of the former. Lowering the pH to the point were the anilinium nitrogen is
protonated leads to a release of the CB[6] followed by the release of the model drug.
Increasing the pH to a point where all three nitrogen groups are deprotonated leads
to a complete lift-off of the CB[6]-cap. Whereas the opening at low pH is reversible,
a complete loss of the cap is observed for high pH values.
A combination of the high loading capacity of MSNs with the exceptional bio-
compatibility of phospholipid bilayers was introduced by Brinker et al., the so-
called supported lipid bilayer (SLB). [84] The whole particle surface was completely
surrounded by a lipid bilayer made of 1,2-dioleolyl-3-trimethylammoniumpropane
(DOTAP) and 1,2-dioleolyl-sn-glycero-3-(phospho-L-serine) (DOPS) by an electro-
statically driven liquid exchange mechanism. In further publications, the successful
targeted delivery of different cargos into living cells was shown. [85,86] In our group,
the concept of SLB was extended by the attachment of photosensitizers that enable
endosomal escape. [87] Upon illumination with light (405 nm) singlet oxygen is pro-
duced by the photosensitizer which leads to a cascaded rupture of the SLB followed
by degradation of the endosomal membrane. Subsequently, the loaded drug can
diffuse out of the mesopores directly into the cytosol as shown in figure 1.9. Schloss-
bauer et al. were able to show the release of chromobodies and their subsequent
coordination to GFP-tubulin of HuH7 cells with this system.
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Figure 1.8: Cartoon of the construction of an pH-activated Curcurbit[6]uril capped MSN. [83]
In a further development of this project, large-pore MSNs were coated with a sup-
ported lipid bilayer. [88] As trigger for endosomal escape, a red-light-photosensitizer
was used. This system offers two major advantages: first, MSNs with larger pores
offer the possibility to deliver space-demanding cargos like proteins or RNA. Second,
the activation of the photosensitizer with red light instead of blue light reduces the
phototoxicity and significantly increases the depth of tissue penetration.
A different way to achieve full surface coverage of MSNs is the use of func-
tional polymer coatings. You et al. used the fact that Poly(N -isopropylacrylamide)
(PNIPAM) shows a change from a hydrated to a dehydrated state at the lower cri-
tical solution temperature (LCST) as demonstrated in Figure 1.10. [89] The resulting
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Figure 1.9: Left: Schematic representation of photoinduced delivery of chromobodies (red) and their subsequent
coordination to GFP-tubulin of HuH7 cells. Right: Confocal microscopy of living HuH7 cells exposed to MSNs
loaded with different model drugs. [87]
polymer-nanoparticle composite showed uptake and release of a model drug at tem-
peratures below the LCST (38 ◦C), whereas at temperatures above the LCST good
sealing of the pores was reported.
Figure 1.10: Schematic representation PNIPAM-polymer-nanoparticle composites. [89]
Using different polymers, Lopez and co-workers designed a system in which
release was observed at temperatures above the LCST. [90,91] Additionally redox-
responsive polymeric cap systems have been reported. [92] The system consists of
poly(N -acryloxysuccinimide)-grafted MSNs, in which the polymer was attached to
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the pore entrance. After loading of the model drug, the openings were blocked by
the addition of a disulfide-based bifunctional primary amine, leading to cross-linking
of the polymer. Addition of reducing agents like dithiothreitol led to reduction of
the disulfide bridges resulting in redox-controlled release of the model drug. Liu et
al. reported on pH-responsive release of model drugs out of poly(4-vinylpyridine)
(P4VP) capped MSNs. [93] P4VP was attached via multipoint anchoring of the amine
residue to the surface of brominated MSNs. At high pH, the deprotonation of the
polymer produced a hydrophobically collapsed state and inhibited the release of
trapped molecules. In the swollen state at low pH, the polymer was permeable to
molecular diffusion, leading to pH-controlled release.
1.5.2 Drug delivery without capping systems
Another possible approach to confine drugs is their covalent attachment to the pores
of MSNs. The major advantage of this approach is that synthetically demanding
gatekeeping systems are not necessary. As the delivered species themselves are re-
versibly attached to the pore walls, they have to feature at least one functional group
that allows for reversible binding. Using this approach, Lin et al. reported on the
successful delivery of the membrane impermeable thiol-containing aminoacid cystein
into living cells. [94] Cystein was reversibly attached to thiol functionalized MSNs via
disulfide bridges. These bridges can either be cleaved in vitro via addition of DTT
or in vivo by the reductive milieu of the cytosol. This approach was further inves-
tigated by live-cell imaging in our group as a joint project with the research group
of Prof. Bräuchle. [95] Direct immobilization of compounds is very interesting for the
delivery of sterically demanding molecules like proteins, as it is very challenging to
seal large-pore materials. Schlossbauer et al. have demonstrated the successful im-
mobilization and release of the bee venom melittin attached via an acetal linker. [96]
After acidification of the sample, the acetal linkers were cleaved and melittin was
able to diffuse out of the pores of SBA-15. Cell experiments showed that the pro-
tein retained its orignial function after the whole procedure. Gao et al. designed a
versatile pH-responsive system based on the coordinative bonding of metal ions to
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amino-groups in the mesopores. [97] Nitrogen-bearing guest molecules were immobi-
lized at free coordination sites of the metal forming a ”host-metal-guest" architec-
ture. Successful release of anticancer drugs bearing coordinatively binding groups
was achieved by lowering the pH. Light induced cis-trans isomerization of azoben-
zenes (”nanoimpellers") was proven to accelerate the release of small molecules from
mesopores (Figure 1.11). [98] Continuous illumination at 413 nm causes a constant
cis-trans photoisomerization about the N=N bond causing dynamic wagging motion
resulting in a release. Without illumination, premature release was almost negligible.
Figure 1.11: Schematic representation of the light driven nanoimpellers. [98]
1.5.3 Targeting of cancer cells
One of the biggest challenges in targeted drug delivery with nanoparticles is to
achieve sufficiently high local drug concentrations in tumors, while sparing healthy
tissue. In anticancer therapy, limited selectivity of cytostatins and cytotoxins to-
wards tumor cells is responsible for many undesired side effects. The therapeutic
index is determined by biodistribution, metabolism, and clearance of nanoparticu-
late drug delivery systems. [99] Nanoparticles have to pass different barriers before
reaching the desired location (Figure 1.12).
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Figure 1.12: In vivo barriers encountered by nanometer-sized drug delivery systems after systemic administration
for cancer therapy and the nanotechnology-based strategies developed for targeted cancer therapy. [99]
Precise understanding of these barriers is crucial for designing nanoparticles with
the ability to bypass these barriers and reach cancer cells, as these barriers are
highly efficient in removing foreign materials including nanoparticles from the body.
Passive targeting relies on the abnormal vascular structure of tumor tissue, which
results in substantial advantages for nanoparticulate drug delivery systems with sizes
ranging from around 30 to 400 nm, and allows nanoparticles to accumulate in the
interstitial tumor space. [100] Enhanced permeability and retention (EPR) describes
passive accumulation of nanoparticles in tumor tissue. Despite the EPR effect,
difficulties still exist for homogeneous distribution of nanoparticles in all regions of
tumor tissue. [99] The limitations in EPR lead to the development of active targeting.
Due to the high metabolic demands for rapid proliferation, cancer cells generally
overexpress folate, transferrin, epidermal growth factor or ανβ3 receptors. [87,101–103]
In this context, nanoparticles functionalized with specific antibodies, peptides, li-
gands, aptamers and oligonucleotides were developed to bind selectively to receptors
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overexpressed on certain cancer cells (Figure 1.12). An efficient uptake of folic acid-
modified nanoparticles compared with unfunctionalized ones was demonstrated by
Linden et al.. [104] Others have reported successful targeting of the ανβ3 receptor
with arginine-glycine-aspartate tripeptide (RGD) modified MSNs.
Figure 1.13: Left: Cartoon of the used delivery vehicle. Right: Unspecific and receptor-mediated endocytosis of
particles with folic acid ligand (b) by KB cells and particles with EGF ligand (d) by HuH7 cells with GFP tagged
tubulins (HuH7tub), respectively. Uptake of particles without targeting ligand is shown in a) and c). [88]
Recently our group together with the group of Prof. Bräuchle showed that MSNs
coated with a lipid bilayer can serve as a versatile platform for the attachment
of different targeting ligands (Figure 1.13). [88] Lipid functionalized folic acid and
EGF ligands were introduced into the delivery vehicle via diffusion. A significantly
enhanced uptake into cancer cells could be observed with live-cell imaging. Wagner
et al. have shown the uptake and gene transfection efficiency in cells of DNA-
polyplexes conjugated with EGF. [105]
1.6 Immobilization of proteins in mesoporous silica
In 1916, the first example of protein immobilization was reported. Nelson et al.
showed that the activity of invertase can be retained after the attachment on char-
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coal. [106] The main goals of immobilization are the enhancement of stability and the
simplification of enzyme recovery and reusability at high activity levels. Therefore,
many different immobilization techniques on numerous support materials have been
investigated. [107–121] An important aspect for the selection of a suitable mesoporous
support material for a specific protein involves the matching of the physicochemi-
cal properties of the protein and the support (Figure 1.14). [122,123] In an ideal case,
the active center of a protein is directed away from the mesoporous surface, with
sufficient mobility to retain its catalytic acitivity but without leaching from the
support.
Figure 1.14: Important factors for the generation of a novel immobilized protein biocatalyst. [122]
1.6.1 Size relation of the mesopores and the protein
Proteins only have access to the inner surface of mesoporous supports if the hydro-
dynamic diameter of the protein is smaller than the pore opening of the mesoporous
host. Otherwise proteins can only be adsorbed without further protection at the
outer surface of the material. Diaz et al. showed that horseradish peroxidase (mean
diameter ca. 4.6 nm) cannot be taken up by MCM-41 (pore diameter ca. 4 nm) as
it is too large to fit into the pores. [124] In similar experiments 8 µmol per gram of
cytochrome c could be adsorbed on MCM-41 with a pore diameter of 4.5 nm but
with smaller pores in the range of 2.8 nm, only less than 1 µmol g−1 was obtained at
same adsorption conditions. [125] These experiments show that matching the hydro-
19
Chapter 1. Introduction
dynamic diameter of the protein and the pore diameter is essential for obtaining high
loadings. However, loading is also strongly influenced by the accessible pore volume
and the specific surface area. The use of mesoporous silica for the immobilization of
antibodies in biosensors is limited by the pore size, although Hu et al. showed the
immobilization of an antibody fragment that showed good binding efficiencies for a
strong neurotoxin from shellfish. [126] The direct entry of proteins in sufficiently large
mesoporous structures still has to be proven by direct imaging of enzymes or proteins
inside the pores. [127] Up to now, entering of proteins into pores has been indicated
indirectly through higher loading capacities and enhanced stability compared with
nonporous reference samples. For DNA, Cauda et al. were able to visualize directly
the confined movement of a labeled DNA double strand in long-range ordered SBA-
15 fibers with single molecule fluorescent microscopy. [128] Takahashi et al. reported
that for enhanced activity in organic solvents and increased hydrothermal stabi-
lity of horseradish peroxidase, it is mandatory to have similar diameters of pores
and guest molecules. [129,130] Similar results regarding optimized fitting for enhanced
stability were published by other research groups. [131–134] Small pore openings can
reduce leakage of proteins which are not attached covalently to the host material.
However there still has to be enough space to ensure diffusion of the substrate. A
reduction of the diffusion ability would lead to a drop of catalytic activity. [132,135]
Additionally, the hydrophobic and hydrophilic nature of the substrate contribute
significantly to the activity of an immobilized enzyme. [125,132,134] Diffusion of a hy-
drophobic substrate can be slowed down in hydrophilic mesoporous silica structures.
This problem can be reduced either by increasing the pore diameter or modification
of the pore walls with hydrophobic residues. On the other hand, a hydrophilic sub-
strate is able to diffuse easily through small pores which offer better stabilization
for the immobilized enzyme.
1.6.2 Particle size and morphology
The pore volume of mesoporous supports after protein immobilization is often de-
creased by a larger extent than the corresponding volume occupied by the immobi-
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lized protein. [136,137] Materials with shorter mesoporous channels (smaller particles)
and similar pore volume show higher loading capacities (37 compared to 5 µmol per
gram SBA-15). The reason for that is a lower amount of blocked pores. [138] As a
consequence, the particle size and morphology need to be taken into account when
comparing adsorption in mesoporous materials. These two attributes significantly
influence adsorption isotherms, adsorption kinetics and specific activities of proteins
on mesoporous materials. [132,138–142]
1.6.3 Stability of the mesoporous material
To ensure reusability of an immobilized enzyme, the support material has to be
stable under working conditions. Degradation of the host material leads to a release
of the enzyme and therefore to a loss in activity after recovery. If the host material
is used as a release and rebind system, the mesoporous material has to maintain its
structure so that the protein is able to diffuse in after the reaction. [143] It has been
reported that SBA-materials are, due to their thicker walls, hydrothermally more
stable than MCM-materials. [137,144,145] However, inconsistant reports exist concer-
ning materials produced by different synthesis protocols. Ji et al. observed, similar
to Katiyar et al., that Al-MCM-41 is instable at pH-values above 9. [146,147] In con-
trast to these findings, Hernandez et al. reported the degradation of MCM-41 at
pH-values of 7.4. [148] Other groups used specific synthesis protocols to enhance the
hydrothermal stability of MCM-41 materials, e. g. zeolitic clusters were used as
silicon dioxide source in combination with numerous surfactants. [132] Periodic meso-
porous organosilicates with bridged amino-groups showed low stability at pH values
between 4-10. Through variation of the surfactant under identical synthetic con-
ditions, more stable materials were obtained in which chloroperoxidase could be
immobilized and recovered without loss of activity. [149]
1.6.4 Isoelectric points of mesoporous silica and protein
The isoelectric point (IP) of a particle or protein corresponds to the specific pH-
value at which the surface charge is zero. Below or above this pH-value, the protein
21
Chapter 1. Introduction
is either positively or negatively charged. It has been discussed that best adsorp-
tion behavior can be achieved in immobilization buffers with a pH below the IP of
the protein and above the IP of the support material. [124] At pH-values below the
IP of the protein, the enzyme will exhibit a net positive surface charge which fa-
vors interaction with the silica material that is negatively charged at pH > 3. [125,136]
Simulations with cytochrome c and trypsin showed that proteins with similar IP can
have different surface potentials at pH 7. [150] While compatible sizes and isoelectric
points are necessary for successful immobilization, they do not automatically lead
to adsorption. [126,151,152] Only low loading could be obtained for subtilisin, which is
small enough to fit into the pores of mesoporous silica modified with cyano groups,
even at appropriate pH-values. [136] Interactions between the two surfaces are influ-
enced by the surface charge density and charge distribution of the enzyme. These
aspects are not described accurately enough by the isoelectric point and need to be
determined more precisely to understand interactions with the surface of the support
material. The isoelectric point of mesoporous silica is often estimated to a value of
approximately 2, [143,153,154] as found for amorphous silica. [155] For MCM-41 Deere et
al. determined a value of 3.6, whereas for commercial silica and mesoporous silica
templated with F127 isoelectric points of 2.9 and 2.8 were found, respectively. [136]
Electrostatic interactions with proteins can further be tuned by the functionalization
of pure mesoporous silica with organic functional groups.
1.6.5 Functional groups at the surfaces of mesoporous silica
and proteins
Strong interactions between proteins and host materials can be obtained by com-
plementary functionalization. Mesoporous silica has been modified with various
different functionalities, which led to different loadings and activities depending on
the way and amount of modification. [149,151,156] However, residual solvent molecules
originating from the functionalization step can lead to a drop in activity. High de-
grees of modification can result in pore blocking or reduction of the pore diameter.
Further functionalization of the pores after protein immobilization can enhance the
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hydrophobicity or amphiphilicity of the support leading to better diffusion kinetics
of the substrate and products. [127,157,158] Covalent linkage of amino-groups at the sur-
face of the mesoporous support to amino-groups of the enzyme via glutaraldehyde
can significantly improve stability, reduce leakage and therefore enable reusabil-
ity. With this approach, many different enzymes like penicillin-G-acylase, [159,160]
glucose oxidase, [161] α-amylase, [162] lipase, [163] glucose isomerase, [164] trypsin, [135] in-
vertase, [165] and glucoamylase [165] have been covalently immobilized. 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) was used to covalently attach chloroper-
oxidase [133,166] and α-L-arabinofuranosidase [141] via amide bond formation between
the carboxylic acid groups of the enzyme and the amino-groups of the support ma-
terial. Proteins can furthermore be attached by reaction of epoxy-modified pores
with amino-groups of the protein, which was demonstrated for penicillin acylase. [167]
Schlossbauer et al. reported on the covalent attachment of alkyne modified trypsin
on azide functionalized SBA-15 via a “click chemistry” approach. [168] The enhanced
rigidity of the enzyme resulting from covalent immobilization can lead to decreased
activity as observed for penicillin acylase, [167] glucose isomerase [164] and trypsin. [168]
Furthermore, the effect of metal ions in mesoporous silica on the adsorption behavior
of proteins and enzymes has been investigated. Aluminum substituted mesoporous
silica has been used to immobilize enzymes like cytochrome c, [132] bovine serum al-
bumine, [146] lysozyme [137,145] and cytochrome P450. [148] Aburto et al. reported on
improved loading of chloroperoxidase on SBA-16 impregnated with Cs+. [133] The
creation of weakly acidic centers through functionalization of MCM-48 with Co2+
leads to better loading of penicillin-G-acylase as shown by Xue et al.. [169]
1.6.6 Interactions between proteins and support
It is difficult to gain detailed information about interactions between a protein and
its host material through loading experiments at specific conditions. In most cases
at least the differentiation between covalent attachment and physical adsoption can
be made. For explicit evaluation of the interactions of absorbed proteins with a sup-
port material such as hydophilic, hydrophobic or electrostatic interactions, different
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experiments have to be performed. Such experiments include the use of desorp-
tive agents like polyethylene glycol, methanol and ammonium sulfate, or the change
of the ionic strength of the immobilizaion buffer. [136,152,170] Depending on the host
material, cytochrome c shows distinct adsorption behavior. Diaz et al. reported
on hydrophilic interactions between cytochrome c and MCM-41. Investigations by
Deere et al. with desorptive agents revealed that electrostatic interactions between
cytochrome c and cyano-modified mesoporous silica play the most important role,
whereas with silica gel hydrophobic interactions are the most prominent. [124,136]
Other studies with cytochrome c on SBA-15 showed electrostatic, with ethylene
bridged periodic mesoporous organosilica hydrophobic/hydrophilic interactions. [123]
Highest loading capacities were found for pH values close to the point of zero charge
of the protein. At this pH, repelling forces between the protein molecules are mini-
mized and therefore loading is enhanced. Similar observations have been made for
the adsorption of lysozyme on MCM-41 and SBA-15. [137,147]
1.6.7 Preservation of the enzymatic activity after immobi-
lization
The activity of an immobilized enzyme can be influenced by the surface of meso-
porous materials. [135,160] It is difficult to obtain host-guest interactions that are on
the one hand strong enough to prevent leakage but on the other hand weak enough
to maintain enzyme flexibility and as a consequence thereof its activity. Evalu-
ation and interpretation of the activity of a leaking enzyme is in most cases not
feasible. Different strategies have been developed to prevent leakage, such as cross-
linking of the enzymes inside the pores (cross-linked enzyme aggregates, CLEAs)
or covalent attachment to the pores. [132,168,171,172] For α-chymotrypsin and mucor-
javanicus-lipase, cross-linking led to a material which showed enhanced stability
against shaking and degradation by trypsin. [132,171] After adsorption on MCM-48
and cross-linking, papain showed only 70% residual activity. However, enhanced
temperature- and pH-stability could be observed. The system could be recycled
for 12 days without further loss of activity. [132] Deere et al. reported on enhanced
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activity of cytochrome c after immobilization on mesoporous materials compared
to the free enzyme in solution, which is due to the high-spin-Fe3+ centers present
in the immobilized state. [136,173] Highest activities were obtained for low loadings
of cytochrome c, because access to the pores can be hindered through high load-
ings or multilayer adsorption. Enhanced protein activity has also been observed for
immobilized glucose oxidase, [132,152] microperoxidase-11 [174] and candida-antarctica-
lipase (CAL). [175] Altogether, enzyme activity depends on the enzymes’ nature, the
mesoporous support and the way of immobilization. Trypsin showed, after covalent
immobilization on SBA-15, only 17 % residual activity compared to the free en-
zyme. [168] Chloroperoxidase immobilized on mesoporous cellular foam showed only
half the activity of the free enzyme, [153] whereas covalent attachment to SBA-16
resulted in enhanced activity compared to the physically adsorbed enzyme. [133] A
loss in activity was found for penicillin acylase adsorbed on differently functionalized
SBA-15. Only vinyl-functionalized SBA-15 showed twice the activity as free peni-
cillin acylase. [159] For some proteins, e. g. α-chymotrypsin and aldolase-I-antibody,
enantioselectivity was maintained after immobilization. [131,176] Every system contain-
ing proteins on mesoporous supports shows different bahavior so that the relative
activity of each biocatalyst needs to be determined.
1.6.8 Reusability and enhanced stability of the biocatalyst
In biocatalysis with composite materials it is mandatory to immobilize the pro-
tein permanently on the support material. Enzymes washed out of the support can
hardly be separated from the reaction mixture. Immobilization inside mesopores can
increase the protein stability against heat, extreme pH values, denaturing agents and
organic solvents. Zheng et al. reported on the enhanced stability against heat under
ideal conditions (pH 8 in the presence of CTAB) for pseudomonas-cepacia-lipase. [177]
The loss in activity of 50 % after 8 cycles was explained by washing out of the enzyme
and incomplete recovery. α-chymotrypsin immobilized in MCM-41 could be used
over 100 cycles within one week. [131] A possibility to prevent leakage is the reduc-
tion of the pore openings by silanization after protein adsorption. [124,178] However,
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this process can lead to deactivation of the protein. As already mentioned for en-
zyme aggregates in subsection 1.6.7, immobilization can enhance storage properties.
Trypsin immobilized on MCM-41 remained active even after storage at 25 ◦C for
one week, whereas free trypsin was completely inactive. [124] For the use as biosensors
with immobilized proteins, storage stability is very crucial. Immobilized antibody
fragments preserved their binding affinity for 42 days, as reported by Hu et al.. [126]
Covalently attached enzymes, even if they show reduced activity, can be the cata-
lyst of choice due to the facile recovery, which makes them promising candidates for
several applications.
1.7 Nanoparticles for biosensing applications
Due to their unique properties, nanoclusters, nanoparticles and nanocomposites
have become very popular objects of study and also tools in research in many lab-
oratories. [179] Since nanoparticles feature sizes similar to biological macromolecules,
they have the ability to provide information about the studied system (e. g. liv-
ing cells) in the form of fluorescent emission or the release of certain compounds.
Recently, nanocomposites have found many practical applications, e. g., clinical di-
agnostics, [180] food safety control, [181] environmental monitoring [182] and detection
of biological warfare agents. [183] To realize sensing of special analytes, nanoparti-
cles should possess the ability to specifically recognize their targets and translate
the recognition into detectable signals. As already discussed in the sections 1.5
and 1.6, mesoporous silica materials are able to combine both requirements: tar-
geting and the production of coloured compounds by enzymatic reactions. A very
popular approach to realise nano-bioconjugation uses the biotin-avidin (or strepta-
vidin) interaction as a universal linkage that connects the desired recognition site
to the nanoparticle. [179,184] Furthermore, nanostructures can be functionalized with
enzymes, antibodies, affinity proteins and cell receptor specific ligands. [185] Among
those, the high specificity of antibodies makes them - in combination with nanopar-
ticles - a very interesting tool for immunoassays.
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1.7.1 Immunoassays
If analytes cannot be detected directly via substrate-specific characteristics (e.g.
extinction coefficient, enzymatic activity,...), or the concentration of the analyte ex-
cludes other procedures, immunoassays are usually used. For the use of immunoas-
says the chemical structure of the analyte has to be known in order to be able to pro-
duce specific antibodies, or a specific natural antibody has to be known. [186] Yalow
and Berson were the first scientists reporting on the development of immunoassays
in the 1950s. [187] Immunoassays became considerably simpler to perform and more
popular in the late 1960s, when it was shown that enzymes can be chemically linked
to antibodies. Today, a variety of different labels for detection of antibodies and
antigens are known. The most prominet labels are enzymes, radioactive isotopes,
DNA reporters, electroluminescent tags and fluorophores including nanoparticles
among others. [188] Furthermore, label-free immunoassays have been reported that
are based on the fact that changes in resistance of an electrode can occur upon
binding of antibodies or antigens. [189] Antibodies (also known as immunoglobulin)
are large Y-shaped proteins of the immune system that are able to recognize unique
parts of a foreign target, called an antigen. [190] They consist of four polypeptide
chains: two identical heavy chains and two identical light chains connected by disul-
fide bridges (Figure 1.15).
Figure 1.15: Schematic representation of an antibody. [191]
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Each chain is composed of structural domains called immunoglobulin (Ig) do-
mains which exhibit a characteristic immunoglobulin fold in which two beta sheets
create a ”sandwich" shape that is held together by interactions between conserved
cysteins and charged amino acids. The region of an antibody that binds to the
antigen is called antigen-binding fragment, which is composed of one constant and
one variable domain of each of the heavy and the light chain. These domains shape
the paratope and bind the epitope of the corresponding antigen. [192] This specific
binding behavior can be used to design analytic assays, of which the enzyme-linked-
immunosorbent-assay (ELISA) and the lateral-flow-immunoassay (LFIA) will be
further described in the following sections.
1.7.2 Enzyme-linked-immunosorbent-assay (ELISA)
Before the development of the ELISA technique, radioimmunoassays were the only
option for conducting an immunoassay. The potential risk of using radioactive
labels led to the attachment of enzymes onto the antibodies to enable optical read-
out. [193,194] Today, different approaches can be used for ELISA, indirect, competitive
and the most used sandwich type (Figure 1.16).
Figure 1.16: Left: Scheme of a sandwich ELISA. Ab = antibody, HRP = horseradish peroxidase, TMB =
tetramethylbenzidine. Right: Image of a multiwell plate ready for optical read-out. [195,196]
First, a capture antibody specific to the analyte of interest is immobilized on a
solid phase (e. g. microtiter plate). Subsequently, all nonspecific binding sites on the
surface are blocked before the antigen-containing sample is applied to the plate. The
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analyte is captured by the immobilized antibody and detected by a second analyte-
specific antibody. Hence, the antigen is stuck between two antibodies forming a
”sandwich"). The second antibody is bearing either an enzyme (e. g. horseradish
peroxidase) or a label that allows to attach further molecules (e. g. biotin) which
enable the translatation of the concentration of the antigen into an optical signal.
To determine the concentration, calibration curves have to be recorded. ELISA is
limited to large molecules such as proteins, since the analyte has to feature two
epitopes. [197]
1.7.3 Lateral-flow-immunoassay (LFIA)
Lateral-flow tests represent simple devices which report on the presence or absence
of an analyte. Based on the technique developed for ELISA, LFIA uses immobilized
antibodies that capture and detect the analyte. One major difference compared to
ELISA is that a liquid sample has to move along a strip made of different membranes.
The LFIA is assembled from different components including (Figure1.17): [197]
- Sample pad
- Conjugate pad
- Reaction membrane
- Absorbent pad
- Backing material
The assay has two lines (test and control) that appear when a positive sample
is added to the sample pad. The test line indicates that an antibody-coated label
has bound to the antigen captured by the antibody immobilized on the nitrocellu-
lose membrane. First, the sample is added to the sample pad and starts to flow
through the membrane due to capillary forces. The analyte molecules move to the
second membrane (conjugate pad) where particles containing antibodies specific for
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Figure 1.17: Schematic of a lateral flow strip (upper part) and lateral flow immunoassay (LFIA) based on a
sandwich format (lower part). [198]
the analyte are deposited. The analyte interacts with an antibody-coated particle,
producing the analyte-antibody-particle-complex. The complexes flow into the re-
action membrane, where antibodies specific to the antigen (test line) and to the
antibody from the particles (control line) are immobilized in line format. In the
first line, the antigen-antibody-particle complexes are trapped by atigen-antibody
interactions and produce a signal which is characteristic for the particles. Most of
the commercial tests are based on gold nanoparticles, developing a red line as a
positive result. The antibody-coated particles that do not bind to the analyte are
trapped in the control line by antibody-antibody interactions. The excess of liquid
is absorbed in the absorbent pad. [197] The success of the analysis can be read out
directly. If two lines appear in the read-out window, the analyte was present in the
sample. A negative result is obtained if only the control line appears coloured. In
the case where no line is observable, the test failed.
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Characterization Techniques
2.1 Infrared (IR) and Raman spectroscopy
Analytical infrared studies are based on the absorption of electromagnetic radia-
tion between 200 - 4000 cm−1. [1] Infrared (IR) and Raman vibrational spectroscopy
techniques are two of the most common spectroscopic methods used for compound
identification. Especially for organic substances, the light absorbed by the sample
is characteristic for the contained functionalities, resulting in a form of functional
group fingerprinting. [2] Molecules possessing an electric dipole which oscillates with
a specific frequency are able to absorb infrared radiation as long as the frequency
of the incident light is matching the frequency of the oscillating non-symmetrical
bond of the irradiated molecule. [3] In general, photon absorption occurs if the dipole
moment of a molecule changes during the vibration even if the molecule itself does
not have a permanent dipole. The energy of the absorbed light is converted into
energy of molecular vibration, either stretching or bending, while the transmitted
light is detected.
In contrast to IR, Raman spectroscopy relies on the inelastic scattering of monochro-
matic light by interaction with the electron clouds around chemical bonds. The
scattered light can show either a shift towards lower frequencies (Stokes shift), that
corresponds to an energy loss, or towards higher frequencies (anti-Stokes shift), that
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corresponds to an energy gain from the sample (Figure 2.1). [4]
Figure 2.1: Rayleigh-, Stokes-, and anti-Stokes scattering. [4]
To observe a vibrational mode in Raman spectroscopy, the polarizability of the
bond has to change during vibration. In IR spectroscopy using an interferometer,
a time-dependent signal is detected, which can be decomposed into a frequency-
dependent spectrum using Fourier Transformation. [5]
2.2 Dynamic Light Scattering (DLS)
Dynamic light scattering (DLS), which is also known as photon correlation spec-
troscopy (PCS), is a powerful tool to investigate solution dynamics and to determine
hydrodynamic particle diameters in colloidal dispersions. [6] Size information can be
obtained ranging from a few nanometers to about 5 micrometers. A DLS setup
comprises a laser source, a sample cell, a photodetector and a computer with an
autocorrelator (Figure 2.2). [1]
Hydrodynamic particle diameters in colloidal dispersion can be determined by
measuring the intensity fluctuations caused by interference of scattered laser light
from different particles. The Brownian motion of the particles leads to intensity
fluctuations of the laser light. These fluctuations can be mathematically correlated
to the particle size. Coherent laser light scattered from small particles suspended
in a liquid results in a speckle pattern on the detector due to constructive and
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Figure 2.2: Typical instrument arrangement for DLS. [1]
destructive interference of the light resulting from particles at different positions.
Without Brownian motion, the speckle pattern would also remain unchanged. In
dynamic light scattering, intensity fluctuations are correlated across microsecond
time scales by an autocorrelation function. The second order autocorrelation curve
can be directly derived from the intensity profile according to equation 2.1.
g2(q; τ) =
〈I(t)I(t+ τ)〉
〈I(t)2〉
(2.1)
q: Wave vector
τ : Time delay
I: Intensity
For completely monodisperse samples, an exponential function (2.2; 2.3) is ob-
tained for the decay of the autocorrelation function.
g1(q; τ) = e−Γt (2.2)
Γ =
D(
4n0π
λ
sin
(
Θ
2
))2 (2.3)
D: Diffusion coefficient
n0: Refractive index of the solution
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λ: Wavelength of the laser
Θ: Angle of the scattering measurement
The diffusion coefficient D of the particles can be determined from the exponent
of the fitted curves. The hydrodynamic diameter of an equivalent sphere is calculated
using the Stokes-Einstein equation (2.4). [7]
D =
kT
3πηd
(2.4)
D: Diffusion coefficient
k: Boltzmann constant
T : Temperature
η: Solvent viscosity
d: Hydrodynamic diameter
In samples with broad or polymodal size distributions, the interpretation of data
based on the particle scattering intensity can be misleading. In order to describe the
scattering of particles with a similar or larger size compared to the wavelength of
the incoming light, Mie theory has to be applied. For small particles, the scattering
intensity in a beam of unpolarized light can be sufficiently described by Rayleigh
scattering (2.5).
I = I0
1 + cos2 Θ
2R2
(
2π
λ
)4 (
n2 − 1
n2 + 2
)2 (
d
2
)6
(2.5)
I: Intensity of the scattered light
I0: Intensity of the incoming light
Θ: Scattering angle
R: Distance to the particle
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λ: Wavelength of the incoming light
n: Refractive index of the particle
d: Particle diameter
In equation 2.5, the scattering intensity is proportional to d6, which leads to the
fact that aggregates or larger particles dominate the distribution curve even if they
are only present in a small amount. Therefore, it is common to give the volume-
weighted or number-weighted size distributions which are proportional to d3 and d,
respectively.
2.3 Zeta potential measurement
The zeta potential is the electrokinetic potential difference between the dispersion
medium and the stationary layer of fluid attached to the dispersed particle. [8] It is
a force that mediates interactions between colloidal particles. Basically, dispersed
particles in aqueous solutions undergo either ionization of their surface groups or
adsorption of charged species, both resulting in a charged particle surface. This
surface charge affects the distribution of surrounding ions, generating different lay-
ers around the particle with ion concentrations that differ from the bulk solution. [9]
Colloidal particles will therefore form an electric double layer in ion-containing me-
dia. The liquid layer formed directly at the particle surface is called the Stern layer.
Here, the ions are strongly bound to the surface in the first few layers. With further
distance to the particle surface, ionic interactions decrease leading to a more diffuse
layer (Figure 2.3). [10]
One possibility for zeta potential determination is the measurement of the elec-
trophoretic mobility. The relation between the electrophoretic mobility and the zeta
potential is described by the Henry equation 2.6. [10]
UE =
2εzf(Ka)
3η
(2.6)
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Figure 2.3: Scheme of the electric double layer around a negatively charged colloid. [11]
UE: Electrophoretic mobility
ε: Dielectric constant
z: Zeta potential
f(Ka): Henry’s function
η: Viscosity of the solvent
The electrophoretic mobility of colloidal nanoparticles can be determined by the
measurement of the particles’ velocity through Laser Doppler Velocimetry (LDV). [12]
Laser light that is scattered from the moving particles is interfered with a reference
beam, resulting in a fluctuating signal intensity due to the Doppler shift. The
Doppler shift corresponds to the velocity of the particles. The resulting frequency
difference forms beat signals, which are proportional to the speed of the particles
between the electrodes in a measurement cell. For very small particles (<200 nm)
dispersed in electrolytes containing less than 10−3 molar salt, the Hückel approxi-
mation is used with f(Ka) = 1.0. For larger particles in more highly concentrated
solvents, the particle radii are better described by the Smoluchowski approximation
with f(Ka) = 1.5.
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2.4 Nitrogen adsorption
Gas adsorption and desorption analysis is a prominent method to characterize porous
materials with respect to the specific surface area, pore size distribution and acces-
sible pore volume. [13] Argon, nitrogen or krypton are the most common adsorptives.
In principle, a known amount of sample is placed in the sample cell before the de-
vice is evacuated (p = 0). The temperature is adjusted to the temperature of the
adsorptive - in the case of nitrogen to 77 K. The adsorptive is successively added to
the sample cell and the resulting pressure is recorded after equilibration. The upper
limit is reached, as soon as the measured pressure p equals the vapor pressure of
nitrogen p0. Plotting the volume of adsorbate on the adsorbent as a function of its
relative pressure p/p0 at a constant temperature T gives an isotherm representing
the adsorption process. Subsequent successive removal of the adsoptive leads to
the corresponding desorption istotherm. [14] Adsorption isotherms can be classified
as one of six different types according to IUPAC nomenclature (Figure 2.4) [15]
Figure 2.4: Types of physisorption isotherms according to IUPAC nomenclature. B represents a monomolecular
adsorbate layer on the material. [15]
Every type of isotherm in Figure 2.4 is characteristic for a certain gas/solid
interaction (Table 2.1).
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Table 2.1: Classification of adsorption isotherms. [15]
Isotherm Type Corresponding Material
I Microporous material, remains static after complete
pore filling
II Nonporous or macroporous material, high adsorption
energy
III Nonporous or macroporous material, low adsorption en-
ergy, weak interaction between adsorbate and adsorbent
IV Mesoporous material
V Mesoporous material with very weak interaction be-
tween adsorbate and adsorbent
VI Stepwise multilayer adsorption on nonporous, uniform
material
The shape of the isotherms is influenced by the phase behavior of fluids in porous
materials: usually, physical adsorption of gases on a porous surface occurs via a layer-
by-layer mechanism, which means that initially a monolayer is built. In the case
of mesoporous materials, the phenomenon of capillary condensation is observed. [16]
The latter is a process, during which multilayer adsorption from the vapor phase
into a porous medium proceeds until the pores are completely filled with condensed
liquid. There exist several different models for describing adsorption isotherms.
The two most prominent methods applied for the study of porous materials are the
Brunauer-Emmett-Teller (BET) model and the density functional theory (DFT).
BET theory is based on the Langmuir model. [17] For small relative pressures in the
range p/p0 < 0.3, the linear form of the BET equation is used (equation 2.7).
p/p0
n(1− p/p0)
=
1
nmC
+
C − 1
nmC
(p/p0) (2.7)
p/p0: Relative pressure
p0: Saturation pressure of the adsorptive
n: Amount of adsorbate
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nm: Monolayer capacity
C: BET constant
Using this equation together with the known cross-sectional area of an adsorbate
molecule, the specific surface area of the material can be calculated from the linear
region in the BET plot.
Based on the Kelvin equation, Barret, Joyner and Halenda (BJH) developed a model
which allows to calculate pore diameters of mesoporous materials. [18] For mesoporous
systems with pores sizes around 4 nm, pore diameters derived from BJH theory are
typically decreased by about 1 nm in comparison with pore sizes determined by
other techniques like TEM. In BJH theory, assumptions of certain pore condensa-
tion and pore filling mechanisms are made, which do not describe the behaviour
of micropores and small mesopores accurately. Besides the macroscopic BJH ap-
proach, several microscopic models including Monte Carlo simulations, molecular
dynamics, statistical mechanics techniques and density functional theory (DFT)
have been developed. These models benefit from yielding more realistic results, but
specific knowledge about the structure and surface atoms of the investigated systems
is required in order to be able to correctly calculate forces and input parameters.
Among these theories, DFT techniques use site-wise attractions between surface
atoms and the adsorbate molecules. Additionally, adsorbate-adsorbate attractions
are taken into account. The minimum in the system’s overall free energy is obtained
by primarily changing the number density as a function of distance from the surface.
Additionally, one has to distinguish between the local and the non-local density func-
tional theory (NLDFT). In local density functional theory, the fluid is assumed to be
structureless for calculating the long-range interactions between adsorbate particles.
However, the solid pore walls of mesoporous materials have considerable influence
on the number density. Therefore, NLDFT has to be used for surface adsorption
with strongly interacting boundaries.
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2.5 Thermogravimetric Analysis (TGA)
Thermogravimetric analysis (TGA) is a tool to determine the content of organic ma-
terial in organic-inorganic hybrids. [19] During a TGA measurement, the mass of a
sample in a controlled atmosphere is recorded continously as a function of tempera-
ture. Usually, the temperature of the sample is increased linearly with time. [20] Since
the mass of the analyte is monitored, the provided information is qunatitative, but
limited to decomposition or oxidation and to physical processes such as vaporization,
sublimation and desorption. [1] A typical setup contains a sensitive thermobalance
which is isolated from the furnace and can detect small changes in mass (0.1 µg).
The furnace usually covers a range from room temperature to 1200 ◦C. Inside the
sample chamber, a constant laminar gas flow is applied, leading to a removal of des-
orbed or combusted material. With this method, information about sample stability
and quantitative data on the amount of organic material attached to the inorganic
core is obtained.
2.6 Transmission electron microscopy (TEM)
Microscopes using light in the visible range (400 to 800 nm) are limited to a res-
olution in the range of about 0.2 µm. In materials science, it is often required to
get visible information down to the atomic level. Through the development of the
first electron microscope by Max Knoll and Ernst Ruska in 1931 and the subsequent
enormous improvements of the technique, it is possible to get information on samples
with a resolution down to 0.05-0.1 nm. The high resolution is obtained by the use
of highly accelerated electrons instead of light. The wavelength of these electrons is
related to the accelerating voltage U as shown in equation 2.8.
λ =
hc
[2m0eU (1 + eU/2m0c2)]
1/2
(2.8)
m0: Mass
e: Elementary charge of an electron
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h: Planck constant
c: Speed of light
In transmission electron microscopy, acceleration voltages between 80 kV and
200 kV are widely used, corresponding to electron wavelength of 15 pm and 2.51 pm
respectively. TEM reveals the internal structure of specimens including cystallinity,
defects and composition. The electron beam is generated by a tungsten filament
or a field emission gun and accelerated by a potential difference between about 40
to 1000 keV. Before and after hitting the specimen, the beam is collimated and
focused by electrostatic and/or electromagnetic lenses. After transmission through
the specimen, the electron beam carries information on the inner structure of the
sample. At the bottom of the setup, a fluorescence screen or a CCD camera detects
the final image.
2.7 Ultraviolet-visible (UV-Vis) spectroscopy
UV-Vis spectroscopy uses light in the ultraviolet or visible range. Absorption of
light can lead to excitation of valence electrons from the ground state to an excited
state. For absorption of light, the energy of the incident light has to match the
energy difference between these two states. The concentration of an analyte in the
sample can be determined using Lambert-Beer’s law (equation 2.9). [2]
A = −log I
I0
= εcd (2.9)
A: Absorbance
I: Transmitted intensity
I0: Intensity of incident light
ε: Molar extinction coefficient of the analyte
c: Concentration of the analyte
d: Path length
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2.8 Fluorescence Spectroscopy
Fluorescence is the result of a three-stage process in the electron shell of certain
molecules (generally polyaromatic hydrocarbons or heterocycles) called fluorophores
or fluorescent dyes. The process of fluorescence can be illustrated by a simplified
electronic state diagram (Jablonski diagram) in Figure 2.5: [21]
Figure 2.5: Jablonski diagram and spectra, illustrating the processes involved on the creation of an excited state
by optical absorption and subsequent emission of fluorescence. [22]
Fluorescence can be divided into three main processes: excitation, Non-radiating
transitions and fluorescence emission.
Excitation: A photon of energy hνex is supplied by an external source such as an
incandescent lamp or a laser and absorbed by the fluorophore. The energy is used
to push an electron from a ground state (S0) niveau to an excited state (S1) niveau.
The absorption occurs in about 1 fs.
Non-radiating transitions: The electron spends a finite time (typically 1 - 10 ns)
in the excited state. During this time, the fluorophore undergoes conformational
changes and is subject to a multitude of possible interactions with its environment
(collision...). The energy of the initial S1 state is partially dissipated, yielding a
relaxed singlet excited state from which fluorescence emission originates. Not all
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molecules that were initially excited by absorption return to the ground state by fluo-
rescence. Other processes such as collisional quenching, fluorescence energy transfer
and intersystem crossing may also depopulate S1 without emitting a photon.
Fluorescence emission: Finally, with a certain probability a photon of energy
hνfl is emitted, returning the fluorophore to its ground state S0. Due to energy dis-
sipation during the excited state lifetime (non-radiative relaxation), the energy of
this photon is lower, and therefore of longer wavelength, than the excitation photon
hνex. The energy difference is related to the Stokes shift, which is the wavelength
difference between the absorption and emission maximum. [22]
2.9 X-ray diffraction (XRD)
X-ray diffraction (XRD) is a powerful and nondestructive method for the analysis
of crystalline and nanostructured materials. [23] XRD can also give information on
particle shape and size in the range from a few nm to about 100 nm. Since larger
structures go along with small angles of diffraction, an angular range of 0.1 - 10 ◦
was applied here. [24] Hence, small angle X-ray scattering (SAXS) was used in this
work to demonstrate the mesostructure of the synthesized silica materials.
X-rays are typically generated by the bombardment of a metal target with an ener-
getic beam of electrons. This electron beam is produced by heating a metal filament.
Emitted electrons are then accelerated towards the metal target by applying a large
electrical potential between the filament and the target. When the electron beam
hits the target, a rapid deceleration of electrons causes a variety of processes: the
emission of X-ray radiation, Auger electrons, photoelectrons and heat. X-ray radia-
tion is emitted in a continuous band of white radiation as well as a series of discrete
lines that are characteristic for the target material. [25] In the case of copper, the
characteristic wavelength of the X-ray beam is 1.54182 Å.
The wavelength of the X-ray beam lies in the same order of magnitude as the dis-
tances of atoms in solid matter. Therefore, information on the atomic structure of
the material can be gained by interpreting the constructive and destructive interfer-
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ences of X-rays scattered by the lattice planes (Figure 2.6).
Figure 2.6: Illustration of the Bragg relation. A constructive interference occurs when the path difference is a
multiple integer of the X-ray wavelength. [26]
The interplanar spacing d of a structure can be determined from the Bragg
equation:
nλ = 2dsin(Θ) (2.10)
n: Diffraction order
λ: Characteristic wavelength
d: Interplanar spacing
Θ: Angle of incidence
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Chapter 3
Tuning the Activity of Immobilized
Enzymes via Pore-Wall Modifications
of Mesoporous Silica Particles with
pH-active Functionalities
The following work is based on a project with Marina Ilg, Evelyn Calta, Axel Schloss-
bauer, and Thomas Bein
3.1 Introduction
Organo-functionalized mesoporous silica materials have attracted much attention
as host systems for biomolecules in the field of biocatalysis and drug delivery. [1–6]
Having most of their active surface area inside the mesopores, high functionaliza-
tion densities can be found in these confined nanospaces. Enzymes are versatile
biocatalysts with a broad range of industrial applications including synthesis and
purification of fine chemicals, due to their high selectivity and activity at moder-
ate temperatures. [7] An important aspect in enzymatic catalysis is the recovery of
the catalyst. As a result of extensive studies, the concept of immobilization was
developed. [8–12] Encapsulation of enzymes in host materials such as mesoporous si-
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lica has proven to be beneficial for resistance against environmental influences like
pH, temperature and solvent variations. Often biomolecules have been immobilized
via physical adsorption or encapsulation. [11–16] Other studies have explored the con-
cept of cross-linking [17] or the covalent attachment of enzymes to solid supports. [10]
However, as a consequence of immobilization, a drop in enzymatic activity can be
observed in many systems. [18–21] This suggests that local interactions of the enzyme
molecules with the pore walls of the host should be further elucidated in order to
understand and optimize the performance of bio-inorganic catalyst systems.
Here we present investigations on the impact of different pore-wall modifications
of mesoporous silica particles on the internal pH of the pores. These modifications
show significant effects on the catalytic activity of immobilized trypsin and hemin
molecules. The active site of trypsin consists of aspartic acid, histidine and serine
residues, creating the catalytic triad that is a key characteristic of serine proteases.
The mechanism of catalytic action depends on protonation and deprotonation steps
within this triad. [22] Hence, the local pH value in the neighborhood of the enzyme
is critical for the activity of the enzyme. We synthesized mesoporous silica parti-
cles with different pore sizes and pore-wall-functionalities Figure 3.1. Furthermore,
the impact of amino- and carboxy-moieties on the catalytic activity of covalently
attached trypsin and hemin was elucidated.
Figure 3.1: Pore-wall modification followed by covalent attachment of a catalyst into the mesoporous system by
click chemistry.
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3.2 Experimental Section
Chemicals
All reagents were purchased from commercial suppliers: tetraethyl orthosilicate
(TEOS, Fluka, >98%), cetyltrimethylammonium bromide (CTAB, Aldrich, 95%),
(3-chloropropyl)triethoxysilane (CPTES, Fluka, 95%), (3-cyanopropyl)triethoxysi-
lane (Cyano-PTES, Fluka, 95%), (3-aminopropyl)triethoxysilane (APTES, Fluka,
95%), mesitylene (Aldrich, 98%), sodium azide (Fluka, 99%), 4-pentynoic acid
(Fluka, 97%), N -(3-dimethylaminopropyl)-N -ethylcarbodiimide hydrochloride (EDC,
Fluka, 97%), trypsin from bovine pancreas (Sigma, lyophilized, essentially salt free,
TPCK treated), N -p-tosyl-L-arginine methyl ester hydrochloride (TAME, Sigma),
hemin (Sigma, >90%), 4-pentynoic acid (Fluka, 95%), propargylamine (Sigma,
98%), 1-hydroxybenzotriazole hydrate (HOBt, Sigma, >99%), N,N -diisopropylethyl-
amine (Sigma, 99%), Cu(I)Br (Sigma, 98%), 4-aminoantipyrine (4-AAP, Sigma,
>98%), diethylaniline (DEA, Sigma, >99%), hydrogen peroxide (Sigma, 30 wt%).
Pluronic P123 was received as a gift from BASF company. (3-azidopropyl)triethoxy-
silane was synthesized according to a procedure published by Nakazawa et al.. [23]
Doubly distilled water from a Millipore system (Milli-Q academie A-10) was used for
all syntheses and purification steps. All solvents and buffer contents were purchased
from Sigma-Aldrich. Unless otherwise noted, all reagents were used without further
purification.
Preparation of micrometer sized MCM-41 particles
MCM-41 was synthesized according to a published procedure. [24] To a stirred so-
lution of CTAB (2.39 g), water (125 g), ethanol (12.5 g) and aqueous ammonia
(25 wt%, 9.18 g), the amount of 17.56 g TEOS was added. After stirring for 2 h
at room temperature, the reaction mixture was filtered off and washed with 50 mL
water. The resulting powder was dried at 60 ◦C for 12 h. Extraction of the organic
components was performed by heating the particles for 45 min under reflux (90 ◦C)
in a solution containing 2 g ammonium nitrate in 100 mL ethanol. After filtration,
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the particles were fully condensed by calcination at 450 ◦C for 4 h (heating rate
1 ◦C/min).
Preparation of large pore SBA-15 particles
SBA-15 was synthesized following a procedure published by Katiyar et al. [25] Pluronic
P123 (3.0 g) was dissolved in hydrochloric acid (HCl, 60 mL, 1.5 M). In a second
reaction vessel CTAB (0.6 g) and mesitylene (0.3 g) were mixed with distilled wa-
ter (25 mL). Both solutions were combined and ethanol (20 mL) was added under
stirring. Subsequently, TEOS (10 mL) was added dropwise. The resulting reaction
mixture was vigorously stirred at 35 ◦C for 45 min before being transferred into a
Parr autoclave for hydrothermal treatment at 75 ◦C for 12 h under static condi-
tions. Subsequently, the reaction mixture was aged at 125 ◦C for another 12 h. The
resulting white powder was filtered off, washed with water (100 mL) and ethanol
(100 mL), and dried at 60 ◦C for 12 h. The template was removed by calcination at
550 ◦C for 6 h (heating rate 1 ◦C/min).
General procedure for organo-functionalized SBA-15 (SBA-15-X) and
MCM-41 (MCM-41-X) particles
SBA-15 and MCM-41 were functionalized according to a published procedure. [10]
Freshly calcined particles (400 mg) were dried at 110 ◦C under vacuum conditions
for 90 minutes. Afterwards, the amount of 6 mL dry toluene was added under ni-
trogen atmosphere. After addition of 3 mmol of the corresponding functionalized
propyltriethoxysilane X(C2−3H4−6)TES (X = CN, NH2, N3), the reaction mixture
was allowed to stir for 4 hours under reflux conditions. The functionalized particles
were filtered off and washed with toluene, methanol and water before being dried at
60 ◦C. For multiple functionalization, two different functionalized propyltriethoxysi-
lanes were used with n1 + n2 = 3 mmol. In SBA-15 particles prepared for click
chemistry, a ratio of NH2:N3 = 100:1 or CN:N3 = 100:1 was used.
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General procedure for the conversion of cyano-functionalized into carboxy-
functionalized particles
Cyano-functionalized particles (200 mg) were resuspended in concentrated HCl (37%,
15 mL) and stirred for 6 h under reflux conditions. Afterwards, the particles were
separated by filtration, washed with water until the filtrate appeared neutral and
dried at 60 ◦C.
Acetylene-functionalization of trypsin (sp-trypsin)
Acetylene-functionalized trypsin was synthesized according to Gole et al. [26] A solu-
tion containing 10 mg trypsin in 10 mL MES buffer (10 mM, pH 5.5) was prepared.
To this solution, 500 µL of an aqueous solution of 4-pentynoic acid (0.1 M) was
added. The resulting mixture was stirred for 2 minutes and stored afterwards at
4 ◦C for 15 minutes. Subsequently, the amount of 9.9 mg EDC hydrochloride was
added and the solution was stirred and kept for an additional 4 h at 4 ◦C. The
mixture was dialyzed in a cold room at 6 ◦C against 10 L sodium phosphate buffer
(10 mM, pH 7.4) for a period of 24 h. The resulting acetylene-functionalized trypsin
was used for click chemistry without further purification.
Preparation of trypsin-functionalized SBA-15 (SBA-15-NH2-trypsin, SBA-
15-COOH-trypsin)
To a solution containing 3 mg of acetylene-functionalized trypsin (3 mL) in PBS
buffer (pH 7.4), the amount of 25 mg SBA-15-NH2-N3 or alternatively SBA-15-
COOH-N3 was added. The amount of 1 mg ascorbic acid was added to a freshly
prepared aqueous solution of CuSO4 · 5 H2O (1 mM, 5 mL) and the resulting
mixture was stirred at room temperature for 10 minutes. Subsequently, 12.5 µL of
the copper-containing solution were added to the reaction mixture. The resulting
mixture was stirred at 4 ◦C for 24 h. The trypsin functionalized particles were
recovered by filtration and washed extensively with PBS buffer (50 mM, pH 7.4).
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Preparation of core-functionalized colloidal mesoporous silica nanoparti-
cles (MSN-N3)
MSN nanoparticles were synthesized by co-condensation according to Cauda et al. [27]
A two phase mixture of TEA (14.3 g), TEOS (1.63 g) and 3-azidopropyltriethoxy-
silane (100 µL) was heated at 90 ◦C for 20 minutes without stirring. After removal
of the oil bath, a preheated (60 ◦C) solution of CTAC (2.14 mL) and water (21.7 g)
was added and stirred afterwards at 500 rpm for 20 min at room temperature.
Subsequently, 180 µL of TEOS was added in four steps (45 µL each) every 3 minu-
tes. The resulting solution was stirred overnight at room temperature at 500 rpm.
Extraction of the organic template was achieved by heating the ethanol-suspended
sample (10 mg/mL) under reflux at 90 ◦C for 1 h in a mixture of 2 g ammonium
nitrate and 100 mL ethanol. Afterwards, the sample was centrifuged for 20 minutes
at 19000 rpm (43146 rcf), redispersed in ethanol and heated under reflux at 90 ◦C
in a solution of 8 mL concentrated HCl and 32 mL ethanol for 45 minutes. After
centrifugation, the particles were redispersed in ethanol, resulting in a colloidal
suspension.
Acetylene-functionalization of hemin (sp-hemin)
In a 50 mL flask, 162 mg hemin and 80 mg HOBt (2 eq.) were dissolved in 6 mL
DMF. Subsequently, 42 µL propargylamine (2.5 eq) and 220 µL EDC (4 eq.) were
added and the solution was stirred for 12 h at r.t.. DMF was evaporated and the
crude product was redissolved in chloroform and washed by extraction with water.
The obtained dark green solid was used without further purification.
Preparation of hemin-functionalized colloidal mesoporous silica nanopar-
ticles (MSN-hemin)
100 mg MSN-N3 were redispersed in 15 mL acetonitrile. Subsequently the amount
of 15 mg sp-hemin, Cu(I)Br (12 mg) and N,N -diisopropylethylamine (16 µL) were
added to start the click reaction. The mixture was stirred overnight. The sample
was washed several times by centrifugation and redispersion in acetonitrile.
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pH modification of MSN-hemin by click chemistry with 4-pentynoic acid
and propargylamine (MSN-COOH-hemin, MSN-NH2-hemin)
20 mg MSN-hemin were redispersed in 5 ml acetonitrile. Subsequently, a large excess
of the desired alkyne (10 mg), Cu(I)Br (6 mg) and N,N -diisopropylethylamine
(8 µL) were added. The mixture was stirred overnight. The sample was washed
several times by centrifugation and redispersion in acetonitrile.
Trypsin activity assay
Following a procedure published by Schlossbauer et al., [10] the TAME assay was
performed by preparing an aqueous TAME stock solution (0.01 M) and an aqueous
enzyme solution with a trypsin concentration of approximately 5 µg/mL. For the
activity determination, a 1.5 mL cuvette containing 1325 µL buffer solution and
175 µL of a mixture of TAME and SBA-15-X-trypsin (X = COOH, NH2) solution
was placed in a spectrophotometer. The extinction at 247 nm was acquired at inter-
vals of one minute. Between each acquisition, the reaction mixture was homogenized
by shaking. The enzyme activity could be calculated from the slope of the obtained
linear equation determined from linear regression of the measured data as follows:
E247
0.54 · Ew
· 1.5 (3.1)
where E247 is the increase in extinction at 247 nm per minute (i.e. the slope of
the linear regression), 0.54 the extinction of 1 µmol N -p-tosyl-L-arginine, Ew the
initial weight of enzyme in mg per 0.1 mL solution and 1.5 the total volume of the
sample in mL. Hence, one activity unit is defined as the amount of enzyme releasing
1 µmol Nα-p-tosyl-L-arginine per minute under the noted conditions.
Hemin activity assay
Stock solutions of 4-AAP (7.5 mM), DEA (7.5 mM) and H2O2 (3 wt%) in Mc-Ilvaine
buffer solution were prepared. For the activity determination, 148 µL 4-AAP, 252 µL
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DEA, 50 µL H2O2, 240 µg MSN-hemin (containing 3.7 µg hemin), and buffer solution
were mixed. The extinction at 554 nm was acquired at intervals of one second. The
catalytic activity could be calculated from the slope of the obtained linear equation
determined from linear regression of the measured data as follows:
E554
16500 ·mhemin
(3.2)
where E554 is the increase in extinction at 554 nm per second, 16500 the molar
extinction coefficient of the produced dye [28] and mhemin the initial weight of enzyme
in 1 mL test solution.
Preparation of buffer solutions
PBS buffer
The amounts of 8.0 g sodium chloride (NaCl), 0.2 g potassium chloride (KCl), 1.44 g
disodium hydrogen phosphate (Na2HPO4), and 0.24 g potassium dihydrogen phos-
phate (KH2PO4) were dissolved in 800 mL water. The pH was adjusted to 7.4 using
1 M hydrochloric acid (HCl). The volume was adjusted to 1 L by addition of dis-
tilled water.
TRIS buffer
The amounts of 5.57 g tris(hydroxymethyl)aminomethane (TRIS, C4H11NO3) and
0.169 g calcium chloride dihydrate (CaCl2 · 2 H2O) were dissolved in 60 mL of water.
The pH was adjusted to 8.1 using 1 M hydrochloric acid (HCl). The volume was
adjusted to 100 mL by addition of distilled water.
Mc Ilvaine buffer
0.2 M aqueous solutions of citric acid (9.61 g, 250 mL) and dipotassium phosphate
(8.71 g, 250 mL) were prepared. The two solutions were mixed in different ratios in
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order to obtain the pH values 4, 5, 6, 7 and 8. Additionally, dilution series of 1:2,
1:20 and 1:200 were prepared for all pH values to give 100 mM, 10 mM and 1 mM
solutions.
3.3 Results and Discussion
pH determination inside the meopores of MCM-41 and SBA-15
For pH control in the mesopores, particles with different pore sizes were prepared and
modified with cyano-, carboxylic acid- and amino-groups and combinations thereof.
Buffers in the reange of pH 4-8 with different ionic strengths were used to ensure
a given pH in the external solution. To obtain information on the pH inside of
the pores, universal indicator dyes were used. Color changes of differently modified
particles allowed inference on the internal pH of the mesopores. The performance
of silica supported trypsin was photometrically quantified by the release of Nα-p-
tosyl-L-arginine from Nα-p-tosyl-L-arginine methyl hydrochloride (TAME). [29] The
chromogenic reaction between hydrogen peroxide, 4-aminoantipyrine (4-AAP), and
N,N -diethylaniline (DEA) was used for investigation of hemin activity. [28]
For the determination of the pH inside the mesopores, calcined samples of SBA-
15 and MCM-41 particles were prepared. Nitrogen sorption experiments showed
typical type IV isotherms, with a BET surface area of 1001 m2/g and an average
pore size of 7.9 nm for SBA-15. Sorption measurements of MCM-41 revealed a BET
surface area of 811 m2/g and an average pore size of 3.9 nm (Figure 3.2).
The calcined samples were functionalized by postsynthetic grafting with differ-
ent organic residues (-NH2, -CN, -COOH, -CN:NH2 1:1, -COOH:NH2 1:1). The
successful functionalization was determined by thermogravimetric analysis (TGA,
Figure 3.3).
To test the effect of functionalization on the pH inside the mesopores, Mc-Ilvaine
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Figure 3.2: Nitrogen sorption isotherms of a) MCM-41 and c) SBA-15. NLDFT pore size distribution of c)
MCM-41 and d) SBA-15.
buffer solutions with different pH (4-8) and ionic strengths (1 mM, 10 mM, 100 mM)
were prepared. The addition of indicator dye solution to the buffered particle dis-
persion (10 mg particles, 3 mL buffer, 5 µL indicator) led to differently colored
particles for the various modified samples (Figure 3.4) and thus, the internal pH
could be obtained through comparison with a color code table.
For calcined MCM-41 particles in a 100 mM buffer (Figure 3.5 a), the high
content of silanol groups led to an acidic medium with a pH < 5 inside the pores
(black bar in Figure 3.5) even for a 100 mM buffer solution with a maximum pH of 8.
The development of the internal pH depending on the pH of the applied buffer can be
followed in Figure 3.5 d). Carboxylic groups show similar behavior, but with a less
pronounced effect. Cyanide, being a weak Lewis-base, did not show a strong impact
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Figure 3.3: TGA curves for differently functionalized samples MCM-41 (left) and SBA-15 (right)
Figure 3.4: Different pore-modifications led to differently colored particles upon indicator dye absorption from
water, indicating different internal pore pH values.
on the internal pH. Immobilization of basic amino residues led to opposite effects
compared to those observed for carboxylic residues. The slight shift of cyano- and
amino-functionalized pores towards acidic pH could be attributed to the presence of
silanol groups. Furthermore, the creation of an internal buffer system through the
simultaneous incorporation of carboxy and amino functionalities led to a pH region
between 5.5 and 7.5. With diminishing ionic strength of the buffer, the effect on the
pH in the mesopores decreased (Figure 3.5 b) and e).
Using a 1 mM buffer, almost no response of the internal pore-pH on the variation
of buffer-pH could be monitored for calcined, carboxy-, amino- and cyano:amino
1:1-functionalized samples. Only cyano- and carboxy:amino 1:1-modified particles
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Figure 3.5: Results of the pH determination in MCM-41. a-c: Pore pH regions (black bars, corresponding to
∆pH (pores) in d-f) for different buffer solutions (yellow bars, corresponding to ∆pH (buffer) in d-f, always 4-8).
a) Mc Ilvaine buffer 100 mM, b) Mc Ilvaine buffer 10 mM, c) Mc Ilvaine buffer 1 mM, d-f: Precise data of the
measurements from which the bar diagrams were prepared. d) Mc Ilvaine buffer 100 mM, e) Mc Ilvaine buffer 10
mM, f) Mc Ilvaine buffer 1 mM.
showed variations in pH. In the latter case, this effect can be explained with the fact
that ammonium acetate buffer systems do not show buffer capacity in the region
around pH 6. A remarkable effect was observed for amino-functionalized pores, as
the internal pH-region was above the pH-region given by the buffer solution. Every
trend discovered for different modifications of the narrow pore host MCM-41 can be
transferred to SBA-15 (Figure 3.6). The only difference is the spread of the black
bars, which indicates that the effect of pore-wall functionalization decreases with
increasing pore-size.
Impact of the pore-functionalization on the activity of immobilized cata-
lytic centers
For the immobilization of sp-trypsin, SBA-15 was modified with functional groups
at a ratio of -X:N3 = 100:1 (X = COOH, NH2). Activity measurements were per-
formed with a previously described photometric assay. [10] The amounts of immobi-
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Figure 3.6: Results of the pH determination in SBA-15. a-c: Pore pH regions (black bars, corresponding to ∆pH
(pores) in d-f) for different buffer solutions (yellow bars, corresponding to ∆pH (buffer) in d-f, always 4-8). a) Mc
Ilvaine buffer 100 mM, b) Mc Ilvaine buffer 10 mM, c) Mc Ilvaine buffer 1 mM, d-f: Precise data of the measurements
from which the bar diagrams were prepared. d) Mc Ilvaine buffer 100 mM, e) Mc Ilvaine buffer 10 mM, f) Mc Ilvaine
buffer 1 mM.
lized trypsin were determined by TGA measurements (Figure 3.7). Data were taken
at 900 ◦C according to Schlossbauer et al.. [10]
Figure 3.7: TGA data obtained for SBA15-COOH-trypsin (left) and SBA15-NH2-trypsin (right)
Activity values obtained for differently modified samples are presented in Table 3.1.
Activity measurements revealed that the incorporation of acidic groups led to a loss
in activity of about 50% compared to unfuntionalized SBA-15-trypsin, whereas an in-
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crease by 296% could be obtained through the incorporation of basic amino-moieties.
Free trypsin has an optimal operating pH of approximately 8. [30] The internal pH of
the mesopores could be increased through the grafting of amino-groups, and thus,
enhanced activity was detected. In the case of amino-functionalization, activity mea-
surements showed that maximum activity was obtained for a slightly acidic buffer
solution (pH 6), whereas for carboxy-modified particles, even at pH 8, the samples
showed very low activity.
Table 3.1: Results of trypsin activity tests.
Sample Activity pH
[U*/mg trypsin] optimum**
Trypsin 346 [10] 7.5
SBA-15-trypsin 65.6 [10] n.d.
SBA-15-COOH-trypsin 32 8
SBA-15-NH2-trypsin 194 6
* 1 Unit = amount of enzymatic activity releasing 1 µmol of Nα-p-tosyl-L-
arginine per minute
** determined with 100 mM McIlvaine’s buffer solutions
To study the impact of pore-wall-modification on the activity of a molecular
catalyst, hemin, the catalytic center of horse radish peroxidase, was attached in the
pores of azide-functionlized MSN-nanoparticles. In a first step, hemin was reacted
with 4-pentynoic acid in an amidation step to give sp-hemin. Sp-hemin was grafted
to the pore walls of the particles via click-chemistry (MSN-hemin). MSN-hemin
was further functionlized by an additional click reaction with 4-pentynoic acid or
propargylamine to give MSN-COOH-hemin and MSN-NH2-hemin. Activity values
obtained for differently modified samples are presented in Table 3.2. Similar results
compared to the enzymatic catalyst trypsin were obtained for the molecular catalyst
hemin. In the case of hemin, an increase by 30 % in activity could be obtained for
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the additional functionalization with acidic moieties, whereas a reduction to 39%
residual activity was found for amino-groups, compared to MSN-hemin (Table 2).
In contrast to trypsin, no change in the external pH-optimum could be observed.
Strikingly through immobilization, the activity of hemin increased 62 times for MSN-
COOH-hemin compared with free hemin.
Table 3.2: Results of hemin activity tests.
Sample Activity pH
[∆n*/mg hemin]·10−5 optimum**
Hemin 0.3 6
MSN-hemin 14.6 5-6
MSN-COOH-hemin 19.0 5-6
MSN-NH2-hemin 5.73 5-6
* ∆ = amount [mmol] of dye released by 1 mg hemin per second
** determined with 200 mM McIlvaine’s buffer solutions
3.4 Conclusions
In summary, we present the impact of pore-wall modifications on the internal pH of
mesoporous silica systems. We could show that depending on the nature of inner
functionality, the pH inside the pores differs significantly from the pH in an outer
buffer solution. In these systems, stronger effects could be observed for smaller pore
diameters, as the amount of functionality per pore volume increases. When reducing
the ionic strength and thus the buffer capacity of the external buffer solutions, the
internal pH controlled through the pore-modifications becomes progressively domi-
nant. The concept of pH-control via pore-wall-functionalization was examined with
two different catalytic systems. Both showed strong dependence of the catalytic
activity on the pore-modification, whereas an impact on the pH-optimum of the
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external buffer could only be observed for the enzymatic catalyst trypsin. Our re-
sults lead to a better understanding of catalyst-pore-wall interactions. We conclude
that the control of pH-values in confined nanospaces such as mesopores can lead to
striking increases in the performance of encapsulated bio-inorganic catalyst systems.
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3.5 Appendix
Nitrogen sorption
Figure 3.8: Nitrogen sorption isotherm (left) and calculated DFT pore size distribution (right) for MSN-N3
TGA data of functionalized MCM-41 and SBA-15
Table 3.3: TGA data obtained for MCM-41
Sample Mass loss [%] m(org. residue) n(org. residue)
at 900 ◦C [mg/gMCM−41] [mmol/gMCM−41]
MCM-41-COOH 6.6 70.7 1.0
MCM-41-CN 6.2 66.1 1.2
MCM-41-NH2 14.4 168 2.9
MCM-41-CN-NH2 11.7 133 2.3
MCM-41-COOH-NH2 12.1 138 2.1
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Table 3.4: TGA data obtained for SBA-15
Sample Mass loss [%] m(org. residue) n(org. residue)
at 900 ◦C [mg/gSBA−15] [mmol/gSBA−15]
SBA-15-COOH 8.0 87.0 1.2
SBA-15-CN 7.9 85.8 1.6
SBA-15-NH2 8.7 95.3 1.6
SBA-15-CN-NH2 11.8 134 2.4
SBA-15-COOH-NH2 12.0 136 2.0
Figure 3.9: TGA data obtained for MSN-N3 (black) and MSN-hemin (red)
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Trypsin activity
Figure 3.10: Activity determinations of (left) SBA-NH2-trypsin and (right) SBA-COOH-trypsin.
Table 3.5: Calculation of trypsin activity in functionalized SBA-15
SBA-15-NH2-trypsin SBA-15-COOH-trypsin
∆E247 [1/min] 0.01189 0.00253
Ew [mg] 0.000170 0.000216
U/mgtrypsin [µmol/min] 194 32.6
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Hemin activity
Figure 3.11: Activity determinations of MSN-hemin (top left), MSN-COOH-hemin (top right), MSN-NH2-hemin
(bottom left) and free hemin (bottom right).
Table 3.6: Calculation of hemin activity in functionalized MSNs
MSN-hemin MSN-NH2-hemin MSN-COOH-hemin Hemin
∆E554 [1/s] 0.00901 0.00353 0.00117 0.000189
mhemin [µg] 3.7 3.7 3.7 3.7
∆n/mghemin · 10−5 14.6 5.73 19.0 0.307
[mmol/s]
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Chapter 4
Lipid-bilayer Coated Nanosized
Bimodal Mesoporous Carbon
Spheres for Controlled Release
Applications
The following work is based on a project with Benjamin Mandlmeier, Alexandra
Schmidt, Jörg Schuster and Thomas Bein
4.1 Introduction
Colloidal mesoporous carbon particles feature several properties that make them
attractive candidates for controlled release and possibly drug delivery applications.
These properties include high surface areas and pore volumes resulting in high loa-
ding capacities and good dispersibility. Additionally carbon can be equipped with
various chemical functionalities, which are often required to create more complex
systems. Up to now, important systems explored in targeted drug delivery are based
on mesoporous silica, [1] liposomes, [2,3] and polymers. [4–7] Different porous carbon
morphologies, such as activated carbon particles, [8,9] carbon nanotubes (CNTs) [9–13]
and ordered mesoporous carbon (CMK-3), [14] loaded with certain compounds and
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exhibiting good biocompatibility [15,16] have been reported in the context of drug
delivery. Combining magnetic properties with carbon nanostructures is also being
discussed for medical applications. [17] Nevertheless, certain carbon nanomaterials
such as multi-walled CNT, carbon fibers and certain types of particles (carbon black)
can lead to cytotoxic effects depending on their size, aspect ratio and surface che-
mistry. [18] Another study showed that functionalization of CNTs reduced toxic effects
to the cytosol. [19] Several reports describe the formation of mesoporous carbon for
drug delivery by replicating silica hard templates. Zhu et al. showed the functio-
nalization of mesoporous carbon with a thermoresponsive polymer. [14] Based on this
work, spherical mesoporous carbon in the size range of 500-800 nm was recently
prepared, exhibiting a BET surface area of 1069 m2/g and high pore volume of
1.49 cc/g, with a pore diameter of 6.0 nm. [19] Many approaches for the preparation
of mesoporous carbons are known, [20] and the morphology can be controlled by the
dimensions of hard templates. For example, MCM-48 silica particles were used
as template for ordered mesoporous carbon (CMK-1). [21] Furthermore mesoporous
carbon nanoparticles (MCNs) were applied in drug delivery experiments providing
a high BET surface area of 2034 m2/g and a pore volume of 1.2 cc/g. [22] Also
hydrophilic amino-functionalized MCNs in the range of 100 to 150 nm were obtained
and their high drug storage capacity was attributed to a BET surface area of 1309
m2/g and a pore volume of 0.9 cc/g (with small pores below 3 nm). [23] A high
biocompatibility was shown for mesoporous carbon nanoparticles hydrothermally
derived from resol as carbon source and the block-copolymer Pluronic F127. [16] With
this approach particle sizes were obtained from ca. 20 to 140 nm, but the highest
BET surface area of 1131 m2/g was accompanied by a small pore size of 2.6 nm
for 90 nm large particles. The influence of the particle size on endocytosis was
demonstrated with MCNs having small diameters of around 90 nm. [24] These samples
were prepared by a hydrothermal route, using the block co-polymer Pluronic F127
as soft-template, resulting in particles with a BET surface area of 746 m2/g, a pore
volume of 0.76 cc/g, and a pore size of 2.7 nm. A novel general route for ordered
mesoporous carbon (OMC) with high porosity involves a concerted co-assembly of
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carbon and silica precursors with Pluronic F127 and successive template removal
after full carbonization, providing a bimodal pore size distribution. [25] Based on this
method, we recently reported dispersible and porous carbon spheres (sized about
330 nm) using macroporous silica as hard template. [26] Those MCNs provided the
highest inner pore volumes for mesoporous carbon nanoparticles of 2.32 cc/g and also
one of the highest surface areas of 2445 m2/g with a bimodal pore size distribution
of large and small mesopores of 6 nm and 3.1 nm. Those properties make them
attractive candidates for drug delivery applications. In this study we report the
synthesis of very small mesoporous carbon nanospheres with extremely high porosity
and present the first efficient cap system for colloidal mesoporous carbon nanospheres
(Figure 4.1).
Figure 4.1: Surfactant induced release of calcein (green) from mesoporous carbon nanoparticles encapsulated by
a supported lipid bilayer.
We synthesized very small mesoporous carbon nanospheres with diameters ran-
ging from 45 to 70 nm using a macroporous silica hard template providing appro-
priate dimensions. Our particles feature a very high BET surface area of 2003 m2/g
and a high pore volume of 1.95 cc/g. To the best of our knowledge this is the
highest specific pore volume for mesoporous carbon nanoparticles at a size below
100 nm and also one of the highest surface areas. Additionally a bimodal porosity
with maxima at 5.9 and 3.1 nm was achieved by removal of F127 from the pores
and silica from the walls. Here we combine an extremely high loading capacity and
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very suitable particle sizes for an improved cell uptake. The use of supporting lipid
bilayers (SLBs) as cap systems has been successfully demonstrated for mesoporous
silica nanoparticles. [26–32] Being a very simple imitation of a cell membrane, SLBs
can enhance circulation times and accumulation in tumor tissue as reported for the
delivery of doxorubicin. [33] Compared to liposomes, the solid nanoparticle core offers
two major advantages. First, narrow size distributions and second, enhanced stabili-
ty in comparison with liposomes can be achieved. [29,30,34,35] Therefore we transferred
the concept of SLBs to mesoporous carbon and present the first efficient cap sys-
tem for colloidal mesoporous carbon nanospheres. Efficient sealing of the mesopores
could be obtained by coating each carbon sphere with an SLB. Regarding the lipid
formulation, we used a mixture of cationic and neutral lipids (DOTAP and DOPC)
and 60 nm NCS. To demonstrate the effectiveness of our cap-system, the controlled
release of calcein was studied in vitro by fluorescence spectroscopy.
4.2 Experimental Section
Chemicals
Sodium dodecyl sulfate, potassium persulfate, ammonium persulfate, methyl meth-
acrylate (99%), tetraethyl orthosilicate (technical grade), concentrated HCl (37% in
water), sodium hydroxide, Pluronic F127, Calcein, Triton X-100, sulfuric acid and
organic solvents were obtained from Aldrich and used without further purification.
Formalin (37 wt% formaldehyde in water) and phenol was purchased from Merck
KGaA and Pluronic F127 from BASF AG. Used lipids: DOPC (1,2-dioleoyl-sn-
glycero-3-phosphocholine, Avanti Polar Lipids), DOTAP (1,2-dioleoyl-3-trimethyl-
ammonium-propane, Avanti Polar Lipids).
Synthesis of PMMA spheres
PMMA spheres of about 60 nm were prepared by a modified route reported else-
where. [36] The emulsion polymerization was started by adding a solution of 227.2 mg
potassium persulfate (K2S2O8, 0.84 mmol) in 2 mL water to a mixture of 27.56 g
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methyl methacrylate (MMA, 275.3 mmol), 196 mg sodium dodecyl sulfate (SDS,
0.68 mmol) in 98 mL water at 70 ◦C. Previously the water was degassed by flushing
with nitrogen for 1 h, before SDS and MMA were added and the mixture was then
stirred under refluxing conditions for 1 h at 70 ◦C. After 2 h of polymerization the
reaction was stopped by external cooling and applying air to the three-bottleneck
flask (250 mL). The resulting colloidal solution was washed three times with water
by centrifugation at 20500 rpm (50228 rcf) for 30 min. This solution was dried in
plastic petri dishes for several days and the resulting flakes of several mm in size
were dried at 80 ◦C for 2 h.
Synthesis of macroporous silica
For the synthesis of the macroporous silica the obtained PMMA flakes were collected
on a filter paper and cast multiple times with a hydrolyzed silica precursor solution.
The residual solution was removed by applying vacuum to the Büchner funnel.
For the silica solution, 12 mL tetraethyl orthosilicate (TEOS, 53.8 mmol) were
added to 8 mL ethanol under stirring. To the clear solution 6 mL water and 1 mL
concentrated hydrochloric acid (HCl, 37%) were dropped and stirred for another
10 min at room temperature. [26] Finally, the PMMA/SiOx composite was calcined
in air at 550 ◦C for 5 h (ramp: 1 ◦C/min).
Synthesis of mesoporous carbon spheres
For this purpose a mixture of resol precursor as carbon source, and silica pre-
cursor were used for casting the previously prepared macroporous silica template.
The resol precursor was prepared according to Meng et al. [37] Here, 21 g formalin
(37 wt% formaldehyde in water, 0.259 mol) was added dropwise at 50 ◦C to a so-
lution of 12.2 g phenol (0.128 mol) and 2.6 g of 20 wt% sodium hydroxide solution
(0.013 mol). The final solution was than heated for 1 h at 75 ◦C and cooled to room
temperature. After neutralizing the basic solution using hydrochloric acid (1 M),
water was removed by rotary evaporation. The resulting product was diluted in
absolute ethanol to achieve a solution of 20 wt% (resol precursor). For the final
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casting solution, 2.0 g of Pluronic F127, 20.0 g of ethanol, and 2.0 g of 0.2 M HCl
were mixed well at 40 ◦C. Then 4.16 g TEOS and 5.0 g of the 20 wt% resol solution
were added. [25] The resulting yellow solution was stirred for another 5 h at the same
temperature. Typically, 10 g of the solution were cast on 100 mg of the macroporous
silica template, and the evaporation of the solvents and self-assembly of the F127
occurred at room temperature in an open Petri dish during 2-3 days. The resulting
and filled flakes were collected and thermopolymerized in air at 100 ◦C for 24 h,
followed by carbonization at 900 ◦C in a stream of nitrogen. Here, the material
was heated first to 350 ◦C (rate: 1 ◦C/min; dwell time: 3 h), then to 600 ◦C (rate:
1 ◦C/min) and finally to 900 ◦C (rate: 5 ◦C/min; dwell time: 2 h). The resulting
shiny black bulk material was additionally treated with aqueous hydrofluoric acid
(10 wt%) for 2 days, to remove silica from the macroporous template and from
walls of the mesoporous carbon phase. This treatment was followed by filtering and
threefold washing with water (MilliporeQ) and absolute ethanol.
Oxidation of nanosized mesoporous carbon spheres
To obtain a colloidal suspension of carbon spheres, the bulk material was oxidized
in a mixture of ammonium persulfate and sulfuric acid. [38] Specifically, 30 mg NCS
were added to a mixture of 2.4 g ammonium persulfate in 4 mL sulfuric acid (1 M).
The resulting suspension was stirred for 24 h at room temperature. Subsequently,
the particles were washed 5 times by centrifugation (14000 rpm, 16873 rcf, 8 min)
and redispersion in 5 mL MilliporeQ water.
Preparation of SLB@NCS loaded with calcein
The amount of 1 mg oxidized colloidal mesoporous carbon was dispersed in 500 µL
of an aqueous solution of calcein (1 mM) and stirred (500 rpm) for 2 h at room
temperature in the dark. After centrifugation (14000 rpm, 16873 rcf, 8 min), 100 µL
of a premixed lipid solution (70 µL DOPC + 30 µL DOTAB, each 2.5 mg/mL in a
mixture of 40 %v EtOH / 60 %v water) were added. Upon addition of 700 µL of
MilliporeQ water, the formation of a supported lipid bilayer on the external surface
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of NCS was induced. The SLB@NCS were then centrifuged and redispersed in
800 µL MilliporeQ water, to eliminate unsupported lipids and ethanol.
In vitro release experiment
An amount of 200 µL of the aqueous suspension containing SLB@NCS loaded with
calcein was transferred into a tube which could be closed with a dialysis membrane
(with a molecular-weight cutoff of 16000 g/mol). [39] This custom made cap fits
on the opening of a fluorescence cuvette, filled with MilliporeQ water. Only the
fluorescent molecules are able to diffuse through the dialysis membrane, whereas
the NCS material stays entrapped in the cap and is not able to enter the cuvette,
where the dye molecules are detected by fluorescence spectroscopy. For the delivery
experiment, a time-based measurement with an excitation wavelength of 495 nm
and an emission wavelength of 517 nm was recorded. The dye-loaded sample was
monitored in the closed state up to 4 h, showing no significant release of the dye
molecules. After the addition of 5 µL Triton X-100 (1:1000 v/v in H2O) into the
tube containing the SLB@NCS, the lysis of the lipids from the NCS nanoparticles
allowed the diffusion of calcein out of the pores through the dialysis membrane and
their detection in the cuvette. The release in the open state was monitored for
additional 3 h.
4.3 Results and Discussions
Three-dimensionally ordered macroporous (3DOM) silica, which was further used
as hard template, was prepared by replicating an array of close-packed PMMA
spheres. PMMA spheres were prepared by emulsion polymerization. The washed
particles were dried in petri dishes at room temperature to obtain millimeter sized
bulk material. Figure 4.2 a represents an SEM image of an ordered domain of packed
PMMA spheres with diameters of around 75 - 80 nm. These PMMA templates were
collected, and cast several times with a prehydrolyzed TEOS precursor solution,
to achieve a complete filling of the interstitial voids. The resulting PMMA/SiOx
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composite was dried for several hours and calcined at 550 ◦C to solidify the silica
precursor and to remove the PMMA template. The resulting pore diameter is ran-
ging between ca. 60 - 70 nm, which is smaller than the initial size of the PMMA
spheres and can be attributed to heating-induced shrinkage. [40,41] The bulk material
shows a good accessibility of the pores through random interpore connections in
the range of about 20 nm. A rough silica surface was attributed to the loose initial
packing of the PMMA spheres. The random orientation is also presented by a diffuse
ring, obtained by the Fast Fourier Transform (inset) of the rectangular area (white).
The diffuse ring indicates a d-spacing of around 70 nm, which is slightly smaller
than the lattice spacings of the PMMA template (Figure 4.2 b).
Figure 4.2: SEM images of (a) the PMMA colloidal crystal template before TEOS impregnation, (b) the corre-
sponding randomly ordered (FFT inset) macroporous silica replicate after calcination at 550 ◦C (inset: a 2D fast
Fourier transform (FFT) of the white square) and (c) bimodal mesoporous carbon spheres after carbonization at
900 ◦C in nitrogen and final removal of silica residues by HF treatment. (d) DLS and photograph (inset) depict a
homogeneous size distribution of the spheres in solution.
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This macroporous silica was further used as hard template for the synthesis of
bimodal mesoporous carbon spheres. As carbon source we used resol, which was co-
assembled with two porogen compounds, TEOS and Pluronic F127. This precursor
mixture enables a homogeneous dispersion of TEOS within the walls of the car-
bon mesostructure during an evaporation-induced self-assembly (EISA), occurring
during the casting and drying of the precursor within the empty voids of the macro-
porous silica hard template. Subsequent thermopolymerization at 100 ◦C for 24 h
and carbonization at 900 ◦C in nitrogen results in full carbonization and conversion
of TEOS into silica, dispersed in the walls of the mesoporous network. Simultane-
ously the total removal of Pluronic F127 is responsible for mesopore formation. All
silica residues were successfully etched with hydrofluoric acid (10 wt%), which cre-
ates a loose packing of nanosized mesoporous carbon (NCS) particles in the range of
45 to 68 nm (Figure 4.2 c). The particles can be separated either by oxidation with
ammonium persulfate or ultrasound treatment, leading to well-dispersed colloidal
suspensions (Figure 4.2 d, photograph). The DLS measurement shows a maximum
size of 59 nm, which is consistent with the SEM data.
The obtained NCS were also characterized by STEM-HAADF (Figure 4.3 a, b),
demonstrating their uniform particle size. The very small carbon spheres feature
a rough surface with accessible mesopores and smaller ones that are present in the
walls. The pore structure seems to be ordered and regarding the small-angle X-ray
scattering (Figure 4.6) a d-spacing of around 8.8 nm for the NCS particles was found.
The broad reflection indicates a disturbed long range order, which we attribute to a
relatively small confined size within this macroporous template. In contrast, we pre-
viously found a pronounced highly ordered hexagonal phase within carbon spheres
having diameters of around 330 nm. [26]
From nitrogen sorption measurements (Figure 4.3 c) a type IV isotherm was
obtained, showing a wide hysteresis and no defined saturation at high relative pres-
sures. We attribute this to a pronounced textural porosity between the particles. A
high BET surface area of 2003 m2/g and a high total pore volume of 1.95 cc/g were
99
Chapter 4. Lipid-bilayer Coated Nanosized Bimodal Mesoporous Carbon Spheres
for Controlled Release Applications
Figure 4.3: (a, b) STEM-HAADF images of mesoporous NCS particles at different magnifications, obtained after
HF treatment. Nitrogen sorption measurements reveal a type IV isotherm (c) and a bimodal pore size distribution
(b).
achieved. The bimodal porosity, resulting from the removal of F127 and silica from
the walls, exhibits two maxima at 5.9 and 3.1 nm, respectively. These properties
suggest that these small mesoporous particles are attractive candidates for introdu-
cing chemical functionality and for applications as potential drug delivery system.
For the creation of an SLB@NCS system, the hydrophobic particle surface had to
be oxidized. Here we used a procedure already known in the literature. [38] The
successful oxidation of NCS in a solution of ammonium persulfate in sulfuric acid
is shown by IR spectroscopy (Figure 4.4). The two peaks arising at 1725 cm−1
and 1618 cm−1 can be attributed to carbonyl (carboxylic acid and keto-groups)
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and hydroxyl groups formed during the oxidation process (black curve). This nega-
tively charged surface can now interact with the positively charged head groups of
the phospholipids, which facilitates the formation of an SLB around the NCS. To
show the potential of SLB@NCS as a release-on-demand system, we demonstrate
that the SLB is able to prevent any premature release of dye molecules out of the
mesostructure.
Figure 4.4: Infrared spectroscopy of as synthesized (red) and oxidized NCS (black).
For this purpose, we loaded a fluorescent dye (calcein) as a model for drug
molecules into the mesopores of NCS and capped the nanospheres with a lipid
bilayer containing DOPC and DOTAP (Figure 4.7). Afterwards, the calcein-loaded
SLB@NCS were transferred into a tube sealed with a dialysis membrane (Figure
4.5 a) and mounted on top of a fluorescence cuvette filled with water. The membrane
only allows the dye molecules to diffuse into the cuvette, whereas the NCS stay
entrapped in the tube. As long as the cap system blocks the release of the dye, no
fluorescence signal can be detected (Figure 4.5 b). [28,39]
In this experiment, even after 4 h, no significant release was observed. Only
after rupture of the SLB through the addition of the surfactant Triton X-100, dye
molecules were able to diffuse out of the bimodal porous carbon particles across
the membrane into the cuvette. The entire amount of calcein was released within
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Figure 4.5: (a) Schematic presentation and photo of the release setup. (b) Release profile of calcein in SLB@NCS.
3 h (also see appendix, Figure 4.8). The amount of 121 µg calcein per mg NCS
illustrates the very high loading capacity of these highly porous carbon spheres (for
calculation, see appendix).
4.4 Conclusions
We present a strategy for the synthesis of 60 nm large and colloidal nanosized carbon
spheres (NCS). Their bimodal porosity features a high BET surface area as well
as a high pore volume, which makes them attractive candidates for drug delivery
agents with high loading capacity. The synthesis is based on the replication of small
macroporous silica hard templates, by concerted co-assembly of a mixture of resol,
TEOS and Pluronic F127. After successive thermopolymerization, carbonization
and silica removal, the bimodal mesoporous carbon spheres can be separated into
colloidal NCS by oxidative treatment. The mesoporous nanoparticles were loaded
from solution with fluorescent calcein as model drug and efficiently sealed with a
stable supported lipid bilayer (SLB) cap system. Molecular release experiments
demonstrate the effective closure and release of this system, providing a tight seal
until the addition of Triton X-100, which destabilizes the lipid bilayer and initiates
a complete and controlled release of the fluorescent dye from the highly porous
carbon. Therefore, our results show the ability of SLB@NCS as effective cap system
around colloidal mesoporous carbon nanoparticles with enhanced loading capacities
for controlled release applications.
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4.5 Appendix
SAXS
Figure 4.6: Small-angle X-ray scattering of dried NCS particles.
Chemical structures of the used phospholipid (DOPC, Avanti Polar Lipids)
and lipid (DOTAP, Avanti Polar Lipids)
Figure 4.7: Chemical structures of 1,2-dioleoyl-sn-glycero-3-phosphocholine (a, DOPC) and 1,2-dioleoyl-3-
trimethylammonium-propane (b, DOTAP).
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UV-Vis
Figure 4.8: UV-Vis spectrum of SLB@NCS dispersion before (black) and after (red) the release experiment.
The black line represents SLB@NCS loaded with calcein. The peak shows the
absorption of the loaded calcein. After the release (red line), no peak is visible,
indicating complete release of the fluorescent dye out of the porous carbon particles.
The absolute amount of calcein released from the sample SLB@NCS was quanti-
fied by fluorescence spectroscopy. A calcein calibration curve was recorded in the
fluorescence spectrometer (Figure 4.9).
Figure 4.9: Calcein calibration curve.
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Calculation of calcein in SLB@NCS
After reaching the plateau at the end of the release experiment, 257826 counts
per second were detected. This intensity leads to a calcein concentration of 10.08
µg mL−1 by using the linear regression of the calibration curve. The cuvette has a
volume of 3 mL which corresponds to an original amount of 30.23 µg calcein.
For the release experiment, only 200 µL of the original 800 µL sample dispersion were
used. Thus the original amount of calcein in 1 mg NCS is calculated to 120.93 µg.
For loading the particles, 500 µL calcein stock solution (1 mM) was used correspond-
ing to a total amount of 311 µg calcein.
In total, 120.93/311 (38.9%) of the initial calcein amount of the stock solution was
adsorbed by the NCS particles.
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Chapter 5
Multifunctional Polymer-Capped
Mesoporous Silica Nanoparticles for
pH-responsive Targeted Drug
Delivery
The following work is based on a joint project with Veronika Weiss, Annika Herr-
mann, Alexandra Schmidt, Daniel Edinger, Ernst Wagner, Christoph Bräuchle and
Thomas Bein
5.1 Introduction
Polymers can be attractive for biological applications due to their biocompatibility,
tuneable properties and derivation from sustainable sources. [1–3] Therefore, polymers
are widely used as responsive coatings of surfaces for selective ion-permeability, [4]
surface structuration [5] and drug delivery with polyplexes, [1,6,7] hybrid dendrimers, [8–10]
and other drug-polymer conjugates. [11,12] Possible issues of pure polymer based drug
delivery vehicles may arise from low loading capacities, the relatively poor stability,
leading to premature release of the drug molecules and an inhomogeneous distribu-
tion thereof in the polymer matrix. [13] On the other hand, recently much effort has
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been extended towards the development of inorganic nanoparticles, such as meso-
porous silica nanoparticles (MSNs) for the delivery of bioactive compounds to cells
and tumors. [14–18] MSNs have a high loading capacity and can be functionalized in-
ternally and on the external surface. [19] To prevent premature release out of these
mesoporous systems, different strategies like covalent attachment of the cargo inside
the mesopores [20,21] or complete capping of the whole particle [22–24] have been per-
sued. The release mechanisms include changes in reduction potential, [21] pH, [15,23]
temperature, [20] and irradiation with light. [12,17,21,25] A combination of the high load-
ing capacity and stability of mesoporous nanoparticles with the biocompatibility and
tuneable properties of polymers offers the possibility to create a stimuli-responsive
and reversible delivery system. For instance, You et al. showed the release be-
haviour of poly(N -isopropylacrylamide) coated mesoporous silica at different tem-
peratures. [26] Drug delivery vehicles based on nanoparticles in a size range of 100 nm
are likely to be taken up by cells via endocytosis. [27] During this process, the endo-
some is being acidified by the action of proton pumps. [28,29] Therefore, pH-responsive
polymer coatings around mesoporous silica nanoparticles offer the possibility to use
the changes in pH during endocytosis as trigger for controlled release. For instance,
attachment of poly(acrylic acid) [30] or poly(2-(diethylamino)ethyl methacrylate) [31]
showed the ability to act as functional polymer coatings around mesoporous silica
nanoparticles. Liu et al. demonstrated the use of poly(4-vinylpyridine) as pH-
responsive capping system for mesoporous silica through multipoint anchoring in a
”grafting to" method. [23] Poly(2-vinylpyridine) (PVP) has been widely used for the
pH-sensitive functionalization of surfaces, due to the pronounced transition between
hydrophilicity and hydrophobicity upon protonation and deprotonation. [5] Atkin et
al. presented a combination of non-porous silica particles and polyvinylpyridine that
could be useful for specific adsorption applications. [32]
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Figure 5.1: Concept of the pH-responsive delivery system. The pores can be reversibly opened and closed through
changes in the water solubility of the polymer.
Here, we describe a multifunctional drug delivery vehicle that combines the high
loading capacities of a mesoporous silica core and environmental sensitivity of a pH-
responsive polymer. As shown in Figure 5.1, at low pH, the protonated polymer is in
a hydrophilic state and therefore, cargo molecules are able to diffuse into and out of
the mesoporous silica nanoparticle. At pH values of 5.5 or higher, deprotonation of
the polymer takes place, producing a hydrophobic state followed by a collapse of the
polymer onto the silica surface, preventing premature release of the cargo. Due to the
pH-responsive switching behavior of the polymer, a site specific release mechanism is
introduced to the delivery vehicle. After endocytic uptake of the particles by a cell,
the endosomes are acidified by proton pumps which are present in the endosomal
membrane. [28] The change in pH can automatically lead to a switch of the particle
into its open state, and therefore trigger the release into the endosomal compartment.
A major advantage of this delivery vehicle is offered by the reversibility of the cap
system. Once the particles have been excreted by the cell before having released
all of their cargo, the cap system is able to return into the closed state due to the
environment (pH > 7) outside of the cell. [28] To maintain colloidal dispersibility, even
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in the hydrophobic closed state, poly(ethylene glycol) was attached to the end of the
PVP cap system. The use of α-,ω-bis-functionalized polymers offers the possibility
for anchoring any functionality of interest (photosensitizers, targeting ligands) step
by step (Figure 5.1).
5.2 Experimental Section
Chemicals
All reagents were purchased from commercial suppliers: tetraethyl orthosilicate
(TEOS, Fluka, >98%), cetyltrimethylammonium bromide (CTAB, Aldrich, 95%),
(3-aminopropyl)triethoxysilane (APTES, Fluka, 95%), (3-mercaptopropyl)triethoxy-
silane (ABCR),N -(3-dimethylaminopropyl)-N -ethylcarbodiimide hydrochloride (EDC,
Fluka, 97%), α-amino-ω-carboxy terminated poly(2-vinylpyridine) (NH2-PVP-COOH,
Polymer source, Mn = 10000, PDI = 1.08), α, ω-polyethyleneglycolbisamine (NH2-
PEG-NH2, Aldrich, Mn = 2000), Boc anhydride (Aldrich, 95%), folic acid (Sigma,
99%), aluminum (lll) Phthalocyanine chloride tetrasulfonic acid (AlPcS2a, Fron-
tier Scientific), N -hydroxysulfosuccinimide sodium salt (Sulfo-NHS, Aldrich, 98%).
Doubly distilled water from a Millipore system (Milli-Q academie A-10) was used for
all syntheses and purification steps. All solvents and buffer contents were purchased
from Sigma-Aldrich. Unless otherwise noted, all reagents were used without further
purification.
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Materials synthesis:
Figure 5.2: Representation of the synthesis strategy.
Preparation of shell-functionalized colloidal mesoporous silica nanoparti-
cles (MSN-NH2)
MSN nanoparticles were prepared by a delayed co-condensation approach as de-
scribed earlier by Cauda et al. [19] In detail, a two phase mixture of TEA (14.3 g)
and TEOS (1.9 g, 9.12 mmol) was heated at 90 ◦C for 20 minutes without stirring.
After removal of the oil bath, a preheated (60 ◦C) solution of CTAC (2.14 mL,
1.62 mmol, 25 wt% in H2O) and water (21.7 g) was added and stirred after-
wards at 500 rpm for 30 min at room temperature. Subsequently, a mixture of
3-aminopropyltriethoxysilane (22.5 µL, 96 µmol) and TEOS (20.5 µL, 92 µmol) was
added. The resulting solution was stirred overnight at room temperature at 500
rpm. The particles were separated by centrifugation (19000 rpm, 43146 rcf) and
redispersion in ethanol. Extraction of the organic template was achieved by hea-
ting the ethanol-suspended sample (10 mg/mL) under reflux at 90 ◦C for 1 h in a
mixture of 2 g ammonium nitrate and 100 mL ethanol. Afterwards, the sample was
centrifuged for 20 minutes at 19000 rpm, redispersed in ethanol and heated under
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reflux at 90 ◦C in a solution of 8 mL concentrated HCl and 32 mL ethanol for 45
minutes. After centrifugation, the particles were redispersed in ethanol, resulting in
a colloidal suspension.
Protection of NH2-PVP-COOH (Boc-PVP-COOH)
To a solution of 500 mg (5 µmol) NH2-PVP-COOH in 10 mL dry dichloromethane, 15
µL (0.11 mmol) triethylamine and 15 mg (6.9 µmol) Boc anhydride were added. The
solution was stirred overnight at room temperature and extracted several times with
brine. The organic phase was dried over MgSO4 and evaporated to dryness to afford
the Boc protected polymer. The polymer was used without further purification.
General procedure for the attachment of poly(2-vinyl pyridine) to MSN-
NH2 (MSN-PVP-Boc)
To a dispersion of 50 mg MSN-NH2 in 10 mL tetrahydrofuran (THF), 60 mg
(5.6 µmol) polymer dissolved in 1.5 mL THF was added. The amidation was acti-
vated by the addition of 10 µL (57.2 µmol) EDC and 1.3 mg (6 µmol) sulfo-NHS.
The mixture was stirred at room temperature for 12 h. Afterwards the particles
were separated by centrifugation (19000 rpm, 43146 rcf, 20 min) and washed three
times by repeated centrifugation and redispersion in 30 mL THF.
Deprotection of MSN-PVP-Boc (MSN-PVP-NH2)
Deprotection of the polymer was achieved through stirring 10 mg polymer func-
tionalized particles in a mixture of 2 mL trifluoroacetic acid and 8 mL water for
24 h. After deprotection, the particles were extensively washed by centrifugation
(19000 rpm, 43146 rcf, 20 min) and redispersion in a mixture of EtOH:water 1:1.
Conversion of MSN-PVP-NH2 to MSN-PVP-COOH
10 mg MSN-PVP-NH2 in 2 mL EtOH (taken from a stock solution) were reacted
with a large excess of oxalic acid (5 mg, 55 µmol) and EDC (9 µL, 51 µmol) for 1
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h. Afterwards the particles were extensively washed by centrifugation (19000 rpm,
43146 rcf, 20 min) and redispersion in a mixture of of EtOH:water 1:1.
PEGylation of MSN-PVP-COOH (MSN-PVP-PEG-NH2)
To a dispersion 1 mg MSN-PVP-COOH (taken from a stock solution) in 500 µL
EtOH, 2 mg (100 nmol) NH2-PEG-NH2 in 500 µL bidistilled water was added and
the reaction was started through the addition of 0.5 µL (2.8 µmol) EDC. After stir-
ring for 1 h at room temperature, the sample was washed 3 times by centrifugation
with a mixture of EtOH:water 1:1.
Attachment of folic acid to MSN-PVP-PEG-NH2 (MSN-PVP-PEG-NH2-
FA)
The amino functionalities of 1 mg MSN-PVP-PEG-NH2 in 1 mL EtOH:water 1:1
were partially reacted with 0.44 µg (1 nmol) folic acid. To start the reaction, 0.5 µL
(2.8 µmol) EDC and a very small amount (≈0.5 mg) of sulfo-NHS were added. After
1 h, the sample was washed 3 time by centrifugation with a mixture of EtOH:water
1:1.
Attachment of AlPcS2a to residual amino groups of MSN-PVP-PEG-NH2-
FA (MSN-PVP-PEG-FA-AlPcS2a)
To the sample MSN-PVP-PEG-NH2-FA in 1 mL DMSO:water 1:1 was added 20 µL
of AlPcS2a (1 mg/mL in DMSO). The resulting mixture was stirred at room tem-
perature in the dark for 24 hours. Subsequently, the sample was washed extensively
with DMSO:water 1:1 (centrifugation 19000 rpm) until there was no photosensitizer
in the supernatant.
Release experiments:
Drug/dye loading
1 mg MSN-PVP-PEG-NH2 were dispersed in 500 µL of a 1 mM drug/dye solution
in water. To open the pores and enable the uptake, 50 µL of citrate buffer (pH
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2) were added. The particles were stirred overnight, centrifuged (19000 rpm), and
redispersed in 1 mL SSC buffer (pH 7) to trigger closure of the polymer shell. The
particles were washed extensively with SSC buffer until no fluorescence was detected
in the supernatant.
In vitro fluorescein release
1 mg fluorescein loaded MSN-PVP-NH2 or MSN-PVP-PEG-NH2 were redispersed
in 200 µL SSC buffer and transferred to the cap of the fluorescence cuvette. This
cap is sealed with a dialysis membrane (molecular weight cutoff of 16000 g/mol)
and placed on top of the fluorescence cuvette, which is also filled with 3 mL SSC
buffer. The ”release" of fluorescein out of the closed particles was monitored for
2 h (λex = 490 nm, λem = 512 nm). Subsequently, the cap was removed and the
particles were centrifuged and redispersed in 200 µL citrate-phosphate buffer (pH
5), before being put into the cap of the release setup. The fluorescence cuvette was
also filled with citrate-phosphate buffer (pH 5). After reassembling of the release
setup, the release of fluorescein was measured for 10 h continuously. For comparison
of the obtained curves, calibration curves of fluorescein in SSC buffer (pH 7) and in
citrate-phosphate buffer (pH 5) were recorded.
Cell culture and in vitro experiments:
Cell culture
KB cells were grown in folic acid deficient Roswell Park Memorial Institute 1640
medium (RPMI 1640, Invitrogen) supplemented with 10% fetal bovine serum (FBS).
HeLa cells were grown in Dulbecco’s modified Eagle’s medium (DMEM):F12 (1:1)
(Invitrogen) with Glutamax I medium supplemented with 10% FBS. Tubulin-GFP
expressing HuH7 cells were grown in Dulbecco’s modified Eagle’s medium:F12 (1:1)
supplemented with 10% FBS. All cells were cultured at 37 ◦C in a 5% CO2 humidified
atmosphere. KB cells were seeded on ibidiTreat µ-Slides (IBIDI). HeLa and tubulin
GFP expressing HuH7 cells were seeded on collagen A-coated LabTek chambered
cover glass (Nunc). For live cell imaging the cells were seeded 48 or 24 h before
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measuring, at a cell density of 1x104 or 2x104 cells / cm2 respectively.
Spinning disc confocal microscopy
Live-cell imaging was performed on a confocal setup based on the Zeiss Cell Observer
SD, utilizing a Yokogawa spinning disc unit CSU-X1. The system was equipped
with a 1.40 NA 100x or 63x Plan apochromat oil immersion objective from Zeiss.
The exposure time was 0.1 s for all experiments und the frame rate varied between
3 frames / s and 1 frame / 30 s, depending on the experiment. WGA 488 and
GFP were imaged with approximately 1.5 W / mm2 and 7.5 W / mm2 of 488 nm
excitation light. Atto 633 was imaged with approximately 0.06 W / mm2 of 639
nm excitation light and DAPI with 1 W / mm2. The photosensitizer AlPcS2a was
excited with approximately 0.12 W / mm2 at 639 nm for imaging and with 1.2 W /
mm2 for photoactivation. In the excitation path a quad-edge dichroic beamsplitter
(FF410/504/582/669-Di01-25xx36, Semrock) was used. For the two-color detection
of calcein and AlPcS2a, WGA 488 and Atto 633 or GFP and Atto 633, a dichroic
mirror (660 nm, Semrock) and band-pass filters 525 / 50 and 690 / 60 (both semrock)
were used in the detection path. Separate images for each fluorescence channel were
acquired using two separate electron multiplier charge coupled devices (EMCCD)
cameras (Photometrics EvolveTM).
Uptake studies
The functionality of the folic acid targeting ligand was evaluated in a receptor com-
petition experiment. For this purpose one part of the KB cells was preincubated
with 3 mM folic acid (Sigma), to block the receptors, for 2 h at 37 ◦C under a
5% CO2 humidified atmosphere. Then the KB cells were incubated with particles
(MSN-PVP-PEG-FA, covalently labeled with Atto633; 25 µg/mL) for 2 h at 37 ◦C
under a 5% CO2 humidified atmosphere. After the incubation the cells were washed
three times with PBS (Invitrogen) and 250 µL of 4% paraformaldehyde (PFA, Sci-
ence Service) were added for 15 min. The PFA was removed and the cells were
washed again three times with PBS. For staining the cell membrane, the cells were
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incubated with a final concentration of 10 µg/mL wheat germ agglutinin Alexa Fluor
488 conjugate (WGA 488, Invitrogen) for one minute. The cells were washed once
with PBS and imaged.
Cargo release experiments
To measure the photoactivated cargo release the cells were incubated with particles
(MSN-PVP-PEG-AlPcS2a-FA, 25 µg/mL) for 16-20 h at 37 ◦C under a 5% CO2
humidified atmosphere. For imaging the medium was replaced by CO2-independent
medium (Invitrogen), during the measurements the cells ware kept on a heated
microscope stage at 37 ◦C. For activation of the photosensitizer the cells were irra-
diated with 1.2 W / mm2 of 639 nm light for 1 min. The release of cell-membrane
permeable cargo due to pH-dependent opening of the PVP-coating inside the endo-
somes was also measured. For this purpose tubulin GFP expressing HuH7 cells in
the case of colchicine-release were incubated with particles (MSN-PVP-PEG-loaded
with colchicine, 100 µg/mL) for 18 h at 37 ◦C under a 5% CO2 humidified atmo-
sphere. In the case of DAPI-release HeLa cells were incubated with either particles
(MSN-PVP-PEG loaded with DAPI, 25 µg/mL) or the quantitatively equal amount
of supernatant of centrifuged particles (14000 rcf, 4 min.). Incubation times of 15
min, 15 h and 46 h under a 5% CO2 humidified atmosphere were chosen to demon-
strate the pH- and therefore time-dependent release of DAPI.
In vivo experiments
For all in vivo experiments female Rj:NMRI-nu (nu/nu) (Janvier, Le Genest-St-Isle,
France) mice were housed in isolated ventilated cages with a 12 h day/night cycle
and food and water ad libitum. Animal experiments were performed according to
guidelines of the German law of protection of animal life and were approved by the
local animal experiments ethical committee.
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MSN retention in tumors
Human cervix carcinoma cells (KB wild-type) were cultured as described above.
Mice were injected with 5x106 cells subcutaneously into the nape and tumors were
allowed to grow for 14 days. At day 14, mice were anesthetized with 3% isoflurane
in oxygen and 100 µg (5 mg/kg) of Cy-7 labeled MSN-PVP-PEG-NH2 with and
without folic acid ligand solved in 50 µL (HBG) were injected intratumorally to
test for differential retention in tumors. The near infrared fluorescence signals were
recorded by a CCD camera immediately after injection and recording was repeated
after 0.25, 0.5, 1, 4, 24 h and daily for one week using the IVIS Lumina system. Data
interpretation was done with equalized color bar scales for each trial and pictures
were analyzed using the Living Image software 3.2 (Caliper Life Sciences, Hopkinton,
MA, USA).
MSN biodistribution
For analysis of MSN, mice were anesthetized with 3% isoflurane in oxygen. A 100 µg
(5 mg/kg) dose of Cy-7 labeled MSN-PVP-PEG-NH2-FA or unfunctionalized MSN
solved in 200 µL (HBG) was injected intravenously into the tail vein of tumor-free
mice. Near-infrared fluorescence imaging by a CCD camera using the IVIS Lumina
system with Living Image software 3.2 (Caliper Life Sciences, Hopkinton, MA, USA)
was started immediately after injection and repeated after 0.25, 0.5, 1, 4, 24, 48 and
72 h.
5.3 Results and Discussion
Particle characterization
According to TEM, the shell functionalized mesoporous silica nanoparticles show an
average particle diameter of 90 nm with a wormlike pore structure (Figure 5.3 a).
Stepwise functionalization with poly(2-vinylpyridine) and PEG was monitored with
several methods and will be discussed in the following.
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Figure 5.3: Characterization of functionalized MSN. (a) transmission electron microscopy, (b) dynamic light
scattering, (c) titration experiments (d) thermogravimetric analysis, (e) infrared spectroscopy, (f) nitrogen sorption.
DLS measurements revealed the need of PEG as stabilizing agent. The hydrody-
namic diameter of shell functionalized MSN in water could be determined to 160 nm
(Figure 5.3 b). MSN nanoparticles functionalized with PVP show strong aggrega-
tion in aqueous media due to its hydrophobicity at pH 7 as can be seen by an
apparent size increase to 550 nm (See appendix Figure 5.15). However, the attach-
ment of PEG to the end group of PVP recovers the colloidal nature of the system
(DLS reveals a size of around 200 nm again).Titration experiments are shown in
Figure 5.3 c. The high zeta potential (+50 mV) of MSN-PVP represents the fully
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protonated state of pyridine. Deprotonation of the polymer cap system occurs at a
pH value of around 5.5 (close to the pKa of PVP), leading to a significant drop in
zeta potential. Together with the zeta potential, DLS measurements were performed
simultaneously at the same pH values. For MSN-PVP the particles showed good col-
loidal dispersability as long as the polymer remained in its protonated state (Figure
5.3 c). Upon deprotonation, the polymer collapses on the particle surface, forming
a hydrophobic shell around the particles which can be observed in the increase in
size due to agglomeration. Further attachment of PEG led to the suppression of
aggregation as no changes in size were observed over the whole pH-range for MSN-
PVP-PEG (Figure 5.3 c).
The functionalization of the mesoporous silica nanoparticles was also monitored
with TGA (Figure 5.3 d). While the shell functionalized nanoparticles (MSN-NH2)
show a relative mass loss of 14.6% (2.97 mmol per gram silica), the relative mass
loss of 61.6% for MSN-PVP-NH2 corresponds to 0.14 mmol PVP per gram silica.
Only 4.7% of the amino-groups present at the surface have reacted with the poly-
mer. Based on the mass loss of 80.4% in the sample MSN-PVP-PEG, the amount
of 1.3 mmol PEG per gram silica could be calculated. This result shows that addi-
tional attachment of PEG to the shell of the MSN must have occurred besides the
attachment to the end of the polymer cap system. IR spectroscopy serves to follow
each step of the synthesis (Figure 5.3 e). The signals at 1590 cm−1 and 1570 cm−1
correspond to the C=C stretch vibrations of the aromatic pyridine ring and can be
found in all spectra after attachment to MSN. Additionally, in these spectra the
C=N stretch vibrations of the aromatic ring can be found at 1474 cm−1 and 1430
cm−1. After deprotection of MSN-PVP and conversion of the amino group into a
carboxy functionality with oxalic acid, a peak at 1677 cm−1 appears which can be
attributed to the asymmetric C=O stretching vibration of MSN-PVP-COOH. This
peak vanishes after the addition of poly(ethylene glycol) bisamine, which underlines
the successful attachment of PEG.
In order to show the ability of poly(2-vinylpyridine) to act as a pH responsive cap
system, nitrogen sorption measurements were performed (Figure 5.3 f, Table 5.1).
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For MSN-PVPopen, the particles where dried from a 0.01 M HCl dispersion at 60
◦C, to keep the PVP functionalized MSN in an open state. The closed state could
be realized through drying from a dispersion in Millipore water. It can be seen that
in the open state, the pores are accessible, whereas in the closed state, the poly-
mer completely blocks the pores. The BET surface area of 51 m2/g in the closed
state is in very good agreement with an estimated BET surface area of 45 m2/g of
spheres with similar density and diameter. The BET surface area of 51 m2/g for
MSN-PVPclosed corresponds to a reduction in surface area of 95% compared with
MSNs without polymer cap system (MSN-NH2), indicating that the surface of the
pore walls after blocking is not accessible, even for nitrogen.
Table 5.1: Summary of nitrogen sorption measurements.
Sample BET surface area NLDFT pore size NLDFT pore volume
[m2/g] [nm] [cm3/g]
MSN-NH2 1097 3.78 0.79
MSN-PVPopen 617 3.42 0.36
MSN-PVPclosed 51 - -
Release experiments
To verify the release properties of the particle-system several experiments were per-
formed. First the pH dependency was tested in vial, in a cuvette system, at pH 7
and pH 5. Second the particles were tested in vitro, therefore they were incubated
with cells to clarify if the acidification of the endosome is efficient enough to deliver
the cargo. For that purpose the MSN were loaded with membrane-permeable and
membrane-impermeable cargos and incubated for several hours with cells. As for
membrane-impermeable cargos no endosomal escape could be observed, a photo-
sensitive molecule was introduced to the system in order to trigger the endosomal
escape externally.
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In vial
The pH-responsive opening of the polymer cap system was demonstrated by quan-
tification of the released calcein molecules with fluorescence spectroscopy (Figure 5.4
a). All intensity values are normalized to the highest obtained fluorescent counts
of the respective sample. Therefore, the highest amount released is set to 100%
relative release. The pH-dependent release curves show the striking capping effect
of the poly(2-vinylpyridine) cap system. At pH 7, the polymer is in its hydrophobic
state and thus successfully blocks the pores of the MSN until the release is triggered
through decreasing the pH. In acidic media, the polymer changes into its water so-
luble hydrophilic state through protonation which allows the cargo the diffuse out of
the pores. As can be seen in Figure 5.4 a, no significant changes in release kinetics
are observed through further attachment of PEG compared with MSN-PVP. The
total amount of cargo loaded into the MSNs could be calculated to 20.4 µg dye per
mg MSN. Long-term release experiments showed that even after 16 h less than 4%
of the initial loading had been released (Figure 5.4 b).
Figure 5.4: Release curves (normalized fluorescence intensity of fluorescein) of (a) MSN-PVP (red) and MSN-
PVP-PEG (blue). (b) Long-term release experiments of MSN-PVP.
In vitro
The release of cargo inside the desired tissue is one of the greatest challenges in drug
delivery. Many systems have been developed and characterized, like fusion, redox-
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sensitive systems and photoactivation. [29] Some of these systems exhibit already a
good temporal and spatial control of the cargo-release. But once they are activated,
the release of the cargo is unstoppable, even if the particles leave the tissue of
interest. One advantage of our newly developed system is the reversibility of the
pore opening. If the pH of the environment turns neutral again, PVP will close the
pores and the delivery system can safely circulate inside the blood system.
Photoactivated release
In the first experiments, MSN-PVP-PEG particles, loaded with calcein were incu-
bated on HeLa cells for 20 h. The incubation time is long enough to allow the
endosomal acidification. [33] But as can be seen in Figure 5.5, the fluorescence colo-
calization of the membrane-impermeable cargo calcein and the covalently to the
particles bound dye Atto 633 remained. Calcein is a membrane impermeable cargo
and therefore is not able to exit intact endosomal compartments without external
trigger, but it should be released inside the endosomal compartment.
Figure 5.5: Fluorescence microscopy of MSN(Atto633)-PVP-PEG (25 µg/mL) nanoparticles loaded with calcein
inside HeLa cells after 20 h incubation. (a) merge of brightfield image and fluorescence image. (b) fluorescence
image of calcein (green) and Atto633 (red) are co-localized (yellow), no spreading of calcein can be observed, thus
no endosomal escape. The scale bar represents 10 µm.
For membrane-impermeable cargos the system had to be further enhanced to
induce endosomal escape. Thus the photosensitizer AlPcS2a (PS) was linked to the
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PEG-chains, in addition to the pH-sensitive polymer. Endosomal escape is expected
to occur after acidification of the endosomes and activation of the photosensitizer
with red light. After activation with red light (639 nm, 1.2 W / mm2) singlet oxygen
is produced and can destroy the endosomal membrane. But as the lifetime of the
singlet oxygen is very short (around 2 x 10−7 s) [34] the diffusion range is limited and
therefore the cargo and also the cell membrane should stay intact, because of the
spatial separation of cargo or cell membrane and PS. Also the red activation region
of the photosensitizer is in a useful region for medical applications and is already
used in photodynamic therapy. [35]
MSN-PVP-PEG-AlPcS2a-FA were incubated on HeLa cells for 18 h. As can be seen
in Figure 5.6 calcein and PS are co-localized (yellow spots, Figure 5.6 c). Directly
after 1 min photoactivation with 1.2 W / mm2 of 639 nm light calcein-spreading
over the whole cell can be observed, and the calcein-fluorescence gets brighter over
time due to de-quenching of the dye (Figure 5.6 e, i, m). In comparison to calcein
the fluorescence of the photosensitizer stays localized in the same dot-like pattern as
before the photo-activation, only the intensity is reduced because of photo-bleaching
effects after the activation (Figure 5.6 f, j, n). The intensity profile along the white
line, indicated in the merged pictures, depict the fluorescence increase of calcein
more clearly (Figure 5.6 d, h, l, p). The cargo release can be also visualized with
a constant PS-activation and simultaneous observation of calcein fluorescence (over
8 min; Figure 5.7). Within two minutes a significant part of the cargo seems to be
released inside the cell.
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Figure 5.6: Fluorescence microscopy of MSN-PVP-PEG-AlPcS2a-FA nanoparticles loaded with calcein after 18 h
incubation on a HeLa cell. (a-c) Calcein (green) and AlPcS2a (red) are co-localized (yellow) prior to photoactiva-
tion. (d) Intensity profile along the white line in the merged image. The red line indicates photoactivation with
1.2 W / mm2 of red light (639 nm). (e-h) after 1 min. photoactivation, (i-l) 5 min. after photoactivation, (m-p)
10 min after photoactivation. The scale bar represents 10 µm.
128
5.3. Results and Discussion
Figure 5.7: Fluorescence microscopy of MSN-PVP-PEG-AlPcS2a-FA (25 µg/mL) nanoparticles loaded with calcein
inside HeLa cells after 24 h incubation. (a-c) calcein (green) and AlPcS2a (red) are co-localized (yellow) prior to
photoactivation. The cell was constantly monitored with a frame rate of 1 frame/s and 0.6 W / mm2 of red light
(639 nm). (d-i) example images after different time points, spreading of calcein can be clearly seen over time,
whereas AlPcS2a stays at the same place. (j) intensity of calcein fluorescence inside the cytosol over time in the
indicated rectangle, after approximately 2 min. increase can be monitored. The scale bar represents 10 µm.
These results were compared to incubation of cells with a solution of free calcein
and PS. As can be seen in Figure 5.8 the amount of internalized calcein is neglible.
We also observe that the PS is spreading over the whole cell. If the PS is not
covalently bound to an MSN the molecules can diffuse inside the whole cell and can
cause much more damage on the cell membrane and other organelles due to the
proximity.
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Figure 5.8: Fluorescence microscopy of free calcein and free AlPcS2a (each 2.5 µg / mL) inside HeLa cells after
24 h incubation. (a-c) Calcein (green) and AlPcS2a (red) are co-localized (yellow) prior to photoactivation. The
cell was constantly monitored with a frame rate of 1 frame / s and 0.6 W / mm2 of red light (639 nm). (d-i)
example images after different time points, spreading of AlPcS2a can be clearly seen over time, whereas the calcein
fluorescence is too weak to be detected after some time. (j) intensity of calcein fluorescence inside the cytosol over
time in the indicated rectangle, no increase inside the cytosol can be detected. The scale bar represents 10 µm.
Release of membrane-permeable cargos
To safely deliver membrane-permeable cargos like DAPI [36] or colchicine [37] inside
cells with our newly developed system the attachment of other endosomal escape
mechanisms is not necessary. It is anticipated that the particles will get uptaken
in endosomal compartments and in the following the endosomes get acidified. This
drop in pH from around 7 to approximately 5 results in the solvation of poly(2-
vinyl pyridine) and thus in release of the cargo out of the pores into the endosome
and consequently into the cytosol if it diffuses through the endosomal membrane.
On the other hand, if the particles get exocytosed the pH will increase and poly(2-
vinyl pyridine) will turn insoluble again. In this case the cargo will stay inside the
particles and they can circulate again and possibly find a new target cell. As model
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systems to examine the delivery of membrane permeable cargos DAPI or colchicine
were used. DAPI preferentially stains dsDNA and thereby produces a fluorescence
enhancement of around 20-fold. [38] In Figure 5.9 the staining of the nucleus after
several time intervals is shown. Shortly after incubation only a weak staining of the
nucleus can be seen, after 15 h the nucleus is clearly visible and after 46 h even the
RNA inside the region of the endoplasmic reticulum gets stained. Because of the
increasing and very strong DAPI-fluorescence signal after several hours of incubation
it could be excluded that the staining is due to free DAPI in the particle solution.
Tests with incubation of particle supernatant show only a negligible staining of the
nucleus (as can be seen in the appendix in Figure 5.20). In the case of free DAPI in
the solution it also would be expected to be detectable shortly after addition, as the
proposed incubation time for nucleus staining with free DAPI in solution is between
1-5 minutes.
Figure 5.9: Fluorescence microscopy of HeLa cell incubated with MSN-PVP-PEG nanoparticles loaded with DAPI
(blue) and labeled with Atto 633 (red) after (a) 15 min (b) 15 h and (c) 46 h incubation on the cells. The nuclear
region is indicated with dashed white circles. The scale bar represents 10 µm.
The second cargo colchicine hinders the polymerization of microtubuli as it binds
to free tubulin. [37] It is blocking the formation of the mitotic spindle but not the
mitosis itself. For this study stable GFP-transfected liver carcinoma cells (HuH7)
were used, such that GFP is attached to the tubulin network. In Figure 5.21 b) a
picture of untreated HuH7 cells with GFP tagged on the tubulin network is depicted,
one can clearly see the fibrous tubulin network. As shown in Figure 5.21 a) MSN-
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PVP-PEG (red) particles loaded with colchicine were incubated for 18 h, and as can
be clearly seen, the fibrous structure vanished completely, because the new formation
of the network is hindered.
Targeting experiments
To achieve an effective drug delivery system, a targeting system is highly desirable.
Generally one can distinguish between passive and active targeting. Modifications
such as attaching PEG at the surface of the delivery system provide shielding against
undesired interactions, and therefore favor the enhanced permeability and retention
effect (passive targeting). Active targeting, on the other hand, takes advantage of
the overexpression of certain ligands on diseased cells by attachment of the corre-
sponding targeting ligand to the delivery vehicle. [39] Therefore the biocompatibility
and effectiveness of the PEGylation procedure was tested further in an in vivo set-
ting in mice. Active targeting was shown in vitro and in vivo using the example of
folic acid (FA) receptor targeting on KB-cells.
Figure 5.10: Unspecific and receptor-mediated uptake of MSN-PVP-PEG-FA particles by KB cells. (a) Incubation
of MSN-PVP-PEG-FA particles with FA pre-incubated KB cells for 2 h at 37 ◦C. (b) Incubation of MSN-PVP-
PEG-FA particles with KB cells, no free FA in cell culture medium, for 2 h at 37 ◦C. The KB cell membrane is
shown in green (WGA 488) and the particles in red (Atto 633). Orthogonal views are given to illustrate the uptake
more precisely. The scale bar represents 10 µm.
In vitro model. The attachment of active targeting ligands is important to
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achieve a functional drug delivery system. [40] Folic acid was chosen as targeting li-
gand because it is an ideal model system for targeting with a small molecule and is
also believed to be a promising candidate in clinical applications. [41] Furthermore the
covalent binding of folic acid to the particles can be achieved with an EDC-mediated
coupling and could be easily substituted by other targeting ligands without chan-
ging the coupling chemistry. To demonstrate the functionality of the particles, they
were incubated on KB-cells, which are known to overexpress FA-receptors. [41] In a
competition experiment, with either free folic acid to block the FA-receptors or unin-
hibited FA-receptors, the uptake of MSN-PVP-PEG-NH2-FA particles and therefore
the targeting abilities were monitored. For the visualization of nanoparticle-uptake,
z-stacks of the cells were recorded with a spinning disk confocal fluorescence micro-
scope, which allows us to detect MSNs inside or outside the cell after staining the cell
membrane. In Figure 5.10 a, a typical confocal cut through the cells together with
the orthogonal projection is shown. In the case of pre-incubation with free folic acid
only a few individual particles are present inside the cell (Figure 5.10 a), and also
in the full stacks the quasi absence of nanoparticles can be seen, independent of the
chosen focal plane. In contrast, incubation of MSN-PVP-PEG-NH2-FA on KB-cells
without pre-incubation of FA resulted in significant uptake of particles (Figure 5.10
b). The particles appear in the representative z-slice as well as in the entire height
of the cell as can be seen in the orthogonal views. In the case of blocked receptors
there should only occur unspecific uptake, therefore the results indicate the specific
folate-receptor mediated endocytosis within two hours with only a minor rate of
unspecific uptake.
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Figure 5.11: Intratumoral administration of MSNs. Left: Retention of MSNs in subcutaneous KB-tumors in mice
after intratumoral injection of FA-targeted (red) or untargeted (blue) MSNs over 168 h. Retention was determined
by fluorescent signal for the Cy7-labeled MSNs and normalized to 0 min (3 mice per group). Right: Representative
pictures of NIR fluorescence imaging of FA-targeted MSNs (top) and untargeted MSNs (bottom).
Prolonged retention in (subcutaneous) tumors of mice. As the multi-
functional MSNs have shown to work in vitro, folic acid as targeting ligand was
tested further in an in vivo setting. For this purpose, Cy7-labeled targeted and
untargeted MSNs were injected intratumorally into subcutaneous KB-tumors. Near
infrared fluorescence imaging after intratumoral injection revealed that for the first
hours the folic acid modification results in a increased retention in the tumor tissue
compared to nontargeted particles (Figure 5.11). After more than 24 hours no dif-
ference between targeted and untargeted particles is observable. Interestingly, both
type of particles show a prolonged retention in tumors for the whole observation
period of 7 days (Figure 5.11). This retention in tumors remarkably differs from
lower persistence upon intravenous administration (Figure 5.12). The slightly en-
hanced retention of receptor-targeted over non-targeted MSN particles with cap in
the initial phase can be explained by a pronounced washout of non-receptor bound
particles into the blood vessel system.
Biodistribution and biocompatibility upon intravenous injection in mice
In a next step, the biodistribution of unfunctionalized MSN and MSN with FA and
the cap system was evaluated in vivo. Cy7-labeled MSN were injected in mice (n=3)
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via the tail vein. Near infrared fluorescence imaging revealed short circulation times
for both particle types. A partial clearance via the kidney detectable due to the
bladder signals at 0.5 and 1 hours was observed (Figure 5.12), which is consistent
with partial dissociation/disassembly before clearance through the kidneys, as the
renal filtration limit is 6 nm in diameter. Preferred accumulation to the liver was
observed for several days, with shielded particles having lower signals than unfunc-
tionalized MSN. Importantly, both particle types were well tolerated by the mice
and were almost completely excreted after 72 h.
Figure 5.12: Intravenous administration of MSNs. Time dependent distribution of 100 µg per animal Cy7-labeled
MSN-PVP-PEG-NH2-FA or unfunctionalized MSNs over 72 h. Upper panel: ventral position. Lower panel: dorsal
position. Experiments were performed in triplicates; a representative mouse of each group is shown.
Stability tests in artificial cell media
To test the ability of the polymer cap system to prevent the mesoporous silica
nanoparticles from degradation, biostability assays in Dulbecco’s Modified Eagle’s
Medium (DMEM) at 37 ◦C and two different pH values (5 and 7) have been per-
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formed. As a widely used basal medium for growing many mammalian cells, DMEM
contains various amino acids, vitamins and inorganic salts, amongst others, and is
used here to simulate a biological environment. Samples were removed after specific
times, washed and dried. The nanoparticles were then characterized with trans-
mission electron microscopy and nitrogen sorption. TEM images shown in Figure
5.13 reveal significant degradation of the nanoparticle structure for unfunctionalized
MSN after 24 h immersion at pH 7, which is in good agreement with results reported
before. [12]
Figure 5.13: TEM images showing MSN after 24 h incubation in DMEM media. (a) MSN pH 7, (b) MSN-PVP-
PEG pH 7, (c) MSN-PVP-PEG pH 5.
In contrast, nanoparticles functionalized with PVP offer very good stability in
DMEM at pH 7. At this pH, the polymer cap system forms a tight, hydropho-
bic, and therefore for water, proteins and salts impermeable envelope around the
MSN. Additionally, the polymer shell improves the stability of the MSN in DMEM
at pH 5, where the cap system is in its open state. In comparison with uncoated
nanoparticles, MSN-PVP show less degradation, which was also confirmed by ni-
trogen sorption experiments (see appendix Figure 5.22). In both cases, the open
and the closed state of the cap system, no changes in the pore-size distribution are
observed, indicating that the pores are not affected by the media.
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Longterm storage stability of loaded MSNs
To demonstrate the good shielding of the silica core by the polymer layer, MSN-
PVP-PEG-AlPcS2a particles loaded with calcein were stored at 4 ◦C without stirring
for three weeks. Cell experiments revealed that even after such a long period, the
nanoparticles exhibit the same calcein release behaviour as can be seen in Figure
5.14.
Figure 5.14: Fluorescence microscopy of MSN-PVP-PEG-AlPcS2a-FA nanoparticles loaded with calcein inside
KB cells, particles have been stored three weeks at 4 ◦C. (a-c) Calcein (green) and AlPcS2a (red) are co-localized
(yellow) prior to photoactivation. The red line indicates photoactivation with 1.2 W / mm2 of red light (639 nm).
(d-f) after 1 min photoactivation, (h-i) 5 min after photoactivation, (j-l) 10 min after photoactivation. The scale
bar represents 10 µm.
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Conclusions
In this work, we have developed a multifunctional drug delivery vehicle based on
polymer-functionalized mesoporous silica nanoparticles. This system combines at-
tractive features such as the high loading capacity of MSNs with the tunable func-
tionality of a polymer. The use of bis-functionalized polymers allowed us to cova-
lently attach step-by-step any functionality of interest. We were able to demonstrate
that covalently bound poly(2-vinylpyridine) in combination with a PEG block is
able to act as a pH-responsive cap system for MSNs. With this system, we could
show the successful delivery of different cargos into cells. Membrane permeable
cargos were delivered without any external trigger. Covalent attachment of a red-
light-photosensitizer offered the possibility to deliver membrane-impermeable cargos
through irradiation with light. Very effective targeting of folic acid receptor express-
ing cells was enabled by the covalent attachment of folic acid. Stability tests revealed
the effectiveness of poly(2-vinylpyridine) not only as cap system, but also as a pro-
tecting agent of MSNs against aggressive body fluids. Biodistribution experiments
in vivo revealed no agglomeration and an almost complete excretion of the particles
within 72 h after intravenous administration in mice. With this new system, we
have developed a multifunctional toolbox based on MSNs that is able to open and
close its cap depending on the environment. One major advantage of our system
derives from the covalent attachment of all components which allows the system to
operate for several cycles. We anticipate that the possible integration of almost any
functionality of interest as well as the efficient synthesis make this system highly
promising for wide-ranging biological and medical applications, especially in cancer
therapy.
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5.4 Appendix
Dynamic Light Scattering
Figure 5.15: DLS data of MSN-NH2 (black), MSN-PVP-NH2 (red), MSN-PVP-PEG-NH2 (blue)
Raman measurements
Figure 5.16: Raman spectra of MSN-NH2 (black), MSN-PVP-NH2 (red) and HOOC-PVP-NH2 (blue). Signals
from the polymer appearing clearly in the sample MSN-PVP-NH2 are marked with an asterisc.
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Longterm release experiments
Fluorescence spectroscopy
Experimental setup
Fluorescence experiments were performed in order to show the time-dependent re-
lease of fluorescein from the mesopores of colloidal mesoporous silica spheres. The
measurements were recorded on a PTI fluorescence system featuring a PTI 814 pho-
tomultiplier detector and a PTI A1010B Xenon arc lamp driven by a PTI LPS-220B
lamp power supply. For temperature settings, a Quantum Northwest TC 125 sample
holder was used. Fluorescein was excited with 490 nm and emission was detected at
512 nm (excitation slit 1.0 mm, emission slit 1.0 mm, 1 point per 30 min). For the
release experiment, a ROTH Visking Typ 8/32 dialysis membrane with a molecular
cut-off of 14000 g/mol was used. An image of this custom made Teflon container
can be seen in Figure 5.17.
Figure 5.17: Custom made release experiment setup featuring a 200 µL Teflon tube (a) which is closed by a
dialysis membrane (b). This setup is put onto a fluorescence cuvette filled with the desired buffer (c).
1 mg MSN were loaded by redispersing in 500 µL of a 1 mM fluorescein solu-
tion and acidified with 50 µL of a citrate/phosphate buffer pH 2. After 12 h, the
particles were washed by centrifugation and redispersion in 1 mL SSC buffer pH 7
until no fluorescence was observed in the supernatant. For the release experiment,
the particles were redispersed in 200 µL SSC buffer pH 7 and put into a container
(see Figure 5.17), which was subsequently closed by a dialysis membrane. The
140
5.4. Appendix
closed container was then put onto a fluorescence cuvette, which was completely
filled with SSC buffer pH 7. The released dye is able to pass through the applied
membrane while the relatively larger particles are retained. After 16 h, the particles
were centrifuged and redispersed in 200 µL Mc Ilvaine buffer pH 5, put into the
container and closed by the dialysis membrane. The closed container was then put
onto the fluorescence cuvette, which was completely filled with Mc Ilvaine buffer
pH 5. The release was measured every 30 min until no further release was observed.
As the fluorescence of fluorescein is strongly dependent on the pH, calibration curves
at pH 7 and pH 5 were recorded (Figure 5.18) to be able to compare fluorescence
signals in the closed and open state.
Figure 5.18: Calibration curves of fluorescein at pH 7 (red) and pH 5 (blue).
UV-Vis spectroscopy
The loading capacity of the MSN particles was quantified by UV-Vis spectroscopy.
1 mg particles were loaded with calcein and washed as described above. Afterwards
the particles were stirred for 48 h in 1 mL Mc Ilvaine buffer pH 5, centrifuged and
the absorption of the supernatant was measured on a Thermo Scientific PeQLab
Nanodrop 2000c. For determination of the calcein concentration, a calibration curve
of calcein in Mc Ilvaine buffer pH 5 at 495 nm was recorded (Figure 5.19).
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Figure 5.19: Calcein calibration curve.
The measured absorbance at 495 nm of 0.147 leads to a concentration of 32.81 nmol/mL
by using a linear regression of the calibration curve. The total amount of calcein
released from 1 mg MSN is 0.020 mg.
Release behavior of the membrane permeable cargo colchicine
To show that the entire amount of DAPI was delivered to into the cells by the
particles, the supernatant of the sample was tested on cells. The scaling of the
pictures within Figure 5.20 is equal, but not the same as for Figure 5.9. Nevertheless
it could be clearly observed, that the supernatant alone is not able to stain the
nucleus.
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Figure 5.20: Fluorescence microscopy of membrane stained HeLa cells (green) incubated with (a) MSN-PVP-PEG
nanoparticles loaded with DAPI (blue) and labeled with Atto 633 (red) after 30 min incubation on the cells and (b)
with the supernatant of MSN-PVP-PEG nanoparticles loaded with DAPI. White circles indicate the region of the
nuclei. The scale bar represents 10 µm.
Figure 5.21 demonstrates the release of colchicine inside cancer cells. As colchicine
hinders the polymerization of the tubulin network, cells with GFP-labeled tubulins
were used. In the case of particle addition the tubulin structure is completely de-
stroyed and only a uniform fluorescence across the whole cytoplasm could be de-
tected. In the case of untreated cells the tubulin network can be clearly observed.
Figure 5.21: Fluorescence microscopy of HuH7 cell expressing tubulin GFP (green). (a)MSN-PVP-PEG nanopar-
ticles loaded with colchicine and labeled with Atto 633 (red) after 18 h incubation on the cells (b) untreated cells.
The scale bar represents 10 µm.
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Stability tests
Nitrogen sorption
Figure 5.22: Top: Nitrogen sorption isotherms (left) and pore size distributions (right) for different immersion
times in DMEM at pH 7. Bottom: Nitrogen sorption isotherms (left) and pore size distributions (right) for different
immersion times in DMEM at pH 5.
After immersion of the particles in DMEM for different times at different pH, they
were extensively washed and dried from an acidified (some droplets of 0.01 M HCl)
aqueous solution at 60 ◦C to end up with opened particles for sorption experiments.
Nitrogen sorption measurements were performed on a Quantachrome Instruments
NOVA 4000e at 77 K. It can be seen that all isotherms maintain the shape of a type
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4 isotherm. Additionally no significant changes in the NLDFT pore size distribution
are observed, which shows that the pore structure is not much affected by the media.
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Chapter 6
Polymer-Capped Metal-Organic
Framework Nanoparticles for
Controlled Release Applications
The following work is based on a project with Andreas Zimpel and Stefan Wuttke
6.1 Introduction
Metal-organic frameworks (MOFs) describe a family of porous materials with crys-
talline architectures created by coordinative bonding between metal ion centers and
organic linker molecules. [1] Besides their tremendous structural variety, high porosity
and sometimes enormous surface area (up to 6000 m2 g−1), MOFs contain two fur-
ther advantages that are useful for bio-applications. [2] One major benefit is the abil-
ity of tailoring the pore functionality by incorporation of additional side chains into
the linker molecules. By controlling the host-guest interactions in the porous system,
it should be possible to precisely regulate drug release kinetics. Another advantage
of MOFs is the biocompatibility and biodegradability of so-called ”BioMOFs”. [3–7]
Since the discovery of MOFs with particle sizes in the range of 30 - 200 nm, [8] this
class of materials became highly interesting for the development of MOF-based drug
delivery carriers. The high loading capacity of MOFs was reported by Horcajada
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et al.. They were able to load 1.38 g ibuprofen to 1 g dehydrated MIL-101(Cr)
material. [9] Lin et al. demonstrated the incorporation of the anticancer drug cis-
platin into a Tb3+ based metal-organic framework. [10] The covalent attachment of
drug molecules to anchoring groups of the linkers in the pores was demonstrated
by Taylor-Pashow et al.. [11] In this system, the release of the drug relied on the
complete degradation of the MOF itself.
In this chapter, we report on the ability of creating a polymer-based cap system
around MOF nanoparticles to demonstrate pH-responsive release behavior. It should
be noted, that on-demand delivery of molecules (e.g. drugs), encapsulated within a
MOF nanocarrier, has not been established to date. Therefore we transferred the
concept of the PVP cap system that showed good results for MSNs to MIL-101(Cr)
nanoparticles, serving as model system. MIL-101(Cr) consists of Cr3+ metal cen-
ters that are connected by terephthalic acid linker molecules. [12] This system was
chosen due to its outstanding stability of the crystalline porous framework, even if
chromium-based materials may not be the best choice for biomedical applications.
As the polymer cap system offers the possibility of reversible opening and closure,
the nanoparticular core should feature high stability to maintain the covalent at-
tachment of the cap system.
6.2 Experimental Section
Synthesis of MIL-101(Cr) nanoparticles
For the microwave synthesis of MIL-101(Cr) nanoparticles, chromium(III) nitrate
nonahydrate (1.48 g, 3.70 mmol) and terephthalic acid (615 mg, 3.70 mmol) were
heated in 20 mL H2O bidest. to 220 ◦C under solvothermal conditions (p = 18 bar)
within four minutes. The mixture was kept at 220 ◦C for two minutes and the resul-
ting suspension was cooled down to room temperature. The resulting nanoparticles
were separated from the additional bulk material by filtration. For purification, the
filtrate was washed four times by centrifugation (1st: 20000 rpm (45417 rcf), 60 min;
2nd-4th: 20000 rpm, 45 min) followed by redispersion in ethanol.
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Protection of NH2-PVP-COOH (Boc-PVP-COOH)
To a solution of 500 mg (5 µmol) NH2-PVP-COOH in 10 mL dry dichloromethane,
15 µL (0.11 mmol) triethylamine and 15 mg (6.9 µmol) Boc anhydride were added.
The solution was stirred overnight and extracted several times with brine. The
organic phase was dried over MgSO4 and evaporated to dryness to afford the Boc
protected polymer. The polymer was used without further purification.
Reaction of MIL-101(Cr) with ethylenediamine (MIL-NH2)
To convert free standing carboxylic acid functionalities of MIL-101(Cr) into amino
groups, the nanoparticles were reacted with ethylenediamine. 150 mg MIL-101(Cr)
in 40 mL ethanol were mixed with an excess ethylenediamine (100 µL). Subse-
quently, 50 µL EDC were added and the mixture was stirred at room temperature.
After 1 h, the particles were washed three times by centrifugation (20000 rpm,
45 min) and redispersion in ethanol.
General procedure for the attachment of poly(2-vinyl pyridine) to MIL-
NH2 (MIL-PVP-Boc)
To a dispersion of 100 mg MIL-NH2 in 10 mL ethanol, 120 mg (10.2 µmol) polymer
dissolved in 3 mL ethanol was added. The amidation was activated by the addition
of 20 µL (114.4 µmol) EDC and 2.6 mg (12 µmol) Sulfo-NHS. The mixture was
stirred at room temperature for 12 h. Afterwards the particles were separated by
centrifugation (19000 rpm, 20 min) and washed three times by repeated centrifuga-
tion and redispersion in 30 mL ethanol.
Deprotection of MIL-PVP-Boc (MIL-PVP-NH2)
Deprotection of the polymer was achieved through stirring 10 mg polymer-functionalized
particles in a mixture of 2 mL trifluoroacetic acid and 8 mL water for 24 h. After
deprotection, the particles were extensively washed by centrifugation (19000 rpm,
20 min) and redispersion in a 1:1 mixture of water and ethanol.
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Conversion of MIL-PVP-NH2 to MIL-PVP-COOH
10 mg MIL-PVP-NH2 in 2 mL ethanol were reacted with an excess of oxalic acid
(5 mg, 55 µmol) and EDC (9 µL, 51 µmol) for 1 h. Afterwards the particles were
extensively washed by centrifugation (19000 rpm, 20 min) and redispersion in a 1:1
mixture of water and ethanol.
PEGylation of MIL-PVP-COOH (MIL-PVP-PEG-NH2)
To a dispersion of 1 mg MIL-PVP-COOH in 500 µL ethanol, 2 mg (100 nmol)
NH2-PEG-NH2 in 500 µL bidistilled water was added and the reaction was started
through the addition of 0.5 µL (2.8 µmol) EDC. After stirring for 1 h at room
temperature, the sample was washed three times by centrifugation with a mixture
of ethanol:water 1:1.
Release experiments:
Dye loading
The amount of 1 mg MIL-PVP-PEG-NH2 was dispersed in 500 µL of a 1 mM dye
solution in water. To open the pores and enable the uptake, 50 µL of citrate buffer
(pH 2) was added. The particles were stirred overnight, centrifuged, and redispersed
in 1 mL SSC buffer (pH 7) to trigger closure of the polymer shell. The particles
were washed extensively with SSC buffer until no fluorescence was detected in the
supernatant.
Fluorescein release
1 mg fluorescein loaded MIL-PVP-NH2 or MIL-PVP-PEG-NH2 was redispersed in
200 µL SSC buffer and transferred to the cap of the fluorescence cuvette. This cap is
sealed with a dialysis membrane (molecular weight cutoff of 14000 g/mol) and placed
on top of the fluorescence cuvette, which is also filled with SSC buffer. The ”release"
of fluorescein out of the closed particles was monitored for 2 h (λex = 490 nm, λem =
512 nm). Subsequently, the cap was removed and the particles were centrifuged and
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redispersed in 200 µL citrate-phosphate buffer (pH 5), before being put into the cap
of the release setup. The fluorescence cuvette was also filled with citrate-phosphate
buffer (pH 5). After reassembling of the release setup, the release of fluorescein was
measured for 10 h continuously. For comparison of the obtained curves, calibration
curves of fluorescein in SSC buffer (pH 7) and in citrate-phosphate buffer (pH 5)
were recorded.
6.3 Results and Discussions
Particle characterization
MIL-101(Cr) nanoparticles were prepared in a solvothermal microwave-assisted syn-
thesis. After adjustment of the synthetic conditions, MIL-101(Cr) nanoparticles
consisting of Cr3+ centers conected by terephthalic acid molecules (Figure 6.1) were
obtained.
Figure 6.1: Scheme of the nanoparticle synthesis. Figure was taken from the Master thesis of Andreas Zimpel.
DLS measurements of the resulting nanoparticles in ethanol reveal a mean dia-
meter of around 60 nm (Figure 6.2) with some aggregated particles in the sample.
These results are in good agreement with data obtained by TEM (Figure 6.6).
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Figure 6.2: DLS data of MIL-101(Cr) nanoparticles in ethanol.
Nitrogen sorption experiments revealed a BET surface area of 2778 m2/g and
a multimodal pore size distribution with maxima at 1.8 nm, 2.5 nm and 3.2 nm,
which is in good agreement with the literature. [2]
Figure 6.3: Left: Nitrogen sorption data of MIL-101(Cr) nanoparticles. Right: DFT pore size distribution.
For the use of MIL-101(Cr) as drug delivery vehicle, a cap system based on
poly(2-vinyl pyridine) was attached. In a first step, the carboxylic acid moieties
on the external surface of the nanoparticles were reacted with ethylenediamine to
create an anchoring point for PVP (MIL-NH2). PVP was attached to the amine
residues followed by deprotection (MIL-PVP-NH2). Finally, anchoring of PEG led
to a water dispersible drug delivery system (MIL-PVP-PEG-NH2). Each synthetic
step was monitored by IR and zeta potential measurements.
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Infrared spectroscopy
The as synthesized MIL-101(Cr) nanoparticles showed a significant signal at 1708 cm−1
that can be attributed to the C=O stretching vibration of terminal carboxylic acid
moieties (Figure 6.4). After reaction with ethylenediamine a reduced intensity of
the C=O vibration was observed. A new signal at 1590 cm−1, corresponding to the
N-H deformation vibration of terminal aliphatic amines was found. Additionally, the
broadening of the signal between 1660 cm−1 and 1520 cm−1 points to the successful
creation of amide bonds, as these signals appear in this region.
Figure 6.4: IR data of each synthetic step of the MIL based drug delivery vehicle.
Further attachment of PVP to MIL-NH2 was shown by the rise in intensity of
the signals at 1594 cm−1 and 1478 cm−1 that can be clearly attributed to PVP
by comparison with the spectra of the pure polymer. Deprotection of the terminal
amino-functionality of PVP did not lead to significant changes in IR. For further at-
tachment of PEG, the terminal amino-functionality was converted into a carboxylic
acid by attachment of oxalic acid. The success of the reaction was observed by the
appearance of two new peaks at 1712 cm−1 for to the C=O stretching vibration of
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COOH and 1688 cm−1 for the corresponding carboxylate anion. After attachment of
PEG, the peaks of the terminal acid groups vanished and thus proving the successful
reaction.
Zeta potential
Additionally to IR, each step of the synthesis was also monitored by zeta potential
measurements (Figure 6.5). For as synthesized MIL-101(Cr) nanoparticles, a zeta
potential of +24 mV was measured at pH 2. An increase in zeta potential was
observed after the reaction with ethylenediamine due to the conversion of terminal
carboxylic acid- into amino moieties. A significant change in zeta potential up to a
value of +39 mV was recorded after attachment of PVP. At pH 2, PVP is present
in the fully protonated state resulting in the creation of a highly positively charged
particle surface.
Figure 6.5: Zeta potential data of each synthetic step of the MIL based drug delivery vehicle.
After complete synthesis, the nanoparticles were investigated with TEM and
XRD and these data were compared to data obtained after synthesis of MIL-101(Cr)
(Figure 6.6). XRD measurements revealed no significant changes in crystallinity.
The smoothing of reflexes in MIL-PVP-PEG can be explained by the introduction
of a high amount of organic polymers. TEM micrographs were taken to obtain infor-
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mation on the crystallinity, morphology and aggregation behaviour of the nanopar-
ticles.
Figure 6.6: Left: XRD pattern of MIL nanoparticles before (black) and after attachment of the polymer cap
system. Middle: TEM micrograph of MIL-101(Cr) nanoparticles. Right: TEM micrograph of MIL-PVP-PEG.
In Figure 6.6 it can be seen that after synthesis of MIL-101(Cr) crystalline
nanoparticles with sizes in the range of 30 to 60 nm were obtained. These nanocrys-
tals often exhibit an octahedron-like morphology, which is in accordance with the
fact that MIL-101(Cr) belongs to the cubic space group. In the TEM image of
MIL-101(Cr) no intergrown particles were observed. TEM micrographs of MIL-
PVP-PEG-NH2 yielded similar results compared to MIL-101(Cr), from which we
can conclude that the nanoparticles were not affected by the demanding synthesis
conditions (e. g. stirring in trifluoroacetic acid for 24 h) for the polymer cap system.
Release experiments
To test the ability of MIL-PVP-PEG nanoparticles to act as a pH responsive drug
delivery system, release experiments were performed in the same way as already
described in chapter 5. In summary, MIL-PVP-PEG nanoparticles were loaded with
a fluorescent dye by stirring in an acidified solution. Closure of the nanoparticles
was obtained by centrifugation and redisperion in SSC buffer at pH 7. After washing
the nanoparticles, the sample was measured in our release setup in the closed state.
The release was triggered by exchanging the buffer to reach a pH of5. Figure 6.7
shows the resulting release curve of MIL-PVP-PEG.
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Figure 6.7: Release data obtained for MIL-PVP-PEG nanoparticles.
Analysis of the release data revealed a premature release of fluorescein of 4.5%
within 2 h. A burst of release was observed after opening of the cap system leading
to a complete release of the dye within 4.5 h. Compared with mesoporous silica
nanoparticles capped with PVP, a slightly higher premature release was recorded.
This might be due to sharp edges of the MIL nanocrystals leading to incomplete
coverage of the particles with a tight polymer layer. Another possible explanation is
the relative small amount of accessible anchor molecules at the particle surface, as
with terephthalic acid a bifunctional linker bearing only two carboxyl functionalities
was used for particle synthesis. However, these first release experiments clearly prove
the ability of PVP to act as a cap system for MOF nanoparticles.
6.4 Conclusions
In this chapter a drug delivery system based on MIL-101(Cr) nanoparticles covered
with a pH-responsive polymer was reported. We could demonstrate that it is possible
to functionalize the nanoparticles with poly(2-vinyl pyridine) without affecting the
shape and crystallinity of the nanoparticles. Finally, the ability of the system to act
as a potetial drug delivery vehicle was demonstrated by in vitro release experiments
of a model drug. In comparison with PVP-capped MSN systems, a slightly more
pronounced premature release was observed for MIL-MSN-PVP. In future work, it
will be examined if the creation of further anchor groups on the surface of the MOF
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nanoparticles can lead to the attachment of an increased amount of polymer, and
thus, leading to a more effecting sealing of the system.
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Chapter 7
Mesoporous Silica Nanoparticles for
Immunoassay applications
The following work is based on a collaboration with Elisangela Linares and Stefan
Thalhammer
7.1 Introduction
In the developing world, there is a lack of convenient and accurate tools that di-
agnose diseases and other health problems. As a result, many health risks remain
undetected or receive inappropriate treatment. Among the diseases, dengue fever
(DF) is classified as a neglected disease, and has emerged as a rapidly spreading
vector-borne disease mainly in developing countries. [1] DF results from infection
with a virus transmitted mainly by Aedes aegypti, a species of mosquito with a
global distribution. Over 2.5 billion people are now endangered by dengue. The
World Health Organization estimates 100 million cases of dengue fever and 500
thousand cases of dengue hemorrhagic fever (DHF) with 2.5% of annual mortality
from DHF. [2] The disease is now endemic in more than 100 countries in Africa,
America, Eastern Mediterranean, South-east Asia and Western Pacific. For DHF,
medical care can save numerous lives, decreasing mortality rates from more than
20% to less than 1%. [3]
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For DF, as for many other diseases, numerous barriers exist for early diagnosis in
impoverished environments, including poor laboratory infrastructure, low financial
support, harsh environmental conditions and unskilled people. The current tech-
niques used in laboratories suffer from problems, starting from the storage. The
high temperatures and the large variations in humidity limit the shelf life and the
efficiency of the available assays. Some diagnostic devices based on dried chemicals
have been used as an alternative to the conventional assays, but they still show li-
mitations in sensitivity, reproducibility, and may require expensive readers. Lateral
flow immunoassays are a promising alternative, but the lack of sensitivity and the
difficulties to quantify analytes limit its application as substitute for more common
techniques. Among the current diagnostic tools, enzyme linked immunosorbent as-
say (ELISA) is the most commonly used serological technique for diagnosis. The
method is based on the principle of a solid phase enzyme-linked immunosorbent
assay with colorimetric detection. The detection signal is based on the reaction
between an enzyme-labeled antibody and a substrate, whose product is colorful and
where the intensity is (inversely) proportional to the analyte concentration, depen-
ding on the used arrangement. ELISA offers a sensitive and specific approach with
typical detection limits in the low ng/ml range. In some applications, ELISA shows
superior performance than virus isolation and real-time polymerase chain reaction
(RT-PCR). [4] Analogous to ELISA principles, an immunospotting assay (ISA) has
been used for diagnosis. A low volume of serum sample is applied onto a nitrocel-
lulose membrane and a labeled antibody is used for detection. The possibility of
applying the sample directly to a high surface area nitrocellulose membrane allows
the use of low sample volume and avoids the necessity of two antibodies for capture
and detection. Generally, the immunospot test allows diagnoses in less than one
hour with high specificity and sensitivity, low complexity and by using conventional
apparatus in clinical analysis laboratories. Although these techniques have many
advantages, their application is limited in environments where storage and use con-
ditions are not well controlled. The use of ELISA at high temperatures can cause
significant loss of enzymatic acitivity or even denaturation of the enzyme, which de-
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creases the sensitivity or excludes its application due to unreliable results. Several
strategies have been described to overcome the limitations of ELISA, e.g., replacing
the detection label by nanoparticles. [5–8]. However, the sensitivity of these novel
approaches is still not comparable with the high sensitivity of colorimetric reactions
catalyzed by enzymes. A step forward towards the use of enzymes in harsh con-
ditions has been made with the incorporation of enzymes or prostetic groups into
nanoparticles. [9,10] The encapsulation increases the stability, thus avoiding unfolding
and destabilization of the native conformation. This approach allows the develop-
ment of more robust assays based on enzymes. [11] As already described in section
1.6, enzymes have also been successfully incorporated into mesoporous silica parti-
cles. Thus, the use of mesoporous silica particles can provide enzyme stabilization
for applications that require operations in relatively harsh conditions.
Motivated the necessity to enhance the stability of enzyme-based assays in unfa-
vorable environments, we have developed ELISA and immunospotting assays for
DF detection based on mesoporous silica nanoparticles loaded with hemin groups in
the core and selective binding sites on the outer shell (Figure 7.1). For early stage
detection, a highly conserved viral non-structural glycoprotein (NS1) of the Dengue
virus has been used as a high potential analyte target for early DF detection, which
is developed in the first day after the onset of symptoms. [12,13]
The detection system is based on core-shell functionalized mesoporous silica nanopar-
ticles. The pores of the MSNs are functionalized with high amounts of hemin
molecules. This catalyst is able to convert specific substrates into dye molecules
that enable optical read out. To the outer surface, PEG is attached as spacer
molecule to ensure diffusion into and from the pores. BSA molecules are attached
to PEG for enhanced solvation of the particles. Finally, streptavidin is covalently
bound to BSA for the creation of selective binding sites for biotin functionalized
antibodies from the ELISA test.
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Figure 7.1: Schematic representation of MSNs developed for enhanced NS1 detection. The system consists of
MSNs (grey), hemin (purple), PEG (light blue), BSA (dark blue), streptavidin (yellow) and NS1 antibodies (green).
7.2 Experimental Section
Chemicals
Bovine serum albumin (BSA) powder, streptavidin, N -(3-Dimethylaminopropyl)-
N ’-ethylcarbodiimide hydrochloride (EDC), biotin-NHS, Tween 20, Tris-HCl, potas-
sium phosphate mono- and dibasic were purchased from Sigma-Aldrich (Milwaukee,
USA). Dengue NS1 Ag ELISA was obtained from Standard Diagnostics (Hagal-dong,
Korea). Dengue Virus NS1 glycoprotein mouse monoclonal antibody (supernatant)
was obtained from Abcam (Cambridge, United Kingdom). Hitrap protein G HP
column for affinity chromatography and the PD10 desalting column were purchased
from GE Healthcare (Uppsala, Sweden). Nitrocellulose membrane, pore size 5 µm,
and Nunc microplate 96-well were purchased from Whatman (Dassel, Germany)
and Fisher Scientific (Schwerte, Germany). Backing card was provided by Lohmann
(San Jose, USA). For particle synthesis, triethanolamine (TEA, AppliChem, >99%),
tetraethyl orthosilicate (TEOS, Fluka, >98%), cetyltrimethylammonium chloride
(CTAC, 25 wt% in water), 3-mercaptopropyltriethoxysilane (ABCR, 92%), sodium
azide (Fluka, 99%), N -(3-dimethylaminopropyl)-N ’-ethylcarbodiimide hydrochlo-
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ride (EDC, Fluka, 97%), hemin (Sigma, >90%), propargylamine (Sigma, 98%), 1-
hydroxybenzotriazole hydrate (HOBt, Sigma, >99%), N,N -diisopropylethylamine
(Sigma, 99%), Cu(I)Br (Sigma, 98%), maleimid-PEG(8)-COOH (Iris Biotech), 3-
azidopropyltriethoxysilane was synthesized according to a procedure published by
Nakazawa et al. [14] Doubly distilled water from a Millipore system (Milli-Q academie
A-10) was used for all syntheses and purification steps. All solvents and buffer con-
tents were purchased from Sigma-Aldrich. Unless otherwise noted, all reagents were
used without further purification.
Preparation of small core-shell-functionalized colloidal mesoporous silica
nanoparticles (MSN100nm-N3core-SHshell)
MSN nanoparticles were prepared by a delayed co-condensation approach as de-
scribed earlier by Cauda et al.. [15] Specifically, a two phase mixture of TEA (14.3 g),
TEOS (1.63 g, 7.82 mmol) and azidopropyltriethoxysilane (100 µL, 475 µmol) was
heated at 90 ◦C for 20 minutes without stirring. After removal of the oil bath, a
preheated (60 ◦C) solution of CTAC (2.14 mL, 1.62 mmol, 25 wt% in H2O) and
water (21.7 g) was added and stirred afterwards at 500 rpm at room temperature.
After 20 min 172 µL (772 µmol) TEOS were added in four steps (43 µL each) every
three minutes and the mixture was stirred for 30 min. Subsequently, a mixture of
3-mercaptopropyltriethoxysilane (2.2 µL, 9.4 µmol) and TEOS (40.8 µL, 183 µmol)
was added. The resulting solution was stirred overnight at room temperature at
500 rpm. Extraction of the organic template was achieved by heating the ethanol-
suspended sample (10 mg/mL) under reflux at 90 ◦C for 1 h in a mixture of 2 g
ammonium nitrate and 100 mL ethanol. Afterwards, the sample was centrifuged
for 20 minutes at 19000 rpm (43146 rcf), redispersed in ethanol and heated under
reflux at 90 ◦C in a solution of 8 mL concentrated HCl and 32 mL ethanol for
45 minutes. After centrifugation, the particles were redispersed in ethanol, resulting
in a colloidal suspension.
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Preparation of large core-shell-functionalized colloidal mesoporous silica
nanoparticles (MSN300nm-N3core-SHshell)
MSN nanoparticles were prepared by a modified delayed co-condensation approach
as described earlier by Cauda et al.. [15] Specifically, a two phase mixture of TEA
(14.3 g), TEOS (1.63 g, 7.82 mmol) and azidopropyltriethoxysilane (100 µL, 475 µmol)
was heated at 90 ◦C for 20 minutes without stirring. After removal of the oil bath,
a preheated (60 ◦C) solution of OTAB (0.724 g, 1.99 mmol) in water (24.1 g)
was added and stirred afterwards at 700 rpm at room temperature. After 20 min
172 µL (772 µmol) TEOS were added in four steps (43 µL each) every three
minutes and the mixture was stirred for 30 min. Subsequently, a mixture of 3-
mercaptopropyltriethoxysilane (2.2 µL, 9.4 µmol) and TEOS (40.8 µL, 183 µmol)
was added. The resulting solution was stirred overnight at room temperature at
700 rpm. Extraction of the organic template was achieved by heating the ethanol-
suspended sample (10 mg/mL) under reflux at 90 ◦C for 1 h in a mixture of 2 g
ammonium nitrate and 100 mL ethanol. Afterwards, the sample was centrifuged
for 20 minutes at 19000 rpm (43146 rcf), redispersed in ethanol and heated under
reflux at 90 ◦C in a solution of 8 mL concentrated HCl and 32 mL ethanol for
45 minutes. After centrifugation, the particles were redispersed in ethanol, resulting
in a colloidal suspension.
Acetylene-functionalization of hemin (sp-hemin)
In a 50 mL flask, 162 mg hemin and 80 mg HOBt (2 eq.) were dissolved in 6 mL
DMF. Subsequently, 42 µL propargylamine (2.5 eq.) and 220 µL EDC (4 eq.) were
added and the solution was stirred for 12 h at r.t.. DMF was evaporated and the
crude product was redissolved in chloroform and washed by extraction with water.
The obtained dark green solid was used without further purification.
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Each of the following steps was carried out identically for both types of
particles:
Preparation of hemin-functionalized colloidal mesoporous silica nanopar-
ticles (MSN-hemincore-SHshell)
100 mg MSN-N3core-SHshell were redispersed in 15 mL acetonitrile. Subsequently
the amount of 20 mg sp-hemin, Cu(I)Br (12 mg) and N,N -diisopropylethylamine
(16 µL) were added to start the click reaction. The mixture was stirred overnight.
The sample was washed several times by centrifugation and redispersion in acetoni-
trile.
PEGylation of MSN-hemincore-SHshell (MSN-hemincore-PEG-COOHshell)
10 mg MSN-hemincore-SHshell were redispersed in a mixture of 2.5 ml ethanol and
2.5 ml SSC-buffer. Subsequently the amount of 2 mg maleimide-PEG(8)-COOH
was added and the mixture was stirred at room temperature. After 3 h the sample
was washed several times by centrifugation and redispersion in ethanol/water 1:1.
Attachment of BSA to MSN-hemincore-PEG-COOHshell (MSN-hemincore-
BSAshell)
To a dispersion of 1 mg MSN-hemincore-PEG-COOHshell in 1 ml citrate-phosphate
buffer (0.1 M, pH 6.5), 0.3 mg BSA was added. After 30 min incubation at 4 ◦C,
BSA was covalently attached by the addition of 0.5 µl EDC. The mixture was
stirred for 30 min and washed afterwards by centrifugation and redispersion in
citrate-phosphate buffer (0.1 M, pH 6.5) at 4 ◦C.
Attachment of streptavidin to MSN-hemincore-BSAshell (MSN-hemincore-
BSA-streptavidinshell)
To a dispersion of 1 mg MSN-hemincore-BSAshell in 1 ml citrate-phosphate buffer
(0.1 M, pH 6.5), 0.1 mg streptavidin was added. After 30 min incubation at 4 ◦C,
streptavidin was covalently attached by the addition of 0.5 µl EDC. The mixture
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was stirred for 30 min and washed afterwards by centrifugation and redispersion in
citrate-phosphate buffer (0.1 M, pH 6.5) at 4 ◦C.
Serum samples
Serum samples infected with Dengue virus type 2 from the epidemic in Santos (2002)
were obtained by the Sao Paulo Institute of Tropical Medicine, University of Sao
Paulo, Brazil. The tests were approved by the ethics committee of the university.
The samples were analyzed for NS1 using the commercial kit PlateliaTM NS1 (Biorad
Laboratories, Marnes-La-Coquette, France).
Conjugation of anti-NS1 monoclonal antibodies with peroxidase
The conjugation was performed adapting the protocol described by Wisdom. [16]
An aliquot of 0.1 mg of anti-NS1 was added to 20 µL of phosphate buffer saline,
PBS, containing 20 mmol/L of phosphate buffer and 0.15 mol/L of sodium chloride
(pH 7.2). Subsequently, 0.3 mg of peroxidase was added to the antibody solution.
After mixing the solution, glutaraldehyde was added to a final concentration of 0.2%
and the solution was stirred for 2 h at 20 ◦C. The solution was then diluted by adding
200 µL of PBS and dialyzed overnight against PBS at 4 ◦C. Afterwards, 2 mL of
Tris-HCl buffer (50 mmol/L containing 1 mmol/L of MgCl2 and 2% of BSA) was
added.
Biotinylation of anti-NS1 monoclonal antibodies
The amount of 0.1 mg of anti-NS1 antibody was diluted in 1 mL of phosphate
buffer and 4 mg of biotin-NHS was added to the antibody solution. The mixture
was stirred for 2 h at room temperature. Subsequently, the solution was dialyzed
overnight against phosphate buffer (0.01 mol/L, pH 7.4) at 4 ◦C. The antibodies
were freshly biotinylated before their use in the immunoassay.
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Sandwich enzyme linked immunosorbent assay
An aliquot of 100 µL of sample (NS1 protein solution or infected serum) was added
to a microplate well previously coated with anti-NS1 antibodies (0.83 ± 0.16 µg
of antibody per well). The samples were diluted in phosphate buffer saline (9%
containing 2% BSA and 0.01% Proclin 300, as described by the kit company). The
microplate was incubated for 60 min at 37 ◦C. Subsequently, the wells were washed
five times with washing buffer (9% phosphate buffer saline, 2% Tween 20, 0.01%
Proclin 300) from the commercial kit. Then, 100 µL of 0.001 µg of anti-NS1 anti-
bodies (peroxidase or biotin coated) in phosphate buffer saline (9% containing 2%
BSA and 0.01% Proclin 300) was added to the well and kept for 60 min at 37 ◦C.
Then the wells were washed five times with washing buffer. For the assay using
streptavidin coated particles, 100 µL of 0.001 mg of particles in phosphate buffer
(0.01 mol/L, pH 7.4) were added and incubated for 30 min at 37 ◦C. After that,
the microplate was washed five times with washing buffer and 100 µL of the sub-
strate (0.05% Tetramethylbenzidine, 0.05% chloridric acid, 1.3% sodium acetate and
0.01% hydrogen peroxide) was added. The peroxidase based assay was incubated
for 15 min and then 50 µL of sulfuric acid (5 mol/L) stopped the reaction. For
the particle based assay, the incubation was kept for 20 min. The positive control
consisted of recombinant Dengue NS1 protein and the negative control consisted of
a Dengue NS1 protein negative human serum.
Immunospotting assay
A piece of nitrocellulose membrane (7mm x 7mm) was supported on a backing card
and fixed on a plastic stick. An aliquot of 6 µL containing the NS1 protein was
deposited on the nitrocellulose membrane and dried at ambient conditions. Af-
ter drying, 20 µL of 5% BSA solution was deposited on the dried droplet. After
2 minutes, the membrane was immersed in a well containing 50 µL of 0.001 µg of
biotinylated anti-NS1 previously mixed with 1 µg of particles for 30 min. The mem-
brane was then washed with TRIS-HCl (0.05 mol/L of containing 0.5% of Tween 20)
during 3 min. Subsequently, the membrane was immersed in TMB substrate (0.05%
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Tetramethylbenzidine, 0.05% chloridric acid, 1.3% sodium acetate and 0.01% hydro-
gen peroxide) from the commercial ELISA kit. After 20 min, 25 µL of sulfuric acid
(5 mol/L) was added to stop the reaction. The whole procedure took approximately
1 h. The membrane was removed and the absorbance of the immersion liquid was
measured at 450 nm using a reference wavelength at 620 nm.
7.3 Results and Discussions
Mesoporous silica nanoparticles with azide-functionalized core and thiol-functionalized
shell were synthesized by a delayed co-condensation approach. A reaction mixture
containing tetraethyl orthosilicate (TEOS), 3-azidopropyl-triethoxysilane (5 mol%
of total silica), surfactant (CTAC or OTAB), and triethanolamine (TEA) results
in the spontaneous generation of seeds that grow further radially. After 20 min,
TEOS was added and the mixture was stirred for 30 min. Finally, a 1:1 mixture of
3-mercaptopropyltriethoxysilane (0.1 mol% of total silica) and TEOS was added to
the reaction to yield thiol functionality only at the outer surface of the nanoparti-
cles. Depending on the used surfactant, nanoparticles with sizes of 100 nm (CTAC,
MSN100nm) and 300 nm (OTAB, MSN300nm) were obtained. DLS measurements of
both samples can be found in Figure 7.2. These data show a fairly narrow size
distribution without observeable aggregation for both types of particles.
Figure 7.2: DLS data of MSNs synthesized with CTAC (left) and CTAB (right).
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The porous properties of the samples were characterized by nitrogen sorption
measurements (Figure 7.3). Both particle types resulted in type IV isotherms, ty-
pical for MSNs. Brunauer-Emmett-Teller surface areas of 1133 m2g−1 for MSN100nm
and 869 m2g−1 for MSN300nm were obtained. Pore sizes of 3.8 nm for MSN100nm
and 4.1 nm for MSN300nm were calculated with nonlocal density functional theory.
Pore volumes were determined to 0.76 cm3g−1 for MSN100nm and 0.75 cm3g−1 for
MSN300nm.
Figure 7.3: Nitrogen sorption isotherms of MSN100nm (left) and MSN300nm (right). Insets show NLDFT size
distributions calculated from the isotherms.
In a first step, the cores of the MSNs were functionalized with sp-hemin using
a copper-catalyzed click chemistry approach resulting in dark green particles. Sub-
sequently, the outer surface was reacted with PEG to avoid pore clogging through
further attachment of the bulky proteins bovine serum albumin and streptavidin.
The progress of functionalization was monitored by infrared spectroscopy, thermo-
gravimetric analysis and zeta potential measurements. As the characterization of
both particle types featured similar results, only data of MSN100nm will be discussed
in the following.
Infrared spectroscopy
The as-synthesized particles show a characteristic azide vibration at 2105 cm−1 that
almost vanishes after attachment of hemin, confirming the successful click reaction
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(Figure 7.4). The next synthesis step was the attachment of PEG to the outer sur-
face of MSNs. This reaction was confirmed by the emerging carbonyl vibrations at
1699 cm−1 that can be attributed to the terminal carboxylic acid group of PEG.
After attachment of BSA to PEG, the carbonyl vibrations disappear. Additionally,
amide signals arising at 1656 cm−1 and 1546 cm−1 can be assigned to BSA, confirm-
ing the successful attachment. In a last step, streptavidin was anchored to BSA.
This reaction is indicated by in the further increase of the amide signals at 1656
cm−1 and 1546 cm−1.
Figure 7.4: Infrared data obtained for each step of the particle synthesis. Signals discussed in the text are marked
with an asterisc.
Thermogravimetric analysis
Additionally, all synthesis steps were monitored with TGA (Figure 7.5). The rela-
tively high mass loss for MSN-hemincore-SHshell of 13.4% at 600 ◦C, corresponding
to 155 mg hemin per gram particles, reveals the high degree of functionalization of
the internal core of the particles. After attachment of mal-PEG-COOH, a further
mass loss of 6.2% corresponds to the addition of 66.0 mg PEG per gram particles,
confirming a successful reaction. The additional mass loss of 24% of the sample
MSN-hemincore-PEG-BSAshell corresponds to the attachment of 300 mg BSA per
gram particles, confirming an almost 100% reaction efficiency. For streptavidin,
the additional mass loss of 8.71% (94.0 mg per gram particles) corresponds to the
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attachment of 94% of the inital amount of streptavidin.
Figure 7.5: TGA data obtained for each step of the particle synthesis.
Zeta potential measurements
Zeta potential data are shown in Figure 7.6. For the as-synthesized MSNs, a zeta
potential of +8.5 mV was recorded at pH 2. The attachment of carboxylic acid
terminated PEG led to a slight decrease of the zeta potential to +7.5 mV, whereas
the attchment of the high molecular weight proteins BSA and streptavidin led to
a significant increase in zeta potential up to +30 mV, confirming the successful
modification of the particles.
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Figure 7.6: Zeta potential data obtained for each step of the surface modification of MSNs.
Finally, the fully synthesized samples were again characterized with DLS (Figure
7.2). For both particle types, the colloidal nature could be maintained. The increase
in diameter of around 30 nm corresponds approximately to the size of the attached
functionalities. Additionally, the data show no aggregation of the particles, which
is essential for a good performance in immunoassays. The need of PEG for the
prevention of pore clogging by BSA was shown by the color reaction already applied
for hemin in chapter 3 (Figure 7.7). For samples using PEG as spacer molecules,
much faster reaction kinetics were observed compared with samples where BSA was
directly attached to the surface of MSN.
Figure 7.7: Comparison of catalytic activity of hemin for MSNs without (left) and with PEG acting as spacer
molecule (right).
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Performance of MSNs in immunosorbant assays
In order to investigate the potential of the mesoporous silica particles as labels
for diagnostic purposes, an enzyme linked immunosorbent assay was performed for
Dengue fever detection and compared to conventional assay using peroxidase la-
beled antibodies. The analytical curves are depicted in the Figure 7.8 a. Two sizes
of particles, 100 nm and 300 nm, were used and compared in terms of absorbance
intensity. The results indicate that the hemin groups incorporated into the particles,
are a better label in comparison to the bare peroxidase for NS1 protein concentra-
tions below 0.1 µg/mL. Above this concentration, the bare enzyme produces higher
signal intensity. This behavior can be related to a particle hindrance effect on the
binding sites of the antibody coated well. This means that for higher NS1 concen-
trations, the distance between the NS1 molecules are too small to be addressed by
two seperate MSN particles. The 100 nm particles showed better performance than
the bigger particles with a diameter of 300 nm.
Figure 7.8: Analytical curves (a) for Dengue NS1 protein detection using particles and bare enzyme and a picture
of the immunoassay microplate. Comparison of the NS1 protein detection signal (b) of serum samples from the 2nd
to the 9th day of the infection after the onset of the symptoms.
The highest sensitivity is observed when using the particles at lower concentra-
tions, this indicates the potential of this system for early Dengue fever detection.
Libraty et al. showed that plasma levels of free Dengue-2 virus secreted NS1 protein
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by day of illness vary between 0.15-0.25 µg/mL for the second day of the disease for
patients infected with secondary infections and Dengue hemorrhagic fever. [17] This
means that the assay using the MSN particles is able to provide a more realiable
diagnosis in the first day of the infection in comparison to the conventional ELISA.
The assay based on the particles was also used to examine infected serum samples
after different days of the infection after the onset of the symptoms from the Dengue
type-2 virus epidemic in Santos, Brazil, from 2002. The Figure 7.8 shows that the
conventional assay provides higher signal in the second and third day of the infec-
tion, when the NS1 protein release reaches its highest concentration in the patient
blood. The graph follows the same behavior described by Libraty and colleages and
the maximum coincides with the viremia peak. On the other hand, for the first day
of the infection, and from the fifth day on, the immunoassay using particles provided
higher signals than the bare enzyme.
Based on these results, the immunoassay using MSNs does not only provide a
more stable label by using a molecular catalyst instead of a protein catalyst, but
also provides more reliable results for early (before second day) and late (after
5th day) detection. To benefit from these characteristics, an immunoassay to be
used in impoverished environments and providing more reliable and fast results was
developed based on immunospotting principles. The Figure 7.9 a shows a scheme
of the assay that includes the addition of only 6 µL of serum on a nitrocellulose
membrane.
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Figure 7.9: (a) Scheme of the immunospotting assay steps using a nitrocellulose membrane. Analytical curve (b)
for the NS1 protein detection using nitrocellulose membrane.
After blocking with BSA, the membrane is immersed in particle-anti-NS1 disper-
sion. The membrane, previously washed with Tween 20, is added into a tetramethyl-
benzidine (TMB) solution and the reaction is stopped after 15 min by the addition
of sulfuric acid. Subsequently the absorbance of the solution can be measured. This
assay is cheaper than the above described one, because less chemicals are used and
only one antibody is necessary, avoiding the necessity to find antibodies that bind to
different epitopes of the protein. The possibility of applying the sample directly to a
high surface area nitrocellulose membrane also allows the use of low sample volumes
and avoids the necessity of two antibodies for capture and detection. Furthermore,
the immunospotting assay allows diagnosing Dengue fever in less than one hour,
instead of 3 h for the conventional ELISA, with high specificity and sensitivity, less
complexity and using conventional apparatus in clinical analysis laboratories.
7.4 Conclusions
To conclude, we have shown the successful synthesis of MSN-hemincore-PEG-BSA-
streptavidinshell nanoparticles. These particles were tested regarding their ability to
act as a diagnostic label for the early stage detection of Dengue fever. Results ob-
tained for sandwich ELISA experiments revealed the high potential of these nanopar-
ticles for the detection of very low NS1 protein concentrations. When comparing
particle types with different sizes, better performance was obtained for smaller par-
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ticles with a mean diameter of 100 nm. In comparison to conventional enzyme-based
ELISA, these new particles showed better performance for low NS1 protein concen-
trations, whereas for higher concentrations the conventionals enzyme based ELISA
results higher signals. We attribute these observations to a particle hindrance effect
on the binding sites of the antibody coated well. Furthermore, the particles were
tested in a nitrocellulose-based detection approach where the ability to detect NS1
proteins could also be demonstrated.
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Chapter 8
Conclusions and Outlook
In the present work, different classes of nanometer-sized, mesoporous materials for
the use in biocatalysis, targeted drug delivery and immunoassay applications have
been developed.
In a first project, the impact of pore-wall modifications on the internal pH of meso-
porous silica systems was presented. It was shown that depending on the nature
of inner functionality, the pH inside the pores differs significantly from the pH in
an external buffer solution. By incorporation of catalytic systems into the pores,
the strong impact of different pore-wall modifications on the catalytic activity was
demonstrated. It is anticipated that with the knowledge about the impact of pore-
wall modification on the catalytic activity of incorporated catalysts, new high per-
formance catalyst systems can be developed.
In chapter 4, the synthesis of colloidal nanosized carbon spheres by a reverse opal
synthesis approach was discussed. After surface oxidation, these particles were
loaded with calcein and sealed with a supported lipid bilayer. The addition of
surfactant caused rupture of the bilayer and the dye was able to diffuse out of the
particles. To the best of our knowledge, we were the first group achieving an on
demand release system based on mesoporous carbon. In future experiments, this
drug delivery system has to be studied regarding its ability for targeted on demand
delivery of drugs in vitro as well as in vivo.
In chapter 5, we have developed a multifunctional drug delivery vehicle based on
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polymer-functionalized mesoporous silica nanoparticles. With this system, the pH-
responsive delivery of membrane-permeable as well as impermeable substances was
demonstrated. The addition of targeting ligands allowed the system to distinguish
between different cells. Biodistribution experiments in vivo revealed no agglomera-
tion and an almost complete excretion of the particles within 72 h after intravenous
administration in mice. In the future, this system should be further developed, to
achieve similar targeting efficacy in mice as has been obtained in single cell exper-
iments. We anticipate that the possible integration of almost any functionality of
interest, as well as the efficient synthesis makes this system a very promising ap-
proach for wide-ranging applications, especially in cancer therapy.
In a further project, this polymeric cap system was transferred to MOF nanoparti-
cles. We could demonstrate that it is possible to functionalize the nanoparticles with
poly(2-vinyl pyridine) without affecting the porosity, shape and crystallinity of the
nanoparticles. Finally, the ability of the system to act as a potential drug delivery
vehicle was demonstrated by in vitro release experiments of a model drug. In future
experiments, this drug delivery system should be studied regarding its ability for
targeted on demand delivery of drugs in vitro as well as in vivo.
Finally, knowlegde on catalysis and targeting of biomolecules obtained in this work
was used to create mesoporous silica nanoparticles for the detection of Dengue fever.
In comparison to conventional enzyme-based ELISA, these new particles showed
better detection performance for low Dengue-related NS1 protein concentrations.
Additionally, the particles were successfully used in a nitrocellulose-based detection
approach for NS1 proteins. In further experiments, this system could be further
refined to develop commercially viable low-cost detection systems.
In summary, the findings of this work expand the scope of applications of various
nanosized mesoporous particle-based systems. We could demonstrate that interdis-
ciplinary collaborations offer the possibility to develop new classes of materials with
unique properties. Additionally, we could gain a deeper understanding of host-guest
interactions, that offer a starting point for the development of high performance
catalysis and sensing devices.
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